Cinemark Usa 10-K 3 Mar 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Mar. 03, 2017	Jun. 30, 2016
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY
Trading Symbol	ck0000885975
Entity Registrant Name	CINEMARK USA INC /TX
Entity Central Index Key	885,975
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Public Float			$ 0
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,500
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		182,648

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents		$ 561,138	$ 588,503
Inventories		16,961	15,954
Accounts receivable		74,993	74,287
Current income tax receivable		7,367	22,877
Prepaid expenses and other		15,754	13,494
Accounts receivable from parent or subsidiaries		10,080	1,171
Total current assets		686,293	716,286
Theatre properties and equipment
Land		103,080	95,479
Buildings		474,453	453,034
Property under capital lease		383,826	336,666
Theatre furniture and equipment		1,089,040	929,180
Leasehold interests and improvements		1,009,355	873,032
Total		3,059,754	2,687,391
Less accumulated depreciation and amortization		1,355,218	1,182,322
Theatre properties and equipment, net		1,704,536	1,505,069
Other assets
Goodwill	[1]	1,262,963	1,247,548
Intangible assets - net		334,899	339,644
Investments in and advances to affiliates		98,317	94,973
Long-term deferred tax asset		2,051	2,114
Deferred charges and other assets - net		37,555	38,243
Total other assets		1,925,780	1,906,277
Total assets		4,316,609	4,127,632
Current liabilities
Current portion of long-term debt		5,671	8,405
Current portion of capital lease obligations		21,139	18,780
Current income tax payable		5,071	7,332
Current liability for uncertain tax positions		10,085	9,155
Accounts payable		110,150	108,844
Accrued film rentals		97,504	97,172
Accrued payroll		49,707	45,811
Accrued property taxes		33,043	31,719
Accrued other current liabilities		110,432	111,951
Total current liabilities		442,802	439,169
Long-term liabilities
Long-term debt, less current portion		1,782,441	1,772,930
Capital lease obligations, less current portion		234,281	208,952
Long-term deferred tax liability		135,014	139,905
Long-term liability for uncertain tax positions		8,105	7,853
Deferred lease expenses		42,378	43,333
Other long-term liabilities		43,580	60,105
Total long-term liabilities		2,589,727	2,575,212
Commitments and contingencies (see Note 15)
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Treasury stock, 57,245 Class B shares at cost		(24,233)	(24,233)
Additional paid-in-capital		1,252,715	1,238,473
Retained earnings		241,926	110,049
Accumulated other comprehensive loss		(247,013)	(271,686)
Total Cinemark USA, Inc. stockholder's equity		1,272,938	1,102,146
Noncontrolling interests		11,142	11,105
Total equity		1,284,080	1,113,251
Total liabilities and equity		4,316,609	4,127,632
NCM
Other assets
Investment in NCM		189,995	183,755
Long-term liabilities
Deferred revenue - NCM		343,928	342,134
Class B common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Total equity		$ 49,543	$ 49,543
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2016	Dec. 31, 2015
Treasury stock, shares at cost	57,245	57,245
Class A common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	1,500	1,500
Common stock, shares outstanding	1,500	1,500
Class B common stock
Common stock, par value
Common stock, shares authorized	1,000,000	1,000,000
Common stock, shares issued	239,893	239,893
Common stock, shares outstanding	182,648	182,648

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues
Admissions		$ 1,789,137	$ 1,765,519	$ 1,644,169
Concession		990,103	936,970	845,376
Other		139,525	150,120	137,445
Total revenues		2,918,765	2,852,609	2,626,990
Cost of operations
Film rentals and advertising		962,655	945,640	856,388
Concession supplies		154,469	144,270	131,985
Salaries and wages		325,765	301,099	273,880
Facility lease expense		321,294	319,761	317,096
Utilities and other		355,926	355,801	335,109
General and administrative expenses		140,637	154,052	148,588
Depreciation and amortization		209,071	189,206	175,656
Impairment of long-lived assets		2,836	8,801	6,647
Loss on sale of assets and other		20,459	8,143	15,715
Total cost of operations		2,493,112	2,426,773	2,261,064
Operating income		425,653	425,836	365,926
Other income (expense)
Interest expense	[1]	(108,313)	(112,741)	(113,698)
Interest income		6,396	8,708	5,599
Foreign currency exchange gain (loss)		6,455	(16,793)	(6,192)
Loss on debt amendments and refinancing		(13,445)	(925)	0
Distributions from NCM		14,656	18,140	18,541
Equity in income of affiliates		31,962	28,126	22,743
Total other income (expense)		(62,289)	(75,485)	(73,007)
Income before income taxes		363,364	350,351	292,919
Income taxes		104,851	129,960	97,150
Net income		258,513	220,391	195,769
Less: Net income attributable to noncontrolling interests		1,736	1,859	1,389
Net income attributable to Cinemark USA, Inc.		$ 256,777	$ 218,532	$ 194,380
[1]	Includes amortization of debt issue costs.

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Net income	$ 258,513	$ 220,391	$ 195,769
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,759, $1,562 and $138, net of settlements	234	2,636	2,846
Unrealized gain (loss) due to fair value adjustments on available-for-sale securities, net of taxes of $1,479 and $572 and $0		(957)	2,507
Other comprehensive income (loss) in equity method investments	89	(3,119)	676
Foreign currency translation adjustments	26,394	(125,512)	(68,997)
Total other comprehensive income (loss), net of tax	26,717	(126,952)	(62,968)
Total comprehensive income, net of tax	285,230	93,439	132,801
Comprehensive income attributable to noncontrolling interests	(1,769)	(1,821)	(1,374)
Comprehensive income attributable to Cinemark USA, Inc.	$ 283,461	$ 91,618	$ 131,427

Consolidated Statements of Com6

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Unrealized loss due to fair value adjustments on interest rate swap agreements, tax	$ 138	$ 1,562	$ 1,759
Unrealized gain (loss) due to fair value adjustments on available-for-sale securities, taxes	$ 0	$ 572	$ 1,479

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A common stock	Class B common stock	Treasury Stock	Additional Paid-in- Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Loss	Total Cinemark USA, Inc.'s Stockholder's Equity	Noncontrolling Interests
Stockholders' equity, Beginning Balance (in shares) at Dec. 31, 2013		2	240	(57)
Stockholders' equity, Beginning Balance at Dec. 31, 2013	$ 1,104,281		$ 49,543	$ (24,233)	$ 1,206,498	$ (54,703)	$ (81,819)	$ 1,095,286	$ 8,995
Share based awards compensation expense	11,875				11,875			11,875
Tax benefit related to stock option exercises and share based award vestings	2,806				2,806			2,806
Noncontrolling interests' share of acquired subsidiary	346								346
Dividends paid to parent	(115,000)					(115,000)		(115,000)
Dividends paid to noncontrolling interests	(386)								(386)
Net income	195,769					194,380		194,380	1,389
Other comprehensive loss	(62,968)						(62,953)	(62,953)	(15)
Stockholders' equity, Ending Balance (in shares) at Dec. 31, 2014		2	240	(57)
Stockholders' equity, Ending Balance at Dec. 31, 2014	1,136,723		$ 49,543	$ (24,233)	1,221,179	24,677	(144,772)	1,126,394	10,329
Share based awards compensation expense	14,873				14,873			14,873
Tax benefit related to stock option exercises and share based award vestings	2,421				2,421			2,421
Dividends paid to parent	(115,225)					(115,225)		(115,225)
Noncash dividends to parent	(17,935)					(17,935)		(17,935)
Dividends paid to noncontrolling interests	(1,045)								(1,045)
Net income	220,391					218,532		218,532	1,859
Other comprehensive loss	(126,952)						(126,914)	(126,914)	(38)
Stockholders' equity, Ending Balance (in shares) at Dec. 31, 2015		2	240	(57)
Stockholders' equity, Ending Balance at Dec. 31, 2015	1,113,251		$ 49,543	$ (24,233)	1,238,473	110,049	(271,686)	1,102,146	11,105
Share based awards compensation expense	12,413				12,413			12,413
Tax benefit related to stock option exercises and share based award vestings	1,856				1,856			1,856
Dividends paid to parent	(124,900)					(124,900)		(124,900)
Dividends paid to noncontrolling interests	(1,309)								(1,309)
Buyout of noncontrolling interests' share of Chilean subsidiary	(450)				(27)			(27)	(423)
Gain realized on available-for-sale securities, net of taxes of $1,180	(2,011)						(2,011)	(2,011)
Net income	258,513					256,777		256,777	1,736
Other comprehensive loss	26,717						26,684	26,684	33
Stockholders' equity, Ending Balance (in shares) at Dec. 31, 2016		2	240	(57)
Stockholders' equity, Ending Balance at Dec. 31, 2016	$ 1,284,080		$ 49,543	$ (24,233)	$ 1,252,715	$ 241,926	$ (247,013)	$ 1,272,938	$ 11,142

Consolidated Statements of Equ8

Consolidated Statements of Equity (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)
Gain realized on available-for-sale securities, taxes	$ 1,180

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating activities
Net income		$ 258,513	$ 220,391	$ 195,769
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		207,091	186,898	173,138
Amortization of intangible and other assets and favorable/unfavorable leases		1,980	2,308	2,518
Amortization of long-term prepaid rents		1,826	2,361	1,542
Amortization of debt issue costs		5,492	5,151	5,245
Amortization of deferred revenues, deferred lease incentives and other		(16,731)	(17,163)	(13,665)
Impairment of long-lived assets		2,836	8,801	6,647
Share based awards compensation expense		12,413	14,873	11,875
Loss on sale of assets and other		20,459	8,143	15,715
Write-off of unamortized debt issue costs associated with early retirement of debt		2,369
Deferred lease expenses		(990)	(1,806)	2,536
Equity in income of affiliates		(31,962)	(28,126)	(22,743)
Deferred income tax expenses		(5,467)	11,095	526
Distributions from equity investees	[1]	21,916	19,027	19,172
Changes in other assets and liabilities:
Inventories		(1,007)	(2,535)	400
Accounts receivable		(2,781)	(28,069)	31,027
Income tax receivable		15,510	(3,527)	(18,681)
Prepaid expenses and other		(2,260)	(2,612)	4,066
Deferred charges and other assets - net		(1,619)	8,126	19,713
Accounts payable and accrued expenses		(30,250)	43,859	33,674
Income tax payable		(2,261)	936	(15,685)
Liabilities for uncertain tax positions		1,182	1,315	(4,437)
Other long-term liabilities		(5,076)	5,779	5,776
Net cash provided by operating activities		451,183	455,225	454,128
Investing activities
Additions to theatre properties and equipment		(326,908)	(331,726)	(244,705)
Proceeds from sale of theatre properties and equipment and other		3,570	9,966	2,545
Acquisition of theatres in the U.S., net of cash acquired		(15,300)		(7,951)
Acquisition of screen advertising business		(1,450)		(1,040)
Proceeds from sale of marketable securities		13,451
Investment in joint ventures and other		(1,132)	(3,711)	(2,188)
Net cash provided by (used for) investing activities		(327,769)	(328,122)	(253,339)
Financing activities
Dividends paid to parent		(124,900)	(115,225)	(115,000)
Payroll taxes paid as a result of restricted stock withholdings		(6,834)	(4,770)	(9,861)
Proceeds from issuance of other Senior Notes, net of discount		222,750
Retirement of Senior Subordinated Notes		(200,000)
Repayments of long-term debt		(16,605)	(8,420)	(9,846)
Payment of debt issue costs		(7,217)	(6,957)
Payments on capital leases		(19,343)	(16,513)	(14,035)
Purchases of non-controlling interests		(450)
Other		554	1,376	2,422
Net cash provided by (used for) financing activities		(152,045)	(150,509)	(146,320)
Effect of exchange rates on cash and cash equivalents		1,266	(26,932)	(15,522)
Increase (decrease) in cash and cash equivalents		(27,365)	(50,338)	38,947
Cash and cash equivalents:
Beginning of year		588,503	638,841	599,894
End of year		$ 561,138	588,503	$ 638,841
Brazil Theatre
Investing activities
Acquisition of theatre in Brazil			$ (2,651)
[1]	Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. In an effort to more closely align our reported Adjusted EBITDA with our operating cash flow, which provides our chief operating decision maker with more comprehensive cash flow information, beginning with the year ended December 31, 2016, Adjusted EBITDA now includes total cash distributions received from equity investees, including the cash distributions recorded as a reduction of the respective investment balance. Adjusted EBITDA for the years ended December 31, 2014 and 2015 has been adjusted to reflect comparable presentations.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2016
Summary of Significant Accounting Policies	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business Principles of Consolidation Cash and Cash Equivalents Accounts Receivable – non-income Inventories (first-in, first-out Theatre Properties and Equipment Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital lease (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) Amortization of capital lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital lease assets as of December 31, 2015 and 2016 was $150,968 and $175,166, respectively. The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, the impact of recent theatre remodels or other substantial improvements, available lease renewal options and other factors considered relevant in its assessment of impairment of individual theatre assets. Long-lived assets are evaluated for impairment on an individual theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the available remaining lease period, which includes the probability the exercise of available renewal periods or extensions, for leased properties and the lesser of twenty years or the building’s remaining useful life for fee-owned 820-10-35, Goodwill and Other Intangible Assets two-step 820-10-35, For the year ended December 31, 2015, the Company performed a qualitative goodwill impairment assessment on all reporting units except one, in accordance with ASU 2011-08 Testing Goodwill for Impairment 2011-08”). two-step For the year ended December 31, 2016, the Company performed a qualitative goodwill impairment assessment on all reporting units. Based on the qualitative assessment performed, the Company determined that it was not more likely than not that the fair value of the reporting units were less than their carrying values. Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. During 2014, the Company estimated the fair value of its tradenames by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, 2011-08. For the year ended December 31, 2016, the Company also performed a quantitative test on our definite-lived tradename associated with the Rave theatres acquired in 2013. During the year ended December 31, 2016, the Company rebranded certain of these theatres with Cinemark signage as part of recliner conversions and other renovations. The Company estimated the fair value of the Rave tradename by applying an estimated market royalty rate that could be charged for the use of the tradename to forecasted future revenues for the theatres using the Rave tradename, with an adjustment for the present value of such royalties. As of December 31, 2016, the estimated fair value of the Rave tradename intangible asset exceeded their carrying value by more than 10%. The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from one to four years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately three to twenty years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to ten years. Deferred Charges and Other Assets Lease Accounting Deferred Revenues Self-Insurance Reserves — Revenue and Expense Recognition on-screen in-theatre. Film rental costs are accrued based on the applicable box office receipts and either firm terms or a sliding scale formula, which are generally established prior to the opening of the film, or estimates of the final rate, which occurs at the conclusion of the film run, subject to the film licensing arrangement. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. Under a sliding scale formula, film rental is paid as a percentage of box office revenues using a pre-determined Loyalty Programs app-based sign-up Accounting for Share Based Awards Income Taxes — two-step more-likely-than-not examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not Segments Use of Estimates Foreign Currency Translations Fair Value Measurements — Goodwill and Other Intangible Assets Theatre Properties and Equipment Acquisitions Accounting Reclassifications The Company has reclassified $26,664 and $30,950 in expenses from film rentals and advertising costs to utilities and other costs on the consolidated statements of income for the years ended December 31, 2014 and 2015, respectively, to be consistent with the presentation for the year ended December 31, 2016. During the year ended December 31, 2016, the Company determined that reclassifying the expenses, which are related to the maintenance and monitoring of projection and sound equipment, results in a more clear presentation of film rentals and advertising costs.

New Accounting Pronouncements

New Accounting Pronouncements	12 Months Ended
	Dec. 31, 2016
New Accounting Pronouncements	2. NEW ACCOUNTING PRONOUNCEMENTS In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606), 2014-09”). 2014-09 2014-09 2014-09 2014-09: • In August 2015, the FASB issued Accounting Standards Update 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date 2015-14”). ASU 2015-14 2014-09: 2014-09). The 2014-09 • In March 2016, the FASB issued Accounting Standards Update 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenues Gross versus Net) 2016-08”). 2016-08 • In April 2016, the FASB issued Accounting Standards Update 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing 2016-10”). 2016-10 • In May 2016, the FASB issued Accounting Standards Update 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients 2016-12”). 2016-12 • In December 2016, the FASB issued Accounting Standards Update 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers 2016-20”). 2016-20 2014-09 The amendments in these accounting standards updates may be applied either using a modified retrospective transition method by means of a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year in which the guidance is effective or retrospectively to each period presented. Early adoption is permitted. The Company will adopt the amendments within these accounting standards updates in the first quarter of 2018. The Company is currently evaluating the impact of these accounting standards updates on its consolidated financial statements, specifically with respect to the Company’s Exhibitor Services Agreement with NCM, loyalty program accounting, breakage income for stored value cards as well as other ancillary and contractual revenues. In February 2015, the FASB issued Accounting Standards Update 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis 2015-02”). 2015-02 2015-02 reporting entities that are involved with certain VIEs. ASU 2015-02 2a-7 2015-02 2015-02, In February 2016, the FASB issued Accounting Standards Update 2016-02, Leases (Topic 842) 2016-02”). 2016-02 2016-02 right-of-use 2016-02 2016-02 2016-02 In March 2016, the FASB issued Accounting Standards Update 2016-04, Liabilities – Extinguishment of Liabilities (Subtopic 405-20) 2016-04”). 2016-04 405-20 2016-04 2016-04 2016-04 In March 2016, the FASB issued Accounting Standards Update 2016-07, Investments – Equity Method and Joint Ventures (Topic 323) 2016-07”). 2016-07 step-by-step 2016-07 2016-07 2016-07 In March 2016, the FASB issued Accounting Standards Update 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting 2016-09”). 2016-09 2016-09 2016-09. 2016-09 2016-09, 2016-09. In August 2016, the FASB issued Accounting Standards Update 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments – a consensus of the FASB Emerging Issues Task Force 2016-15”). 2016-15 2016-15 2016-15. If 2016-15 In October 2016, the FASB issued Accounting Standards Update 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory 2016-16”). 2016-16 2016-16 transition method should be used in the application of the amendments within ASU 2016-16 2016-16 In November 2016, the FASB issued Accounting Standards Update 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash – a consensus of the FASB Emerging Issues Task Force 2016-18”). 2016-18 2016-18 beginning-of-period end-of-period 2016-18 2016-18 2016-18 In January 2017, the FASB issued Accounting Standards Update 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business 2017-01”). 2017-01 2017-01 2017-01 2017-01 In January 2017, the FASB issued Accounting Standards Update 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment 2017-04”). 2017-04 two-step 2017-04 2017-04

Investment in National CineMedi

Investment in National CineMedia Llc	12 Months Ended
	Dec. 31, 2016
NCM
Investment in National CineMedia Llc	3. INVESTMENT IN NATIONAL CINEMEDIA LLC The Company has an investment in National CineMedia, LLC (“NCM”). NCM operates a digital in-theatre non-film on-screen off-screen eighty-two forty-one on-screen As a result of the application of a portion of the proceeds it received from the NCMI initial public offering, the Company had a negative basis in its original membership units in NCM, which is referred to herein as the Company’s Tranche 1 Investment. Following the NCMI IPO, the Company does not recognize undistributed equity in the earnings on its Tranche 1 Investment until NCM’s net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM. The Company believes that the accounting model provided by ASC 323-10-35-22 Common Unit Adjustments Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, AMC and Regal, which we refer to collectively as the Founding Members, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. To account for the receipt of additional common units under the Common Unit Adjustment Agreement, we follow the guidance in FASB ASC 323-10-35-29 EITF 02-18, “Accounting for Subsequent Investments in an Investee after Suspension of Equity Loss Recognition” Below is a summary of common units received by the Company under the Common Unit Adjustment Agreement during the years ended December 31, 2014, 2015 and 2016. Date Number Fair Value Event Received Received Received 2014 Annual common unit adjustment 03/27/14 557,631 $ 8,216 2015 Annual common unit adjustment 03/31/15 1,074,910 $ 15,421 2016 Annual common unit adjustment 03/31/16 753,598 $ 11,111 Each common unit received by the Company is convertible into one share of NCMI common stock. The fair value of the common units received was estimated based on the market price of NCMI stock at the time that the common units were received, adjusted for volatility associated with the estimated period of time it would take to convert the common units and register the respective shares. The fair value measurement used for the common units falls under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC Topic 820-10-35. As of December 31, 2016, the Company owned a total of 26,384,644 common units of NCM, which represented an interest of approximately 19%. Each common unit is convertible into one share of NCMI common stock. The estimated fair value of the Company’s investment in NCM was approximately $388,646 as of December 31, 2016, based on NCMI’s stock price as of December 31, 2016 of $14.73 per share. Summary of Activity with NCM Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. Other Investment Deferred Distributions Equity in Other Comprehensive Cash in NCM Revenue from NCM Earnings Revenue (Income) Loss Received Balance as of January 1, 2014 $ 178,853 $ (334,429 ) Receipt of common units due to annual common unit adjustment 8,216 (8,216 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (9,249 ) — 9,249 Receipt of excess cash distributions (12,574 ) — (14,778 ) — — — 27,352 Receipt under tax receivable agreement (2,594 ) — (3,763 ) — — — 6,357 Equity in earnings 6,142 — — (6,142 ) — — — Equity in other comprehensive income 896 — — — — (896 ) — Amortization of deferred revenue — 7,426 — — (7,426 ) — — Balance as of and for the period ended December 31, 2014 $ 178,939 $ (335,219 ) $ (18,541 ) $ (6,142 ) $ (16,675 ) $ (896 ) $ 42,958 Receipt of common units due to annual common unit adjustment 15,421 (15,421 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,330 ) — 11,330 Receipt of excess cash distributions (14,072 ) — (15,396 ) — — — 29,468 Receipt under tax receivable agreement (2,308 ) — (2,744 ) — — — 5,052 Equity in earnings 8,510 — — (8,510 ) — — — Equity in other comprehensive loss (2,735 ) — — — — 2,735 — Amortization of deferred revenue — 8,506 — — (8,506 ) — — Balance as of and for the period ended December 31, 2015 $ 183,755 $ (342,134 ) $ (18,140 ) $ (8,510 ) $ (19,836 ) $ 2,735 $ 45,850 Receipt of common units due to annual common unit adjustment 11,111 (11,111 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,048 ) — 11,048 Receipt of excess cash distributions (11,233 ) — (11,483 ) — — — 22,716 Receipt under tax receivable agreement (2,985 ) — (3,173 ) — — — 6,158 Equity in earnings 9,347 — — (9,347 ) — — — Amortization of deferred revenue — 9,317 — — (9,317 ) — — Balance as of and for the period ended December 31, 2016 $ 189,995 $ (343,928 ) $ (14,656 ) $ (9,347 ) $ (20,365 ) $ — $ 39,922 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen on-screen On May 5, 2014, NCMI announced that it had entered into a merger agreement to acquire Screenvision, LLC. On November 3, 2014, the U.S. Department of Justice (“DOJ”) filed an antitrust lawsuit seeking to enjoin the proposed merger between NCMI and Screenvision, LLC. On March 16, 2015, NCMI announced that it had agreed with Screenvision, LLC to terminate the merger agreement. The termination of the merger agreement resulted in a $26.8 million termination payment to Screenvision by NCMI. NCM indemnified NCMI for the termination fee. The impact of the termination payment and related merger costs resulted in NCM not making an excess cash distribution to its shareholders for the first quarter of 2015 and reduced the distribution for the second quarter of 2016, as required by NCM’s Amended and Restated Operating Agreement The Company made payments to NCM of approximately $124, $50 and $49 during the years ended December 31, 2014, 2015 and 2016, respectively, related to installation of certain equipment used for digital advertising, which is included in theatre furniture and equipment on the consolidated balance sheets. The tables below present summary financial information for NCM for the periods indicated (financial information for NCM’s fiscal year ended December 29, 2016 is not yet available). Year Ended Nine Months Ended January 1, 2015 December 31, 2015 September 29, 2016 Gross revenues $ 393,994 $ 446,463 $ 305,101 Operating income $ 159,624 $ 140,498 $ 100,911 Net income $ 96,309 $ 87,474 $ 49,619 As of December 31, 2015 As of September 29, 2016 Total assets $ 782,579 $ 758,607 Total liabilities $ 1,049,145 $ 1,007,704

Other Investments

Other Investments	12 Months Ended
	Dec. 31, 2016
Other Investments	4. OTHER INVESTMENTS Below is a summary of activity for each of the Company’s other investments for the periods indicated. DCIP RealD AC JV, DCDC Other Total Balance at January 1, 2014 $ 38,033 $ 10,443 $ 6,426 $ 2,589 $ 2,166 $ 59,657 Cash contributions 2,188 — — — — 2,188 Equity in income (loss) 15,279 — 1,473 (151 ) — 16,601 Equity in other comprehensive loss (219 ) — — — — (219 ) Unrealized holding gain — 3,986 — — — 3,986 Cash distributions received (4,004 ) — — — — (4,004 ) Other — — — — (551 ) (551 ) Balance at December 31, 2014 $ 51,277 $ 14,429 $ 7,899 $ 2,438 $ 1,615 $ 77,658 Cash contributions 3,211 — — — 500 3,711 Equity in income 18,522 — 970 124 — 19,616 Equity in other comprehensive loss (384 ) — — — — (384 ) Unrealized holding loss — (1,529 ) — — — (1,529 ) Sale of investment in Taiwan (1) — — — — (1,383 ) (1,383 ) Cash distributions received (1,047 ) — (1,600 ) — — (2,647 ) Other — — — — (69 ) (69 ) Balance at December 31, 2015 $ 71,579 $ 12,900 $ 7,269 $ 2,562 $ 663 $ 94,973 Cash contributions 717 — — — — 717 Equity in income 21,434 — 311 870 — 22,615 Equity in other comprehensive income 89 — — — — 89 Sale of investment (2) — (12,900 ) — — — (12,900 ) Cash distributions received (6,000 ) — (1,600 ) (98 ) — (7,698 ) Other — — — (584 ) 1,105 521 Balance at December 31, 2016 $ 87,819 $ — $ 5,980 $ 2,750 $ 1,768 $ 98,317 (1) The Company sold its investment in a Taiwan joint venture for $2,634, resulting in a gain of $1,251, which is included in loss on sale of assets and other for the year ended December 31, 2015. (2) See further discussion of the sale of the investment held by the Company under RealD, Inc Digital Cinema Implementation Partners LLC (“DCIP”) On February 12, 2007, the Company, AMC and Regal entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. As of December 31, 2016, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting. Below is summary financial information for DCIP as of and for the years ended December 31, 2014, 2015 and 2016. Year ended December 31, 2014 2015 2016 Net operating revenue $ 170,724 $ 171,203 $ 178,836 Operating income $ 101,956 $ 103,449 $ 107,919 Net income $ 61,293 $ 79,255 $ 89,152 As of December 31, 2015 December 31, 2016 Total assets $ 1,004,757 $ 906,377 Total liabilities $ 675,192 $ 509,197 The digital projection systems are being leased from Kasima LLC (“Kasima”), which is an indirect subsidiary of DCIP and a related party to the Company, under an operating lease with an initial term of twelve years that contains ten one-year Year Ended December 31, 2014 2015 2016 Equipment lease payments $ 4,012 $ 4,474 $ 5,217 Warranty reimbursements from DCIP $ (3,169 ) $ (4,329 ) $ (6,091 ) Management services fees $ 782 $ 825 $ 825 RealD, Inc. (“RealD”) The Company licenses 3-D 3-D The Company owned 1,222,780 shares of RealD and accounted for its investment in RealD as a marketable security, specifically an available-for-sale 320-10-35-1, On March 22, 2016, an affiliate of Rizvi Traverse Management, LLC acquired RealD for $11.00 per share. As a result of the transaction, the Company sold its shares for approximately $13,451 and recognized a gain of $3,742, which included the recognition of a cumulative unrealized holding gain of $3,191 previously recorded in accumulated other comprehensive loss. The gain is reflected within loss on sale of assets and other on the consolidated statement of income for the year ended December 31, 2016. The Company used the proceeds to make a pre-payment AC JV, LLC During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a new joint venture that now owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded includes live and pre-recorded AC was formed by the AC Founding Members and NCM. NCM, under a contribution agreement, contributed the assets associated with its Fathom Events division to AC in exchange for 97% ownership of the Class A Units of AC. Under a separate contribution agreement, the Founding Members each contributed cash of approximately $268 to AC in exchange for 1% of the Class A Units of AC. Subsequently, NCM and the Founding Members entered into a Membership Interest Purchase Agreement, under which NCM sold each of the Founding Members 31% of its Class A Units in AC, the aggregate value of which was determined to be $25,000, in exchange for a six-year Digital Cinema Distribution Coalition The Company is a party to a joint venture with certain exhibitors and distributors called Digital Cinema Distribution Coalition (“DCDC”). DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $741, $807 and $939 to DCDC during the years ended December 31, 2014, 2015 and 2016, respectively, related to content delivery services, which is included in film rentals and advertising costs on the consolidated statements of income.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets - Net	12 Months Ended
	Dec. 31, 2016
Goodwill and Other Intangible Assets - Net	5. GOODWILL AND OTHER INTANGIBLE ASSETS — NET The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at December 31, 2014 (1) $ 1,156,556 $ 120,827 $ 1,277,383 Acquisition of Brazil theatre — 356 356 Foreign currency translation adjustments — (30,191 ) (30,191 ) Balance at December 31, 2015 (1) $ 1,156,556 $ 90,992 $ 1,247,548 Acquisition of U.S. theatres 7,607 — 7,607 Other acquisitions (2) — 1,410 1,410 Foreign currency translation adjustments — 6,398 6,398 Balance at December 31, 2016 (1) $ 1,164,163 $ 98,800 $ 1,262,963 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) Acquisition of screen advertising companies in Central America and Colombia. As of December 31, intangible assets-net, December 31, Amortization Other (1) December 31, Intangible assets with finite lives: Gross carrying amount $ 99,922 $ — $ 46 $ 99,968 Accumulated amortization (52,232 ) (5,716 ) (1,758 ) (59,706 ) Total net intangible assets with finite lives $ 47,690 $ (5,716 ) $ (1,712 ) $ 40,262 Intangible assets with indefinite lives: Tradename 300,334 — (952 ) 299,382 Total intangible assets — net $ 348,024 $ (5,716 ) $ (2,664 ) $ 339,644 December 31, Additions (2) Amortization Other (1) December 31, Intangible assets with finite lives: Gross carrying amount $ 99,968 $ 503 $ — $ (675 ) $ 99,796 Accumulated amortization (59,706 ) — (5,538 ) 638 (64,606 ) Total net intangible assets with finite lives $ 40,262 503 $ (5,538 ) $ (37 ) $ 35,190 Intangible assets with indefinite lives: Tradename 299,382 — — 327 299,709 Total intangible assets — net $ 339,644 $ 503 $ (5,538 ) $ 290 $ 334,899 (1) Activity for 2015 primarily consists of the write-off write-off write-off (2) Activity for 2016 reflects addition of non-compete Estimated aggregate future amortization expense for intangible assets is as follows: For the year ended December 31, 2017 $ 4,887 For the year ended December 31, 2018 4,835 For the year ended December 31, 2019 3,973 For the year ended December 31, 2020 4,304 For the year ended December 31, 2021 2,189 Thereafter 15,002 Total $ 35,190

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets	12 Months Ended
	Dec. 31, 2016
Impairment of Long-Lived Assets	6. IMPAIRMENT OF LONG-LIVED ASSETS The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See Note 1 for discussion of the Company’s impairment policy. The Company’s long-lived asset impairment losses are summarized in the following table: Year Ended December 31, 2014 2015 2016 United States theatre properties $ 6,168 $ 7,052 $ 1,929 International theatre properties — 757 907 Subtotal 6,168 7,809 2,836 Intangible assets (see Note 5) 479 992 — Impairment of long-lived assets $ 6,647 $ 8,801 $ 2,836 The long-lived asset impairment charges recorded during each of the years presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. As of December 31, 2016, the estimated aggregate remaining fair value of the long-lived assets impaired during the year ended December 31, 2016 was approximately $1,595.

Deferred Charges and Other Asse

Deferred Charges and Other Assets - Net	12 Months Ended
	Dec. 31, 2016
Deferred Charges and Other Assets - Net	7. DEFERRED CHARGES AND OTHER ASSETS — NET As of December 31, deferred charges and other assets — net consisted of the following: December 31, 2015 2016 Long-term prepaid rents $ 4,278 $ 5,996 Construction and other deposits 8,459 10,881 Equipment to be placed in service 15,388 12,856 Other 10,118 7,822 Total $ 38,243 $ 37,555

Long-Term Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2016
Long-Term Debt	8. LONG-TERM DEBT As of December 31, long-term debt consisted of the following: December 31, 2015 2016 Cinemark USA, Inc. term loan $ 679,000 $ 663,799 Cinemark USA, Inc. 4.875% senior notes due 2023 530,000 755,000 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 400,000 Cinemark USA, Inc. 7.375% senior subordinated notes due 2021 200,000 — Other (1) 5,572 4,167 Total long-term debt 1,814,572 1,822,966 Less current portion 8,405 5,671 Less debt issuance costs, net of accumulated amortization of $16,058 and $19,364, respectively 33,237 34,854 Long-term debt, less current portion $ 1,772,930 $ 1,782,441 (1) Primarily represents debt owed to NCM in relation to the recently-formed joint venture AC JV, LLC. See Note 4. Senior Secured Credit Facility Cinemark USA, Inc. has a senior secured credit facility that includes a seven year $700,000 term loan and a five year $100,000 revolving credit line (the “Credit Agreement”). On May 8, 2015, Cinemark USA, Inc. amended its Credit Agreement to extend the maturity of the $700,000 term loan from December 2019 to May 2022. After the amendment, quarterly principal payments in the amount of $1,750 were due on the term loan through March 31, 2022, with the remaining principal of $635,250 due on May 8, 2022. The Company incurred debt issue costs of approximately $6,957 in connection with the amendment, which is reflected as a reduction of long-term debt on the consolidated balance sheets. In addition, the Company incurred approximately $925 in legal and other fees that are reflected as loss on debt amendments and refinancing on the consolidated statement of income for the year ended December 31, 2015. On May 16, 2016, Cinemark USA, Inc. made a pre-payment pre-payment pro-rata pre-payment. On June 13, 2016 and December 15, 2016, Cinemark USA, Inc. amended its Credit Agreement to reduce the rate at which the term loan bears interest by 0.25% and then an additional 0.50%, respectively. The Company incurred debt issue costs of approximately $3,515 in connection with these amendments, which are reflected as a reduction of long term debt on the consolidated balance sheet as of December 31, 2016. In addition, the Company incurred approximately $410 in legal and other fees that are reflected as loss on debt amendments and refinancing on the consolidated statement of income for the year ended December 31, 2016. Interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month one-month Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries. The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to satisfy a consolidated net senior secured leverage ratio covenant as defined in the Credit Agreement. The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts. As of December 31, 2016, Cinemark USA, Inc. could have distributed up to approximately $2,390,400 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the Credit Agreement, subject to its available cash and other borrowing restrictions outlined in the agreement. At December 31, 2016, there was $663,799 outstanding under the term loan and no borrowings outstanding under the revolving credit line. Cinemark USA, Inc. had $100,000 in available borrowing capacity on the revolving credit line. Cinemark USA, Inc. had no borrowings under the revolving credit line during the years ended December 31, 2015 or 2016. The average interest rate on outstanding term loan borrowings under the Credit Agreement at December 31, 2016 was approximately 3.0% per annum. 4.875% Senior Notes On May 24, 2013, Cinemark USA, Inc. issued $530,000 aggregate principal amount of 4.875% senior notes due 2023, at par value, (the “4.875% Senior Notes”). Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year. The 4.875% Senior Notes mature on June 1, 2023. On March 21, 2016, Cinemark USA, Inc. issued an additional $225,000 aggregate principal amount of the 4.875% Senior Notes, at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. Proceeds, after payment of fees, were used to finance the redemption of Cinemark, USA, Inc.’s previously outstanding $200,000 7.375% senior subordinated notes due 2021 (the “7.375% Senior Subordinated Notes”), as discussed below. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as Cinemark USA, Inc.’s existing 4.875% Senior Notes. The aggregate principal amount of $755,000 of 4.875% Senior Notes mature on June 1, 2023. The Company incurred debt issue costs of approximately $3,702 in connection with the issuance of the additional notes, which, along with the discount of $2,250, are reflected as a reduction of long term debt, net of accumulated amortization, on the consolidated balance sheet as of December 31, 2016. On April 5, 2016, Cinemark USA, Inc. and its guarantor subsidiaries filed a registration statement with the Securities and Exchange Commission (the “Commission”), pursuant to which Cinemark USA, Inc. offered to exchange the additional 4.875% Senior Notes for substantially identical notes registered under the Securities Act of 1933, as amended, that do not contain terms restricting the transfer thereof or providing for registration rights. The registration statement was declared effective April 18, 2016, and the notes were exchanged on May 17, 2016. The 4.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 4.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior subordinated debt. The 4.875% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 4.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 4.875% Senior Notes. The indenture to the 4.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2016, Cinemark USA, Inc. could have distributed up to approximately $2,261,788 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 4.875% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 4.875% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 4.875% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2016 was approximately 6.3 to 1. Prior to June 1, 2018, Cinemark USA, Inc. may redeem all or any part of the 4.875% Senior Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 4.875% Senior Notes to the date of redemption. After June 1, 2018, Cinemark USA, Inc. may redeem the 4.875% Senior Notes in whole or in part at redemption prices specified in the indenture. 5.125% Senior Notes On December 18, 2012, Cinemark USA, Inc. issued $400,000 aggregate principal amount of 5.125% senior notes due 2022, at par value (the “5.125% Senior Notes”). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022. The 5.125% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.125% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future subordinated debt. The 5.125% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 5.125% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 5.125% Senior Notes. The indenture to the 5.125% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2016, Cinemark USA, Inc. could have distributed up to approximately $2,266,521 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 5.125% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 5.125% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.125% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2015 was approximately 6.4 to 1. Prior to December 15, 2017, Cinemark USA, Inc. may redeem all or any part of the 5.125% Senior Notes at its option at 100% of the principal amount plus a make-whole premium. After December 15, 2017, Cinemark USA, Inc. may redeem the 5.125% Senior Notes in whole or in part at redemption prices described in the 5.125% Senior Notes. In addition, Cinemark USA, Inc. may redeem up to 35% of the aggregate principal amount of the 5.125% Senior Notes from the net proceeds of certain equity offerings at the redemption price set forth in the 5.125% Senior Notes. 7.375% Senior Subordinated Notes On June 3, 2011, Cinemark USA, Inc. issued $200,000 aggregate principal amount of 7.375% senior subordinated notes due 2021, at par value (the “Senior Subordinated Notes”). On March 21, 2016, Cinemark USA, Inc. redeemed its Senior Subordinated Notes at a make-whole premium of approximately 104% plus accrued and unpaid interest, utilizing the proceeds from the issuance of the additional $225,000 Cinemark USA, Inc. 4.875% Senior Notes discussed above. As a result of the redemption, the Company wrote-off Fair Value of Long Term Debt The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35. Covenant Compliance and Debt Maturity As of December 31, 2016, the Company believes it was in full compliance with all agreements, including related covenants, governing its outstanding debt. The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2016 matures as follows: 2017 $ 5,671 2018 7,099 2019 7,099 2020 5,710 2021 5,710 Thereafter 1,791,677 Total $ 1,822,966

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2016
Fair Value Measurements	9. FAIR VALUE MEASUREMENTS The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows: Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date; Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available. As of December 31, 2016, the Company did not have any assets or liabilities measured at fair value on a recurring basis under FASB ASC Topic 820. Below is a summary of assets and liabilities measured at fair value on a recurring basis as of December 31, 2015. Carrying Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities – current (1) $ (373 ) $ — $ — $ (373 ) Investment in RealD (2) $ 12,900 $ 12,900 $ — $ — (1) The Company was previously party to an interest rate swap agreement. That agreement expired in April 2016. (2) The Company’s investment in RealD was sold in March of 2016. See discussion at Note 6. Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3). Liabilities 2015 2016 Beginning balances - January 1 $ 4,572 $ 373 Total (gain) loss included in accumulated other comprehensive loss (155 ) 71 Settlements (4,790 ) (444 ) Ending balances – December 31 $ 373 $ — The Company also uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 5 and Note 6). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 8). There were no changes in valuation techniques during the period. There were no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2014, 2015 and 2016.

Foreign Currency Translation

Foreign Currency Translation	12 Months Ended
	Dec. 31, 2016
Foreign Currency Translation	10. FOREIGN CURRENCY TRANSLATION The accumulated other comprehensive loss account in stockholder’s equity of $271,686 and $247,013 at December 31, 2015 and 2016, respectively, includes the cumulative foreign currency losses of $273,407 and $247,046, respectively, from translating the financial statements of the Company’s international subsidiaries, the change in fair values of the Company’s interest rate swap agreements that were designated as hedges and the changes in fair value of the Company’s previously held available-for-sale All foreign countries where the Company has operations are non-highly Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries as of and for the years ended December 31, 2014, 2015 and 2016. Other Comprehensive Country Exchange Rates as of December 31, Income (Loss) For Year Ended December 31, 2014 2015 2016 2014 2015 2016 Brazil 2.69 3.96 3.26 $ (30,723 ) $ (74,559 ) $ 37,286 Argentina 8.55 12.95 16.04 (20,197 ) (30,520 ) (13,362 ) Colombia 2,392.46 3,149.47 3,000.71 (7,632 ) (8,043 ) 1,278 Chile 606.2 709.16 679.09 (5,580 ) (6,572 ) 1,855 Peru 3.05 3.46 3.45 (2,785 ) (4,882 ) 87 All other (2,066 ) (898 ) (783 ) $ (68,983 ) $ (125,474 ) $ 26,361

Noncontrolling Interests in Sub

Noncontrolling Interests in Subsidiaries	12 Months Ended
	Dec. 31, 2016
Noncontrolling Interests in Subsidiaries	11. NONCONTROLLING INTERESTS IN SUBSIDIARIES Noncontrolling interests in subsidiaries of the Company were as follows at December 31: December 31, 2015 2016 Cinemark Partners II — 24.6% interest (in one theatre) $ 7,753 $ 8,249 Laredo Theatres – 25% interest (in two theatres) 1,761 1,695 Greeley Ltd. — 49% interest (in one theatre) 740 689 Other 851 509 Total $ 11,105 $ 11,142 During December 2016 the Company purchased the remaining 25% noncontrolling interest of one of its Chilean subsidiaries, Flix Impirica S.A. (“Flix Impirica”), for approximately $450 in cash. The increase in the Company’s ownership interest in the Chilean subsidiary was accounted for as an equity transaction in accordance with ASC Topic 810-10-45-23. paid-in-capital Below is a summary of the impact of changes in the Company’s ownership interest in its subsidiaries on its equity. Year ended December 31, 2014 2015 2016 Net income attributable to Cinemark USA, Inc. $ 194,380 $ 218,532 $ 256,777 Transfers from noncontrolling interests Decrease in Cinemark USA, Inc. additional paid-in-capital non-controlling — — (27 ) Net transfers from non-controlling — — (27 ) Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests $ 194,380 $ 218,532 $ 256,750

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2016
Capital Stock	12. CAPITAL STOCK Common and Preferred Stock — pro-rata The Company has 1,000,000 shares of preferred stock, $1.00 par value, authorized with none issued or outstanding. The rights and preferences of preferred stock will be determined by the Board of Directors at the time of issuance. The Company’s ability to pay dividends is effectively limited by the terms of its senior notes indentures, its senior notes indentures and its senior secured credit facility, which also significantly restricts the ability of certain of the Company’s subsidiaries to pay dividends directly or indirectly to it. See Note 8. Furthermore, certain of the Company’s foreign subsidiaries currently have a deficit in retained earnings which prevents the Company from declaring and paying dividends from those subsidiaries. Stock Options Restricted Stock Year Ended Year Ended Year Ended December 31, 2014 December 31, 2015 December 31, 2016 Shares of Weighted Shares of Weighted Shares of Weighted Outstanding at January 1 1,260,913 $ 21.86 878,897 $ 24.92 757,775 $ 30.73 Granted 269,774 $ 28.93 226,212 $ 42.79 335,707 $ 30.98 Vested (625,843 ) $ 20.53 (329,437 ) $ 23.72 (430,056 ) $ 26.60 Forfeited (25,947 ) $ 22.94 (17,897 ) $ 27.58 (56,808 ) $ 33.81 Outstanding at December 31 878,897 $ 24.92 757,775 $ 30.73 606,618 $ 33.51 During the year ended December 31, 2016, Cinemark Holdings, Inc. granted 335,707 shares of restricted stock to its directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of Cinemark Holdings, Inc.’s common stock on the date of grant, which ranged from $29.83 to $38.47 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards. Restricted stock granted to directors vests over a one-year Below is a summary of restricted stock award activity recorded for the periods indicated. Year Ended December 31, 2014 2015 2016 Compensation expense recognized during the period (1) $ 8,591 $ 8,715 $ 7,269 Fair value of restricted shares that vested during the period (2) $ 17,692 $ 13,276 $ 13,739 Income tax deduction upon vesting of restricted stock awards (3) $ 5,171 $ 3,341 $ 5,167 (1) Cinemark Holdings, Inc. recorded an additional $943, $885 and $981 of compensation expense related to these restricted stock awards during the years ended December 31, 2014, 2015 and 2016, respectively. (2) The fair value of shares in which Cinemark Holdings, Inc.’s directors vested was $1,081, $1,148 and $923 during the years ended December 31, 2014, 2015 and 2016, respectively. (3) Cinemark Holdings, Inc. recognized an additional tax benefit of $454, $482 and $388 on these vested awards during the years ended December 31, 2014, 2015 and 2016, respectively. As of December 31, 2016, the remaining unrecognized compensation expense related to these restricted stock awards was approximately $12,328, of which $11,976 will be recognized by the Company and $352 will be recognized by Cinemark Holdings, Inc. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. Restricted Stock Units The financial performance factors and respective vesting rates for each of the 2014, 2015 and 2016 grants are as follows: Year Ended December 31, Percentage of 2014 2015 2016 Threshold IRR 8.5 % 7.5 % 6.0 % 33.3 % Target IRR 10.5 % 9.5 % 8.0 % 66.6 % Maximum IRR 12.5 % 11.5 % 10.0 % 100 % At the time of each of the restricted stock unit grants, the Company assumes the IRR level to be reached for the defined measurement period will be the mid-point mid-point Below is a table summarizing the potential number of units that could vest under restricted stock unit awards granted during the years ended December 31, 2014, 2015 and 2016 at each of the three levels of financial performance (excluding forfeitures). Granted During the Year Ended December 31, 2014 2015 2016 Number of Value at Number of Value at Number of Value at Units Grant (1) Units Grant (1) Units Grant (1) at threshold IRR 65,832 $ 1,879 47,640 $ 2,057 84,554 $ 2,522 at target IRR 131,683 $ 3,758 95,282 $ 4,115 169,107 $ 5,044 at maximum IRR 197,515 $ 5,637 142,917 $ 6,173 253,661 $ 7,568 (1) The grant date fair values for units issued during the years ended December 31, 2014, 2015, and 2016 were $28.54, $43.19 and $29.83, respectively. Below is a summary of activity for restricted stock unit awards for the periods indicated. Year Ended December 31, 2014 2015 2016 Number of restricted stock unit awards that vested during the period 395,751 123,769 213,984 Fair value of restricted stock unit awards that vested during the period $ 11,420 $ 5,483 $ 7,260 Accumulated dividends paid upon vesting of restricted stock unit awards $ 1,352 $ 442 $ 662 Income tax benefit recognized upon vesting of restricted stock unit awards $ 4,796 $ 2,303 $ 3,049 Compensation expense recognized during the period $ 3,284 $ 6,158 $ 5,144 During the year ended December 31, 2015, the Compensation Committee of the Board of Directors of Cinemark Holdings, Inc. approved a modification to each of the 2013 and 2014 restricted stock unit grants. The modifications resulted in a cap on the foreign currency exchange rate devaluation impact to be used in calculating the IRR for the respective measurement periods. The Company revalued each of the grants based on Cinemark Holdings, Inc.’s stock price at the date of modification, which was $33.02. The modifications resulted in incremental compensation expense of approximately $2,460 for the year ended December 31, 2015. During the year ended December 31, 2016, the Compensation Committee of the Board of Directors of Cinemark Holdings, Inc. approved a modification to the 2015 restricted stock unit grants. The modification resulted in a cap on the foreign currency exchange rate devaluation impact to be used in calculating the IRR for the respective measurement periods. The Company revalued each of the grants based on Cinemark Holdings, Inc.’s stock price at the date of modification, which was $37.98. The modifications resulted in incremental compensation expense of approximately $562 for the year ended December 31, 2016. As of December 31, 2016, the Company had restricted stock units outstanding that represented a total 557,077 hypothetical shares of Cinemark Holdings, Inc.’s common stock, net of actual cumulative forfeitures of 30,598 units, assuming the maximum IRR is achieved for all of the outstanding restricted stock unit awards. As of December 31, 2016, the remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $6,791, which reflects the maximum IRR level that was achieved for the 2013 and 2014 grants, the maximum IRR level that was achieved for the 2015 grants and an IRR level of 8.0% that is estimated to be achieved for the 2016 grant. The weighted average period over which this remaining compensation expense will be recognized is approximately two years.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2016
Supplemental Cash Flow Information	13. SUPPLEMENTAL CASH FLOW INFORMATION The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2014 2015 2016 Cash paid for interest $ 107,926 $ 105,155 $ 108,101 Cash paid for income taxes, net of refunds received $ 122,972 $ 108,435 $ 93,368 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ (1,225 ) $ 2,491 $ (29,471 ) Theatre properties and equipment acquired under capital lease $ 19,908 $ 36,544 $ 33,282 Investment in NCM - receipt of common units (see Note 3) $ 8,216 $ 15,421 $ 11,111 Noncash distributions to Cinemark Holdings, Inc. $ — $ (17,935 ) $ — Receipt of promissory note related to sale of investment in a Taiwan joint venture $ — $ 2,304 $ — (1) Additions to theatre properties and equipment included in accounts payable as of December 31, 2015 and 2016 were $11,154 and $40,625, respectively.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2016
Income Taxes	14. INCOME TAXES Income before income taxes consisted of the following: Year Ended December 31, 2014 2015 2016 Income before income taxes: U.S. $ 208,377 $ 262,336 $ 277,474 Foreign 84,542 88,015 85,890 Total $ 292,919 $ 350,351 $ 363,364 Current and deferred income taxes were as follows: Year Ended December 31, 2014 2015 2016 Current: Federal $ 62,686 $ 72,185 $ 66,210 Foreign 27,681 35,874 32,047 State 6,256 10,806 12,061 Total current expense $ 96,623 $ 118,865 $ 110,318 Deferred: Federal $ 6,322 $ 10,420 $ (13,667 ) Foreign (6,437 ) (3,339 ) 1,674 State 642 4,014 6,526 Total deferred taxes 527 11,095 (5,467 ) Income taxes $ 97,150 $ 129,960 $ 104,851 A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows: Year Ended December 31, 2014 2015 2016 Computed statutory tax expense $ 102,522 $ 122,623 $ 127,176 Foreign inflation adjustments 641 (1,295 ) (281 ) State and local income taxes, net of federal income tax impact 4,634 9,640 12,081 Foreign losses not benefited and changes in valuation allowance (275 ) (2,408 ) (34,757 ) Foreign tax rate differential (2,125 ) (2,660 ) (942 ) Foreign dividends 1,083 — 68,684 Foreign tax credits — — (62,815 ) Sale of Mexican subsidiaries and related changes in intangible assets (10,065 ) — — Changes in uncertain tax positions (1,540 ) 3,717 921 Other — net 2,275 343 (5,216 ) Income taxes $ 97,150 $ 129,960 $ 104,851 The Company reinvests the accumulated undistributed earnings of its non-U.S. non-U.S. non-U.S. Deferred Income Taxes The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2015 and 2016 consisted of the following: December 31, 2015 2016 Deferred liabilities: Theatre properties and equipment $ 141,155 $ 176,781 Tax impact of items in accumulated other comprehensive loss 158 — Intangible asset — other 28,889 36,052 Intangible asset — tradenames 112,413 112,747 Investment in partnerships 108,733 107,066 Total deferred liabilities 391,348 432,646 Deferred assets: Deferred lease expenses 26,966 24,026 Exchange (gain) loss 3,736 (731 ) Deferred revenue - NCM 128,642 130,005 Capital lease obligations 75,966 85,721 Tax loss carryforwards 7,379 7,396 Alternative minimum tax and other credit carryforwards 41,300 56,520 Other expenses, not currently deductible for tax purposes 20,204 11,270 Total deferred assets 304,193 314,207 Net deferred income tax liability before valuation allowance 87,155 118,439 Valuation allowance against deferred assets – non-current 50,636 14,524 Net deferred income tax liability $ 137,791 $ 132,963 Net deferred tax liability — Foreign $ 4,212 $ 7,571 Net deferred tax liability — U.S. 133,579 125,392 Total $ 137,791 $ 132,963 The Company’s foreign tax credit carryforwards began to expire in 2015. Some foreign net operating losses will expire in the next reporting period; however, some losses may be carried forward indefinitely. State net operating losses may be carried forward for periods of between five and twenty years with the last expiring year being 2036. The Company’s valuation allowance changed from $50,636 at December 31, 2015 to $14,524 at December 31, 2016. The decrease was a result of the implementation of a foreign holding and financing structure, which increased the Company’s ability to use foreign tax credits that previously had a full valuation allowance. Uncertain Tax Positions The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2014, 2015 and 2016: Year Ended December 31, 2014 2015 2016 Balance at January 1, $ 18,780 $ 16,515 $ 17,133 Gross increases - tax positions in prior periods 10 40 13 Gross decreases - tax positions in prior periods (2,379 ) — — Gross increases - current period tax positions 1,324 2,112 923 Settlements (963 ) (871 ) (924 ) Foreign currency translation adjustments (257 ) (663 ) 258 Balance at December 31, $ 16,515 $ 17,133 $ 17,403 The Company had $17,008 and $18,190 of unrecognized tax benefits, including interest and penalties, as of December 31, 2015 and 2016, respectively. Of these amounts, $17,008 and $18,190 represent the amount of unrecognized tax benefits that if recognized would impact the effective income tax rate for the years ended December 31, 2015 and 2016, respectively. The Company had $3,198 and $4,111 accrued for interest and penalties as of December 31, 2015 and 2016, respectively. The Company participates in the consolidated income tax return of Cinemark Holdings, Inc. in the U.S. federal jurisdiction and in certain state and foreign jurisdictions and is routinely under audit by many different tax authorities. The Company believes that its accrual for tax liabilities is adequate for all open audit years based on its assessment of many factors including past experience and interpretations of tax law. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events. The Company is no longer subject to income tax audits from the Internal Revenue Service for years before 2013. The Company is no longer subject to state income tax examinations by tax authorities in its major state jurisdictions for years before 2012. Certain state returns were amended as a result of the Internal Revenue Service examination closures for 2007 through 2009, and the statutes remain open for those amendments. The Company is no longer subject to non-U.S. non-U.S. The Company is currently under audit in the non-U.S.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2016
Commitments and Contingencies	15. COMMITMENTS AND CONTINGENCIES Leases Year Ended December 31, 2014 2015 2016 Fixed rent expense $ 237,891 $ 240,057 $ 242,927 Contingent rent and other facility lease expenses 79,205 79,704 78,367 Total facility lease expense $ 317,096 $ 319,761 $ 321,294 Future minimum lease payments under noncancelable operating and capital leases that have initial or remaining terms in excess of one year at December 31, 2016 are due as follows: Operating Leases Capital Leases 2017 $ 253,824 $ 38,375 2018 231,489 39,104 2019 204,231 38,519 2020 185,508 37,647 2021 163,938 30,636 Thereafter 641,069 169,425 Total $ 1,680,059 353,706 Amounts representing interest payments (98,286 ) Present value of future minimum payments 255,420 Current portion of capital lease obligations (21,139 ) Capital lease obligations, less current portion $ 234,281 Employment Agreements one-year Effective March 4, 2016, the Company’s former President and Chief Operating Officer, Robert Copple, resigned with good reason as defined within his employment agreement. The Company paid Mr. Copple the payments and benefits pursuant to the terms set forth in his employment agreement. The Company’s post-termination obligations, such as providing continued participation in the Company’s welfare benefit plans and insurance programs, remain in effect for a limited period of time under the employment agreement. All expenses incurred by the Company in relation to the resignation are reflected in general and administrative expenses for the year ended December 31, 2016. The Company’s employment agreement with Mr. Tim Warner, the Company’s former CEO, terminated on April 1, 2016. Retirement Savings Plan Legal Proceedings Joseph Amey, et al. v. Cinemark USA, Inc., Case No. 3:13cv05669, In the United States District Court for the Northern District of California, San Francisco Division. Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles re-framed The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations. From time to time, the Company is involved in other various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance or by indemnification from vendors. The Company believes its potential liability with respect to these types of proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

Segments

Segments	12 Months Ended
	Dec. 31, 2016
Segments	16. SEGMENTS The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report asset information by segment because that information is not used to evaluate the performance or allocate resources between segments. Below is a breakdown of select financial information by reportable operating segment. Year Ended December 31, 2014 2015 2016 Revenues: U.S. $ 1,934,990 $ 2,137,733 $ 2,230,693 International 704,623 728,735 701,573 Eliminations (12,623 ) (13,859 ) (13,501 ) Total revenues $ 2,626,990 $ 2,852,609 $ 2,918,765 Year Ended December 31, Adjusted EBITDA (1) 2014 2015 2016 U.S. $ 457,948 $ 518,165 $ 550,150 International 159,662 166,416 157,690 Total Adjusted EBITDA $ 617,610 $ 684,581 $ 707,840 Year Ended December 31, Capital expenditures: 2014 2015 2016 U.S. $ 148,532 $ 223,213 $ 242,271 International 96,173 108,513 84,637 Total capital expenditures $ 244,705 $ 331,726 $ 326,908 (1) Distributions from NCM are reported entirely within the U.S. operating segment The following table sets forth a reconciliation of net income to Adjusted EBITDA: Year Ended December 31, 2014 2015 2016 Net income $ 195,769 $ 220,391 $ 258,513 Add (deduct): Income taxes 97,150 129,960 104,851 Interest expense (1) 113,698 112,741 108,313 Loss on debt amendments and refinancing — 925 13,445 Other income (2) (22,150 ) (20,041 ) (44,813 ) Other cash distributions from equity investees (3) 19,172 19,027 21,916 Depreciation and amortization 175,656 189,206 209,071 Impairment of long-lived assets 6,647 8,801 2,836 Loss on sale of assets and other 15,715 8,143 20,459 Deferred lease expenses 2,536 (1,806 ) (990 ) Amortization of long-term prepaid rents 1,542 2,361 1,826 Share based awards compensation expense 11,875 14,873 12,413 Adjusted EBITDA $ 617,610 $ 684,581 $ 707,840 (1) Includes amortization of debt issue costs. (2) Includes interest income, foreign currency exchange gain (loss), and equity in income of affiliates and excludes distributions from NCM. (3) Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. In an effort to more closely align our reported Adjusted EBITDA with our operating cash flow, which provides our chief operating decision maker with more comprehensive cash flow information, beginning with the year ended December 31, 2016, Adjusted EBITDA now includes total cash distributions received from equity investees, including the cash distributions recorded as a reduction of the respective investment balance. Adjusted EBITDA for the years ended December 31, 2014 and 2015 has been adjusted to reflect comparable presentations. Financial Information About Geographic Area Below is a breakdown of select financial information by geographic area. Year Ended December 31, 2014 2015 2016 Revenues U.S. $ 1,934,990 $ 2,137,733 $ 2,230,693 Brazil 333,919 291,959 304,407 Other foreign countries 370,704 436,776 397,166 Eliminations (12,623 ) (13,859 ) (13,501 ) Total $ 2,626,990 $ 2,852,609 $ 2,918,765 December 31, 2015 2016 Theatres properties and equipment, net U.S. $ 1,175,535 $ 1,306,643 Brazil 163,505 197,896 Other foreign countries 166,029 199,997 Total $ 1,505,069 $ 1,704,536

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2016
Related Party Transactions	17. RELATED PARTY TRANSACTIONS The Company manages theatres for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the years ended December 31, 2014, 2015 and 2016, the aggregate amounts paid to Copper Beech Capital, LLC for the use of the aircraft was approximately $74, $410 and $110, respectively. The Company held an event for its employees and their families at Pinstack in December of 2016. Pinstack is owned by Mr. Mitchell and his wife, Tandy Mitchell. In connection with the event, the Company paid Pinstack approximately $70. The Company currently leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the years ended December 31, 2014, 2015 and 2016, the Company paid total rent of approximately $21,040, $20,581 and $21,124, respectively, to Syufy. The Company has paid certain fees and expenses on behalf of its parent, Cinemark Holdings, Inc. and Cinemark Holdings, Inc. has paid income taxes on behalf of the Company. The Company paid cash dividends to Cinemark Holdings, Inc. of $115,000, $115,225 and $124,900 during the years ended December 31, 2014, 2015 and 2016, respectively. Additionally, the Company made a noncash distribution to Cinemark Holdings, Inc. of $17,935 during the year ended December 31, 2015 related to expenses paid on behalf of Cinemark Holdings, Inc. The Company had a receivable from Cinemark Holdings, Inc. of $1,171 and $10,080 as of December 31, 2015 and 2016, respectively.

Valuation and Qualifying Accoun

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2016
Valuation and Qualifying Accounts	18. VALUATION AND QUALIFYING ACCOUNTS The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2014, 2015 and 2016 were as follows: Valuation for Deferred Tax Assets Balance at January 1, 2014 $ 25,711 Additions 28,612 Deductions (1,450 ) Balance at December 31, 2014 $ 52,873 Additions 437 Deductions (2,674 ) Balance at December 31, 2015 $ 50,636 Additions 483 Deductions (1) (36,595 ) Balance at December 31, 2016 $ 14,524 (1) See Note 14 for discussion of change in valuation allowance during the year ended December 31, 2016.

Condensed Consolidating Financi

Condensed Consolidating Financial Statement Information of Subsidiary Guarantors	12 Months Ended
	Dec. 31, 2016
Condensed Consolidating Financial Statement Information of Subsidiary Guarantors	19. CONDENSED CONSOLIDATING FINANCIAL INFORMATION OF SUBSIDIARY GUARANTORS As of December 31, 2016, the Company had outstanding $400,000 aggregate principal amount of 5.125% senior notes due 2022, or the 5.125% Senior Notes, and $755,000 aggregate principal amount of 4.875% senior notes due 2023, or the 4.875% Senior Notes, (collectively the “Notes”). These Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by the following subsidiaries of Cinemark USA, Inc.: Sunnymead Cinema Corp., Cinemark Properties, Inc., Greeley Holdings, Inc., Cinemark Partners I, Inc., CNMK Investments, Inc., CNMK Texas Properties, LLC., Cinemark Concessions LLC, Century Theatres, Inc., Marin Theatre Management, LLC, Century Theatres NG, LLC, Cinearts LLC, Cinearts Sacramento, LLC, Corte Madera Theatres, LLC, Novato Theatres, LLC, San Rafael Theatres, LLC, Northbay Theatres, LLC, Century Theatres Summit Sierra, LLC and Century Theatres Seattle, LLC. The following supplemental condensed consolidating financial statement information presents: 1. Condensed consolidating balance sheet information as of December 31, 2015 and 2016, condensed consolidating statements of income information, condensed consolidating statements of comprehensive income (loss) information and condensed consolidating statements of cash flows information for the years ended December 31, 2014, 2015 and 2016. 2. Cinemark USA, Inc. (the “Parent” and “Issuer”), combined Guarantor Subsidiaries and combined Non-Guarantor Non-Guarantor Non-Guarantor Non-Guarantor Non-Guarantor 3. Elimination entries necessary to consolidate the Parent and all of its Subsidiaries. CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503 Other current assets 78,797 18,407 61,432 (32,024 ) 126,612 Accounts receivable from parent or subsidiaries 212,299 — — (211,128 ) 1,171 Total current assets 432,460 114,272 412,706 (243,152 ) 716,286 Theatre properties and equipment - net 539,082 614,821 351,166 — 1,505,069 Investment in subsidiaries 1,326,790 293,900 — (1,620,690 ) — Other assets 1,402,062 135,022 475,187 (105,994 ) 1,906,277 Total assets $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,000 $ — $ 1,405 $ — $ 8,405 Current portion of capital lease obligations 6,426 9,962 2,392 — 18,780 Accounts payable and accrued expenses 197,268 123,759 116,353 (25,396 ) 411,984 Accounts payable to parent or subsidiaries — 23,965 187,163 (211,128 ) — Total current liabilities 210,694 157,686 307,313 (236,524 ) 439,169 Long-term liabilities Long-term debt, less current portion 1,868,763 — 9,534 (105,367 ) 1,772,930 Capital lease obligations, less current portion 114,513 67,440 26,999 — 208,952 Other long-term liabilities and deferrals 404,278 77,774 118,533 (7,255 ) 593,330 Total long-term liabilities 2,387,554 145,214 155,066 (112,622 ) 2,575,212 Commitments and contingencies Equity Cinemark USA, Inc.’s stockholder’s equity: Common stock 49,543 457,369 10,240 (467,609 ) 49,543 Other stockholder’s equity 1,052,603 397,746 755,335 (1,153,081 ) 1,052,603 Total Cinemark USA, Inc. stockholder’s equity 1,102,146 855,115 765,575 (1,620,690 ) 1,102,146 Noncontrolling interests — — 11,105 — 11,105 Total equity 1,102,146 855,115 776,680 (1,620,690 ) 1,113,251 Total liabilities and equity $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 146,855 $ 281,023 $ 133,260 $ — $ 561,138 Other current assets 62,425 15,098 71,706 (34,154 ) 115,075 Accounts receivable from parent or subsidiaries 76,550 121,478 (187,948 ) 10,080 Total current assets 285,830 417,599 204,966 (222,102 ) 686,293 Theatre properties and equipment - net 604,506 678,984 421,046 — 1,704,536 Investment in subsidiaries 1,570,592 132,892 — (1,703,484 ) — Other assets 1,409,320 134,284 488,535 (106,359 ) 1,925,780 Total assets $ 3,870,248 $ 1,363,759 $ 1,114,547 $ (2,031,945 ) $ 4,316,609 Liabilities and equity Current liabilities Current portion of long-term debt $ 4,282 $ — $ 1,409 $ (20 ) $ 5,671 Current portion of capital lease obligations 7,903 9,541 3,695 — 21,139 Accounts payable and accrued expenses 197,789 121,640 113,020 (16,457 ) 415,992 Accounts payable to parent or subsidiaries — — 187,948 (187,948 ) — Total current liabilities 209,974 131,181 306,072 (204,425 ) 442,802 Long-term liabilities Long-term debt, less current portion 1,879,663 — 12,600 (109,822 ) 1,782,441 Capital lease obligations, less current portion 124,944 71,228 38,109 — 234,281 Other long-term liabilities and deferrals 382,729 84,429 120,061 (14,214 ) 573,005 Total long-term liabilities 2,387,336 155,657 170,770 (124,036 ) 2,589,727 Commitments and contingencies Equity Cinemark USA, Inc.’s stockholder’s equity: — Common stock 49,543 457,368 10,239 (467,607 ) 49,543 Other stockholder’s equity 1,223,395 619,553 616,324 (1,235,877 ) 1,223,395 Total Cinemark USA, Inc. stockholder’s equity 1,272,938 1,076,921 626,563 (1,703,484 ) 1,272,938 Noncontrolling interests — — 11,142 — 11,142 Total equity 1,272,938 1,076,921 637,705 (1,703,484 ) 1,284,080 Total liabilities and equity $ 3,870,248 $ 1,363,759 $ 1,114,547 $ (2,031,945 ) $ 4,316,609 CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 851,299 $ 1,084,852 $ 733,435 $ (42,596 ) $ 2,626,990 Cost of operations Theatre operating expenses 693,323 739,686 524,045 (42,596 ) 1,914,458 General and administrative expenses 17,978 74,971 55,639 — 148,588 Depreciation and amortization 50,858 67,460 57,338 — 175,656 Impairment of long-lived assets 6,334 313 — — 6,647 Loss on sale of assets and other 8,954 3,278 3,483 — 15,715 Total cost of operations 777,447 885,708 640,505 (42,596 ) 2,261,064 Operating income 73,852 199,144 92,930 — 365,926 Other income (expense) Interest expense (101,224 ) (9,111 ) (3,392 ) 29 (113,698 ) Distributions from NCM 2,375 — 16,166 — 18,541 Equity in income of affiliates 208,900 53,950 22,464 (262,571 ) 22,743 Other income (expense) 79 — (643 ) (29 ) (593 ) Total other income (expense) 110,130 44,839 34,595 (262,571 ) (73,007 ) Income before income taxes 183,982 243,983 127,525 (262,571 ) 292,919 Income taxes (10,398 ) 71,687 35,861 — 97,150 Net income 194,380 172,296 91,664 (262,571 ) 195,769 Less: Net income attributable to noncontrolling interests — — 1,389 — 1,389 Net income attributable to Cinemark USA, Inc. $ 194,380 $ 172,296 $ 90,275 $ (262,571 ) $ 194,380 CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 959,347 $ 1,178,873 $ 764,631 $ (50,242 ) $ 2,852,609 Cost of operations Theatre operating expenses 767,446 804,236 545,131 (50,242 ) 2,066,571 General and administrative expenses 16,152 81,240 56,660 — 154,052 Depreciation and amortization 59,759 73,708 55,739 — 189,206 Impairment of long-lived assets 6,445 1,600 756 — 8,801 (Gain) loss on sale of assets and other 6,191 3,728 (1,776 ) — 8,143 Total cost of operations 855,993 964,512 656,510 (50,242 ) 2,426,773 Operating income 103,354 214,361 108,121 — 425,836 Other income (expense) Interest expense (100,608 ) (8,500 ) (4,009 ) 376 (112,741 ) Loss on debt amendments and refinancing (925 ) — — — (925 ) Distributions from NCM 2,116 — 16,024 — 18,140 Equity in income of affiliates 217,567 55,082 27,262 (271,785 ) 28,126 Other income (expense) 200 20 (7,929 ) (376 ) (8,085 ) Total other income (expense) 118,350 46,602 31,348 (271,785 ) (75,485 ) Income before income taxes 221,704 260,963 139,469 (271,785 ) 350,351 Income taxes 3,172 79,131 47,657 — 129,960 Net income 218,532 181,832 91,812 (271,785 ) 220,391 Less: Net income attributable to noncontrolling interests — — 1,859 — 1,859 Net income attributable to Cinemark USA, Inc. $ 218,532 $ 181,832 $ 89,953 $ (271,785 ) $ 218,532 CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,014,713 $ 1,219,218 $ 737,981 $ (53,147 ) $ 2,918,765 Cost of operations Theatre operating expenses 804,041 828,905 540,310 (53,147 ) 2,120,109 General and administrative expenses 13,085 84,453 43,099 — 140,637 Depreciation and amortization 70,654 79,139 59,278 — 209,071 Impairment of long-lived assets 1,929 — 907 — 2,836 Loss on sale of assets and other 5,613 13,759 1,087 20,459 Total cost of operations 895,322 1,006,256 644,681 (53,147 ) 2,493,112 Operating income 119,391 212,962 93,300 — 425,653 Other income (expense) Interest expense (96,442 ) (7,538 ) (5,642 ) 1,309 (108,313 ) Loss on debt amendments and refinancing (13,445 ) — — — (13,445 ) Distributions from NCM 1,414 — 13,242 — 14,656 Equity in income of affiliates 245,010 58,528 30,370 (301,946 ) 31,962 Other income 351 19 13,790 (1,309 ) 12,851 Total other income (expense) 136,888 51,009 51,760 (301,946 ) (62,289 ) Income before income taxes 256,279 263,971 145,060 (301,946 ) 363,364 Income taxes (498 ) 52,277 53,072 — 104,851 Net income 256,777 211,694 91,988 (301,946 ) 258,513 Less: Net income attributable to noncontrolling interests — — 1,736 — 1,736 Net income attributable to Cinemark USA, Inc. $ 256,777 $ 211,694 $ 90,252 $ (301,946 ) $ 256,777 CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 194,380 $ 172,296 $ 91,664 $ (262,571 ) $ 195,769 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,759, net of settlements 2,846 — — — 2,846 Unrealized gain due to fair value adjustments on available-for-sale 2,507 — — — 2,507 Other comprehensive income in equity method investments 676 — 643 (643 ) 676 Foreign currency translation adjustments (68,982 ) — (68,997 ) 68,982 (68,997 ) Total other comprehensive loss, net of tax (62,953 ) — (68,354 ) 68,339 (62,968 ) Total comprehensive income, net of tax $ 131,427 $ 172,296 $ 23,310 $ (194,232 ) $ 132,801 Comprehensive income attributable to noncontrolling interests — — (1,374 ) — (1,374 ) Comprehensive income attributable to Cinemark USA, Inc. $ 131,427 $ 172,296 $ 21,936 $ (194,232 ) $ 131,427 CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,562, net of settlements 2,636 — — — 2,636 Unrealized loss due to fair value adjustments on available-for-sale (957 ) — — — (957 ) Other comprehensive loss in equity method investments (3,119 ) — (3,086 ) 3,086 (3,119 ) Foreign currency translation adjustments (125,474 ) — (125,512 ) 125,474 (125,512 ) Total other comprehensive loss, net of tax (126,914 ) — (128,598 ) 128,560 (126,952 ) Total comprehensive income (loss), net of tax $ 91,618 $ 181,832 $ (36,786 ) $ (143,225 ) $ 93,439 Comprehensive income attributable to noncontrolling interests — — (1,821 ) — (1,821 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ 91,618 $ 181,832 $ (38,607 ) $ (143,225 ) $ 91,618 CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $138, net of settlements 234 — — — 234 Other comprehensive income in equity method investments 89 — 89 (89 ) 89 Foreign currency translation adjustments 26,361 — 26,394 (26,361 ) 26,394 Total other comprehensive income, net of tax 26,684 — 26,483 (26,450 ) 26,717 Total comprehensive income, net of tax $ 283,461 $ 211,694 $ 118,471 $ (328,396 ) $ 285,230 Comprehensive income attributable to noncontrolling interests — — (1,769 ) — (1,769 ) Comprehensive income attributable to Cinemark USA, Inc. $ 283,461 $ 211,694 $ 116,702 $ (328,396 ) $ 283,461 CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 194,380 $ 172,296 $ 91,664 $ (262,571 ) $ 195,769 Adjustments to reconcile net income to cash provided by (used for) operating activities (134,559 ) 42,620 31,874 262,571 202,506 Changes in assets and liabilities 232,167 (246,598 ) 70,284 — 55,853 Net cash provided by (used for) operating activities 291,988 (31,682 ) 193,822 — 454,128 Investing activities Additions to theatre properties and equipment (93,608 ) (52,896 ) (98,201 ) — (244,705 ) Acquisition of theatres in the U.S., net of cash acquired (7,951 ) — — — (7,951 ) Acquisition of screen advertising business — — (1,040 ) — (1,040 ) Proceeds from sale of theatre properties and equipment and other 1,109 98 1,338 — 2,545 Dividends received from subsidiaries 1,094 8 — (1,102 ) — Investments in, and loans to, subsidiaries (1,918 ) — — 1,918 — Investment in joint ventures and other — — (2,188 ) — (2,188 ) Net cash used for investing activities (101,274 ) (52,790 ) (100,091 ) 816 (253,339 ) Financing activities Dividends paid to parent (115,000 ) (700 ) (402 ) 1,102 (115,000 ) Repayments of other long-term debt (7,000 ) — (2,846 ) — (9,846 ) Payments on capital leases (4,082 ) (8,000 ) (1,953 ) — (14,035 ) Capital contributions and loans from parent — 1,918 — (1,918 ) — Other 2,808 (9,861 ) (386 ) — (7,439 ) Net cash used for financing activities (123,274 ) (16,643 ) (5,587 ) (816 ) (146,320 ) Effect of exchange rate changes on cash and cash equivalents — — (15,522 ) — (15,522 ) Increase (decrease) in cash and cash equivalents 67,440 (101,115 ) 72,622 — 38,947 Cash and cash equivalents: Beginning of year 62,065 175,758 362,071 — 599,894 End of year $ 129,505 $ 74,643 $ 434,693 $ — $ 638,841 CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Adjustments to reconcile net income to cash provided by operating activities (142,602 ) 39,156 43,223 271,785 211,562 Changes in assets and liabilities 67,253 (67,850 ) 23,869 — 23,272 Net cash provided by operating activities 143,183 153,138 158,904 — 455,225 Investing activities Additions to theatre properties and equipment (98,193 ) (121,605 ) (111,928 ) — (331,726 ) Proceeds from sale of theatre properties and equipment and other 2,737 5,264 1,965 — 9,966 Acquisition of theatre in Brazil — — (2,651 ) — (2,651 ) Dividends received from subsidiaries 1,685 15 — (1,700 ) — Intercompany note issuances (3,500 ) — (100,000 ) 103,500 — Investment in joint ventures and other (518 ) — (3,211 ) 18 (3,711 ) Net cash used for investing activities (97,789 ) (116,326 ) (215,825 ) 101,818 (328,122 ) Financing activities Dividends paid to parent (115,225 ) (1,700 ) — 1,700 (115,225 ) Repayments of long-term debt (8,385 ) — (35 ) — (8,420 ) Payments of debt issue costs (6,957 ) — — — (6,957 ) Payments on capital leases (5,389 ) (9,120 ) (2,004 ) — (16,513 ) Intercompany loan proceeds 100,000 — 3,518 (103,518 ) — Other 2,421 (4,770 ) (1,045 ) — (3,394 ) Net cash provided by (used for) financing activities (33,535 ) (15,590 ) 434 (101,818 ) (150,509 ) Effect of exchange rate changes on cash and cash equivalents — — (26,932 ) — (26,932 ) Increase (decrease) in cash and cash equivalents 11,859 21,222 (83,419 ) — (50,338 ) Cash and cash equivalents: Beginning of year 129,505 74,643 434,693 — 638,841 End of year $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503 CINEMARK USA, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Adjustments to reconcile net income to cash provided by operating activities (189,223 ) 55,128 53,381 301,946 221,232 Changes in assets and liabilities 154,085 (164,005 ) (18,642 ) — (28,562 ) Net cash provided by operating activities 221,639 102,817 126,727 — 451,183 Investing activities Additions to theatre properties and equipment (108,439 ) (130,843 ) (87,626 ) — (326,908 ) Acquisition of theatres in the US (15,300 ) — — — (15,300 ) Acquisition of screen advertising business — — (1,450 ) — (1,450 ) Proceeds from sale of theatre properties and equipment and other 2,912 374 284 — 3,570 Proceeds from sale of marketable securities 13,451 — — — 13,451 Intercompany note issuances (4,455 ) — — 4,455 — Dividends received from subsidiaries 26,033 229,649 — (255,682 ) — Investment in joint ventures and other (1,000 ) — (132 ) — (1,132 ) Net cash provided by (used for) investing activities (86,798 ) 99,180 (88,924 ) (251,227 ) (327,769 ) Financing activities Dividends paid to parent (124,900 ) — (255,682 ) 255,682 (124,900 ) Proceeds from issuance of Senior Notes, net of discount 222,750 — — — 222,750 Retirement of Senior Subordinated Notes (200,000 ) — — — (200,000 ) Repayments of long-term debt (15,201 ) — (1,404 ) — (16,605 ) Payments of debt issue costs (7,217 ) — — — (7,217 ) Intercompany loan proceeds — — 4,455 (4,455 ) — Payments on capital leases (6,645 ) (10,005 ) (2,693 ) — (19,343 ) Other 1,863 (6,834 ) (1,759 ) — (6,730 ) Net cash used for financing activities (129,350 ) (16,839 ) (257,083 ) 251,227 (152,045 ) Effect of exchange rate changes on cash and cash equivalents — — 1,266 — 1,266 Increase (decrease) in cash and cash equivalents 5,491 185,158 (218,014 ) — (27,365 ) Cash and cash equivalents: Beginning of year 141,364 95,865 351,274 — 588,503 End of year $ 146,855 $ 281,023 $ 133,260 $ — $ 561,138

Unaudited Supplemental Schedule

Unaudited Supplemental Schedules	12 Months Ended
	Dec. 31, 2016
Unaudited Supplemental Schedules	UNAUDITED SUPPLEMENTAL SCHEDULES As required by the indentures governing the Company’s 5.125% Senior Notes and 4.875% Senior Notes (collectively the “Notes”), the Company has included in this filing, financial information for its subsidiaries that have been designated as unrestricted subsidiaries as defined by the indentures. As required by the indentures governing the Notes, the Company has included a condensed consolidating balance sheet and condensed consolidating statements of income, comprehensive income and cash flows for the Company and its subsidiaries. These supplementary schedules separately identify the Company’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2016 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 559,964 $ 1,174 $ — $ 561,138 Other current assets 224,298 (98,405 ) (738 ) 125,155 Total current assets 784,262 (97,231 ) (738 ) 686,293 Theatre properties and equipment, net 1,704,536 — — 1,704,536 Other assets 1,779,736 473,063 (327,019 ) 1,925,780 Total assets $ 4,268,534 $ 375,832 $ (327,757 ) $ 4,316,609 Liabilities and equity Current liabilities Current portion of long-term debt $ 4,282 $ 1,389 $ — $ 5,671 Current portion of capital lease obligations 21,139 — — 21,139 Accounts payable and accrued expenses 416,677 53 (738 ) 415,992 Total current liabilities 442,098 1,442 (738 ) 442,802 Long-term liabilities Long-term debt, less current portion 1,999,663 2,778 (220,000 ) 1,782,441 Capital lease obligations, less current portion 234,281 — — 234,281 Other long-term liabilities and deferrals 472,878 100,127 — 573,005 Total long-term liabilities 2,706,822 102,905 (220,000 ) 2,589,727 Commitments and contingencies Equity 1,119,614 271,485 (107,019 ) 1,284,080 Total liabilities and equity $ 4,268,534 $ 375,832 $ (327,757 ) $ 4,316,609 Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Revenues $ 2,918,765 $ — $ — $ 2,918,765 Cost of operations Theatre operating costs 2,120,109 — — 2,120,109 General and administrative expenses 140,634 3 — 140,637 Depreciation and amortization 209,071 — — 209,071 Impairment of long-lived assets 2,836 — — 2,836 Loss on sale of assets and other 20,459 — — 20,459 Total cost of operations 2,493,109 3 — 2,493,112 Operating income (loss) 425,656 (3 ) — 425,653 Other income (expense) (106,492 ) 44,203 — (62,289 ) Income before income taxes 319,164 44,200 — 363,364 Income taxes 87,878 16,973 — 104,851 Net income 231,286 27,227 — 258,513 Less: Net income attributable to noncontrolling interests 1,736 — — 1,736 Net income attributable to Cinemark USA, Inc. $ 229,550 $ 27,227 $ — $ 256,777 Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 (In thousands) Restricted Unrestricted Eliminations Consolidated Net income $ 231,286 $ 27,227 $ — $ 258,513 Other comprehensive income, net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $138 234 — — 234 Other comprehensive income in equity method investments — 89 — 89 Foreign currency translation adjustments 26,394 — — 26,394 Total other comprehensive income , net of tax 26,628 89 — 26,717 Total comprehensive income, net of tax 257,914 27,316 — 285,230 Comprehensive income attributable to noncontrolling interests (1,769 ) — — (1,769 ) Comprehensive income attributable to Cinemark USA, Inc. $ 256,145 $ 27,316 $ — $ 283,461 Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2016 (In thousands) Restricted Unrestricted Eliminations Consolidated Operating activities Net income $ 231,286 $ 27,227 $ — $ 258,513 Adjustments to reconcile net income to cash provided by operating activities 239,502 (18,270 ) — 221,232 Changes in assets and liabilities (49,232 ) 20,670 — (28,562 ) Net cash provided by operating activities 421,556 29,627 — 451,183 Investing activities Additions to theatre properties and equipment and other (326,908 ) — — (326,908 ) Acquisition of theatres in U.S. (15,300 ) — — (15,300 ) Acquisition of screen advertising business (1,450 ) — — (1,450 ) Proceeds from sale of theatre properties and equipment and other 17,021 — — 17,021 Intercompany note issuances — (220,000 ) 220,000 — Investment in joint ventures and other (417 ) (715 ) — (1,132 ) Net cash used for investing activities (327,054 ) (220,715 ) 220,000 (327,769 ) Financing activities Dividends paid to parent (124,900 ) — — (124,900 ) Proceeds from issuance of Senior Notes, net of discount 222,750 — — 222,750 Retirement of Senior Subordinated Notes (200,000 ) — — (200,000 ) Repayments of long-term debt (15,216 ) (1,389 ) — (16,605 ) Payment of debt issue costs (7,217 ) — — (7,217 ) Intercompany loan proceeds 220,000 — (220,000 ) — Payments on capital leases (19,343 ) — — (19,343 ) Other (6,730 ) — — (6,730 ) Net cash provided by (used for) financing activities 69,344 (1,389 ) (220,000 ) (152,045 ) Effect of exchange rate changes on cash and cash equivalents 1,266 — — 1,266 Increase (decrease) in cash and cash equivalents 165,112 (192,477 ) — (27,365 ) Cash and cash equivalents: Beginning of year 394,852 193,651 — 588,503 End of year $ 559,964 $ 1,174 $ — $ 561,138 Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

Summary of Significant Accoun30

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2016
Business	Business
Principles of Consolidation	Principles of Consolidation
Cash and Cash Equivalents	Cash and Cash Equivalents
Accounts Receivable	Accounts Receivable – non-income
Inventories	Inventories (first-in, first-out
Theatre Properties and Equipment	Theatre Properties and Equipment Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital lease (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) Amortization of capital lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital lease assets as of December 31, 2015 and 2016 was $150,968 and $175,166, respectively. The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, the impact of recent theatre remodels or other substantial improvements, available lease renewal options and other factors considered relevant in its assessment of impairment of individual theatre assets. Long-lived assets are evaluated for impairment on an individual theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the available remaining lease period, which includes the probability the exercise of available renewal periods or extensions, for leased properties and the lesser of twenty years or the building’s remaining useful life for fee-owned 820-10-35,
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets two-step 820-10-35, For the year ended December 31, 2015, the Company performed a qualitative goodwill impairment assessment on all reporting units except one, in accordance with ASU 2011-08 Testing Goodwill for Impairment 2011-08”). two-step For the year ended December 31, 2016, the Company performed a qualitative goodwill impairment assessment on all reporting units. Based on the qualitative assessment performed, the Company determined that it was not more likely than not that the fair value of the reporting units were less than their carrying values. Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. During 2014, the Company estimated the fair value of its tradenames by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, 2011-08. For the year ended December 31, 2016, the Company also performed a quantitative test on our definite-lived tradename associated with the Rave theatres acquired in 2013. During the year ended December 31, 2016, the Company rebranded certain of these theatres with Cinemark signage as part of recliner conversions and other renovations. The Company estimated the fair value of the Rave tradename by applying an estimated market royalty rate that could be charged for the use of the tradename to forecasted future revenues for the theatres using the Rave tradename, with an adjustment for the present value of such royalties. As of December 31, 2016, the estimated fair value of the Rave tradename intangible asset exceeded their carrying value by more than 10%. The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from one to four years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately three to twenty years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to ten years.
Deferred Charges and Other Assets	Deferred Charges and Other Assets
Lease Accounting	Lease Accounting
Deferred Revenues	Deferred Revenues
Self-Insurance Reserves	Self-Insurance Reserves —
Revenue and Expense Recognition	Revenue and Expense Recognition on-screen in-theatre. Film rental costs are accrued based on the applicable box office receipts and either firm terms or a sliding scale formula, which are generally established prior to the opening of the film, or estimates of the final rate, which occurs at the conclusion of the film run, subject to the film licensing arrangement. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. Under a sliding scale formula, film rental is paid as a percentage of box office revenues using a pre-determined
Loyalty Programs	Loyalty Programs app-based sign-up
Accounting for Share Based Awards	Accounting for Share Based Awards
Income Taxes	Income Taxes — two-step more-likely-than-not examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not
Segments	Segments
Use of Estimates	Use of Estimates
Foreign Currency Translations	Foreign Currency Translations
Fair Value Measurements	Fair Value Measurements — Goodwill and Other Intangible Assets Theatre Properties and Equipment
Acquisitions	Acquisitions
Accounting Reclassifications	Accounting Reclassifications The Company has reclassified $26,664 and $30,950 in expenses from film rentals and advertising costs to utilities and other costs on the consolidated statements of income for the years ended December 31, 2014 and 2015, respectively, to be consistent with the presentation for the year ended December 31, 2016. During the year ended December 31, 2016, the Company determined that reclassifying the expenses, which are related to the maintenance and monitoring of projection and sound equipment, results in a more clear presentation of film rentals and advertising costs.

Summary of Significant Accoun31

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2016
Estimated Useful Life of Assets	Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital lease (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) Amortization of capital lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital lease assets as of December 31, 2015 and 2016 was $150,968 and $175,166, respectively.
Intangible Assets and Amortization Method Used	The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from one to four years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately three to twenty years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to ten years.

Investment in National CineMe32

Investment in National CineMedia Llc (Tables) - NCM	12 Months Ended
	Dec. 31, 2016
Summary of Common Units Received Under Common Unit Adjustment Agreement	Below is a summary of common units received by the Company under the Common Unit Adjustment Agreement during the years ended December 31, 2014, 2015 and 2016. Date Number Fair Value Event Received Received Received 2014 Annual common unit adjustment 03/27/14 557,631 $ 8,216 2015 Annual common unit adjustment 03/31/15 1,074,910 $ 15,421 2016 Annual common unit adjustment 03/31/16 753,598 $ 11,111
Summary of Activity with NCM Included in Company's Consolidated Financial Statements	Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. Other Investment Deferred Distributions Equity in Other Comprehensive Cash in NCM Revenue from NCM Earnings Revenue (Income) Loss Received Balance as of January 1, 2014 $ 178,853 $ (334,429 ) Receipt of common units due to annual common unit adjustment 8,216 (8,216 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (9,249 ) — 9,249 Receipt of excess cash distributions (12,574 ) — (14,778 ) — — — 27,352 Receipt under tax receivable agreement (2,594 ) — (3,763 ) — — — 6,357 Equity in earnings 6,142 — — (6,142 ) — — — Equity in other comprehensive income 896 — — — — (896 ) — Amortization of deferred revenue — 7,426 — — (7,426 ) — — Balance as of and for the period ended December 31, 2014 $ 178,939 $ (335,219 ) $ (18,541 ) $ (6,142 ) $ (16,675 ) $ (896 ) $ 42,958 Receipt of common units due to annual common unit adjustment 15,421 (15,421 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,330 ) — 11,330 Receipt of excess cash distributions (14,072 ) — (15,396 ) — — — 29,468 Receipt under tax receivable agreement (2,308 ) — (2,744 ) — — — 5,052 Equity in earnings 8,510 — — (8,510 ) — — — Equity in other comprehensive loss (2,735 ) — — — — 2,735 — Amortization of deferred revenue — 8,506 — — (8,506 ) — — Balance as of and for the period ended December 31, 2015 $ 183,755 $ (342,134 ) $ (18,140 ) $ (8,510 ) $ (19,836 ) $ 2,735 $ 45,850 Receipt of common units due to annual common unit adjustment 11,111 (11,111 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,048 ) — 11,048 Receipt of excess cash distributions (11,233 ) — (11,483 ) — — — 22,716 Receipt under tax receivable agreement (2,985 ) — (3,173 ) — — — 6,158 Equity in earnings 9,347 — — (9,347 ) — — — Amortization of deferred revenue — 9,317 — — (9,317 ) — — Balance as of and for the period ended December 31, 2016 $ 189,995 $ (343,928 ) $ (14,656 ) $ (9,347 ) $ (20,365 ) $ — $ 39,922 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen on-screen

Other Investments (Tables)

Other Investments (Tables)	12 Months Ended
	Dec. 31, 2016
Summary of Activity for Each of Investments	Below is a summary of activity for each of the Company’s other investments for the periods indicated. DCIP RealD AC JV, DCDC Other Total Balance at January 1, 2014 $ 38,033 $ 10,443 $ 6,426 $ 2,589 $ 2,166 $ 59,657 Cash contributions 2,188 — — — — 2,188 Equity in income (loss) 15,279 — 1,473 (151 ) — 16,601 Equity in other comprehensive loss (219 ) — — — — (219 ) Unrealized holding gain — 3,986 — — — 3,986 Cash distributions received (4,004 ) — — — — (4,004 ) Other — — — — (551 ) (551 ) Balance at December 31, 2014 $ 51,277 $ 14,429 $ 7,899 $ 2,438 $ 1,615 $ 77,658 Cash contributions 3,211 — — — 500 3,711 Equity in income 18,522 — 970 124 — 19,616 Equity in other comprehensive loss (384 ) — — — — (384 ) Unrealized holding loss — (1,529 ) — — — (1,529 ) Sale of investment in Taiwan (1) — — — — (1,383 ) (1,383 ) Cash distributions received (1,047 ) — (1,600 ) — — (2,647 ) Other — — — — (69 ) (69 ) Balance at December 31, 2015 $ 71,579 $ 12,900 $ 7,269 $ 2,562 $ 663 $ 94,973 Cash contributions 717 — — — — 717 Equity in income 21,434 — 311 870 — 22,615 Equity in other comprehensive income 89 — — — — 89 Sale of investment (2) — (12,900 ) — — — (12,900 ) Cash distributions received (6,000 ) — (1,600 ) (98 ) — (7,698 ) Other — — — (584 ) 1,105 521 Balance at December 31, 2016 $ 87,819 $ — $ 5,980 $ 2,750 $ 1,768 $ 98,317 (1) The Company sold its investment in a Taiwan joint venture for $2,634, resulting in a gain of $1,251, which is included in loss on sale of assets and other for the year ended December 31, 2015. (2) See further discussion of the sale of the investment held by the Company under RealD, Inc
Transactions with DCIP	The Company had the following transactions with DCIP during the years ended December 31, 2014, 2015 and 2016: Year Ended December 31, 2014 2015 2016 Equipment lease payments $ 4,012 $ 4,474 $ 5,217 Warranty reimbursements from DCIP $ (3,169 ) $ (4,329 ) $ (6,091 ) Management services fees $ 782 $ 825 $ 825
NCM
Summary of Financial Information	The tables below present summary financial information for NCM for the periods indicated (financial information for NCM’s fiscal year ended December 29, 2016 is not yet available). Year Ended Nine Months Ended January 1, 2015 December 31, 2015 September 29, 2016 Gross revenues $ 393,994 $ 446,463 $ 305,101 Operating income $ 159,624 $ 140,498 $ 100,911 Net income $ 96,309 $ 87,474 $ 49,619 As of December 31, 2015 As of September 29, 2016 Total assets $ 782,579 $ 758,607 Total liabilities $ 1,049,145 $ 1,007,704
Digital Cinema Implementation Partners LLC
Summary of Financial Information	Below is summary financial information for DCIP as of and for the years ended December 31, 2014, 2015 and 2016. Year ended December 31, 2014 2015 2016 Net operating revenue $ 170,724 $ 171,203 $ 178,836 Operating income $ 101,956 $ 103,449 $ 107,919 Net income $ 61,293 $ 79,255 $ 89,152 As of December 31, 2015 December 31, 2016 Total assets $ 1,004,757 $ 906,377 Total liabilities $ 675,192 $ 509,197

Goodwill and Other Intangible34

Goodwill and Other Intangible Assets - Net (Tables)	12 Months Ended
	Dec. 31, 2016
Summary of Goodwill	The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at December 31, 2014 (1) $ 1,156,556 $ 120,827 $ 1,277,383 Acquisition of Brazil theatre — 356 356 Foreign currency translation adjustments — (30,191 ) (30,191 ) Balance at December 31, 2015 (1) $ 1,156,556 $ 90,992 $ 1,247,548 Acquisition of U.S. theatres 7,607 — 7,607 Other acquisitions (2) — 1,410 1,410 Foreign currency translation adjustments — 6,398 6,398 Balance at December 31, 2016 (1) $ 1,164,163 $ 98,800 $ 1,262,963 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) Acquisition of screen advertising companies in Central America and Colombia.
Intangible Assets	As of December 31, intangible assets-net, December 31, Amortization Other (1) December 31, Intangible assets with finite lives: Gross carrying amount $ 99,922 $ — $ 46 $ 99,968 Accumulated amortization (52,232 ) (5,716 ) (1,758 ) (59,706 ) Total net intangible assets with finite lives $ 47,690 $ (5,716 ) $ (1,712 ) $ 40,262 Intangible assets with indefinite lives: Tradename 300,334 — (952 ) 299,382 Total intangible assets — net $ 348,024 $ (5,716 ) $ (2,664 ) $ 339,644 December 31, Additions (2) Amortization Other (1) December 31, Intangible assets with finite lives: Gross carrying amount $ 99,968 $ 503 $ — $ (675 ) $ 99,796 Accumulated amortization (59,706 ) — (5,538 ) 638 (64,606 ) Total net intangible assets with finite lives $ 40,262 503 $ (5,538 ) $ (37 ) $ 35,190 Intangible assets with indefinite lives: Tradename 299,382 — — 327 299,709 Total intangible assets — net $ 339,644 $ 503 $ (5,538 ) $ 290 $ 334,899 (1) Activity for 2015 primarily consists of the write-off write-off write-off (2) Activity for 2016 reflects addition of non-compete
Estimated Aggregate Future Amortization Expense for Intangible Assets	Estimated aggregate future amortization expense for intangible assets is as follows: For the year ended December 31, 2017 $ 4,887 For the year ended December 31, 2018 4,835 For the year ended December 31, 2019 3,973 For the year ended December 31, 2020 4,304 For the year ended December 31, 2021 2,189 Thereafter 15,002 Total $ 35,190

Impairment of Long-Lived Asse35

Impairment of Long-Lived Assets (Tables)	12 Months Ended
	Dec. 31, 2016
Long-Lived Asset Impairment Losses	The Company’s long-lived asset impairment losses are summarized in the following table: Year Ended December 31, 2014 2015 2016 United States theatre properties $ 6,168 $ 7,052 $ 1,929 International theatre properties — 757 907 Subtotal 6,168 7,809 2,836 Intangible assets (see Note 5) 479 992 — Impairment of long-lived assets $ 6,647 $ 8,801 $ 2,836

Deferred Charges and Other As36

Deferred Charges and Other Assets - Net (Tables)	12 Months Ended
	Dec. 31, 2016
Deferred Charges and Other Assets Net	As of December 31, deferred charges and other assets — net consisted of the following: December 31, 2015 2016 Long-term prepaid rents $ 4,278 $ 5,996 Construction and other deposits 8,459 10,881 Equipment to be placed in service 15,388 12,856 Other 10,118 7,822 Total $ 38,243 $ 37,555

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2016
Components of Long-Term Debt	As of December 31, long-term debt consisted of the following: December 31, 2015 2016 Cinemark USA, Inc. term loan $ 679,000 $ 663,799 Cinemark USA, Inc. 4.875% senior notes due 2023 530,000 755,000 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 400,000 Cinemark USA, Inc. 7.375% senior subordinated notes due 2021 200,000 — Other (1) 5,572 4,167 Total long-term debt 1,814,572 1,822,966 Less current portion 8,405 5,671 Less debt issuance costs, net of accumulated amortization of $16,058 and $19,364, respectively 33,237 34,854 Long-term debt, less current portion $ 1,772,930 $ 1,782,441 (1) Primarily represents debt owed to NCM in relation to the recently-formed joint venture AC JV, LLC. See Note 4.
Maturities of Long-Term Debt	The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2016 matures as follows: 2017 $ 5,671 2018 7,099 2019 7,099 2020 5,710 2021 5,710 Thereafter 1,791,677 Total $ 1,822,966

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2016
Fair Value Measurement of Assets and Liabilities on Recurring Basis	Below is a summary of assets and liabilities measured at fair value on a recurring basis as of December 31, 2015. Carrying Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities – current (1) $ (373 ) $ — $ — $ (373 ) Investment in RealD (2) $ 12,900 $ 12,900 $ — $ — (1) The Company was previously party to an interest rate swap agreement. That agreement expired in April 2016. (2) The Company’s investment in RealD was sold in March of 2016. See discussion at Note 6.
Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value	Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3). Liabilities 2015 2016 Beginning balances - January 1 $ 4,572 $ 373 Total (gain) loss included in accumulated other comprehensive loss (155 ) 71 Settlements (4,790 ) (444 ) Ending balances – December 31 $ 373 $ —

Foreign Currency Translation (T

Foreign Currency Translation (Tables)	12 Months Ended
	Dec. 31, 2016
Summary of Impact of Translating Financial Statements of Certain of Company's International Subsidiaries	Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries as of and for the years ended December 31, 2014, 2015 and 2016. Other Comprehensive Country Exchange Rates as of December 31, Income (Loss) For Year Ended December 31, 2014 2015 2016 2014 2015 2016 Brazil 2.69 3.96 3.26 $ (30,723 ) $ (74,559 ) $ 37,286 Argentina 8.55 12.95 16.04 (20,197 ) (30,520 ) (13,362 ) Colombia 2,392.46 3,149.47 3,000.71 (7,632 ) (8,043 ) 1,278 Chile 606.2 709.16 679.09 (5,580 ) (6,572 ) 1,855 Peru 3.05 3.46 3.45 (2,785 ) (4,882 ) 87 All other (2,066 ) (898 ) (783 ) $ (68,983 ) $ (125,474 ) $ 26,361

Noncontrolling Interests in S40

Noncontrolling Interests in Subsidiaries (Tables)	12 Months Ended
	Dec. 31, 2016
Noncontrolling Interests in Subsidiaries	Noncontrolling interests in subsidiaries of the Company were as follows at December 31: December 31, 2015 2016 Cinemark Partners II — 24.6% interest (in one theatre) $ 7,753 $ 8,249 Laredo Theatres – 25% interest (in two theatres) 1,761 1,695 Greeley Ltd. — 49% interest (in one theatre) 740 689 Other 851 509 Total $ 11,105 $ 11,142
Summary of Impact of Changes in Company's Ownership Interest in its Subsidiaries on Its Equity	Below is a summary of the impact of changes in the Company’s ownership interest in its subsidiaries on its equity. Year ended December 31, 2014 2015 2016 Net income attributable to Cinemark USA, Inc. $ 194,380 $ 218,532 $ 256,777 Transfers from noncontrolling interests Decrease in Cinemark USA, Inc. additional paid-in-capital non-controlling — — (27 ) Net transfers from non-controlling — — (27 ) Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests $ 194,380 $ 218,532 $ 256,750

Capital Stock (Tables)

Capital Stock (Tables)	12 Months Ended
	Dec. 31, 2016
Summary of Restricted Stock Activity	Restricted Stock Year Ended Year Ended Year Ended December 31, 2014 December 31, 2015 December 31, 2016 Shares of Weighted Shares of Weighted Shares of Weighted Outstanding at January 1 1,260,913 $ 21.86 878,897 $ 24.92 757,775 $ 30.73 Granted 269,774 $ 28.93 226,212 $ 42.79 335,707 $ 30.98 Vested (625,843 ) $ 20.53 (329,437 ) $ 23.72 (430,056 ) $ 26.60 Forfeited (25,947 ) $ 22.94 (17,897 ) $ 27.58 (56,808 ) $ 33.81 Outstanding at December 31 878,897 $ 24.92 757,775 $ 30.73 606,618 $ 33.51
Financial Performance Factors and Respective Vesting	The financial performance factors and respective vesting rates for each of the 2014, 2015 and 2016 grants are as follows: Year Ended December 31, Percentage of 2014 2015 2016 Threshold IRR 8.5 % 7.5 % 6.0 % 33.3 % Target IRR 10.5 % 9.5 % 8.0 % 66.6 % Maximum IRR 12.5 % 11.5 % 10.0 % 100 %
Number of Units Vested Under Restricted Stock Unit Awards	Below is a table summarizing the potential number of units that could vest under restricted stock unit awards granted during the years ended December 31, 2014, 2015 and 2016 at each of the three levels of financial performance (excluding forfeitures). Granted During the Year Ended December 31, 2014 2015 2016 Number of Value at Number of Value at Number of Value at Units Grant (1) Units Grant (1) Units Grant (1) at threshold IRR 65,832 $ 1,879 47,640 $ 2,057 84,554 $ 2,522 at target IRR 131,683 $ 3,758 95,282 $ 4,115 169,107 $ 5,044 at maximum IRR 197,515 $ 5,637 142,917 $ 6,173 253,661 $ 7,568 (1) The grant date fair values for units issued during the years ended December 31, 2014, 2015, and 2016 were $28.54, $43.19 and $29.83, respectively.
Restricted Stock
Summary of Restricted Stock Award Activity	Below is a summary of restricted stock award activity recorded for the periods indicated. Year Ended December 31, 2014 2015 2016 Compensation expense recognized during the period (1) $ 8,591 $ 8,715 $ 7,269 Fair value of restricted shares that vested during the period (2) $ 17,692 $ 13,276 $ 13,739 Income tax deduction upon vesting of restricted stock awards (3) $ 5,171 $ 3,341 $ 5,167 (1) Cinemark Holdings, Inc. recorded an additional $943, $885 and $981 of compensation expense related to these restricted stock awards during the years ended December 31, 2014, 2015 and 2016, respectively. (2) The fair value of shares in which Cinemark Holdings, Inc.’s directors vested was $1,081, $1,148 and $923 during the years ended December 31, 2014, 2015 and 2016, respectively. (3) Cinemark Holdings, Inc. recognized an additional tax benefit of $454, $482 and $388 on these vested awards during the years ended December 31, 2014, 2015 and 2016, respectively.
Restricted Stock Units (RSUs)
Summary of Restricted Stock Unit Award Activity	Below is a summary of activity for restricted stock unit awards for the periods indicated. Year Ended December 31, 2014 2015 2016 Number of restricted stock unit awards that vested during the period 395,751 123,769 213,984 Fair value of restricted stock unit awards that vested during the period $ 11,420 $ 5,483 $ 7,260 Accumulated dividends paid upon vesting of restricted stock unit awards $ 1,352 $ 442 $ 662 Income tax benefit recognized upon vesting of restricted stock unit awards $ 4,796 $ 2,303 $ 3,049 Compensation expense recognized during the period $ 3,284 $ 6,158 $ 5,144

Supplemental Cash Flow Inform42

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2016
Supplemental Information to Consolidated Statements of Cash Flows	The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2014 2015 2016 Cash paid for interest $ 107,926 $ 105,155 $ 108,101 Cash paid for income taxes, net of refunds received $ 122,972 $ 108,435 $ 93,368 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ (1,225 ) $ 2,491 $ (29,471 ) Theatre properties and equipment acquired under capital lease $ 19,908 $ 36,544 $ 33,282 Investment in NCM - receipt of common units (see Note 3) $ 8,216 $ 15,421 $ 11,111 Noncash distributions to Cinemark Holdings, Inc. $ — $ (17,935 ) $ — Receipt of promissory note related to sale of investment in a Taiwan joint venture $ — $ 2,304 $ — (1) Additions to theatre properties and equipment included in accounts payable as of December 31, 2015 and 2016 were $11,154 and $40,625, respectively.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2016
Income Before Income Taxes	Income before income taxes consisted of the following: Year Ended December 31, 2014 2015 2016 Income before income taxes: U.S. $ 208,377 $ 262,336 $ 277,474 Foreign 84,542 88,015 85,890 Total $ 292,919 $ 350,351 $ 363,364
Current and Deferred Income Taxes	Current and deferred income taxes were as follows: Year Ended December 31, 2014 2015 2016 Current: Federal $ 62,686 $ 72,185 $ 66,210 Foreign 27,681 35,874 32,047 State 6,256 10,806 12,061 Total current expense $ 96,623 $ 118,865 $ 110,318 Deferred: Federal $ 6,322 $ 10,420 $ (13,667 ) Foreign (6,437 ) (3,339 ) 1,674 State 642 4,014 6,526 Total deferred taxes 527 11,095 (5,467 ) Income taxes $ 97,150 $ 129,960 $ 104,851
Reconciliation Between Income Tax Expense and Taxes Computed	A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows: Year Ended December 31, 2014 2015 2016 Computed statutory tax expense $ 102,522 $ 122,623 $ 127,176 Foreign inflation adjustments 641 (1,295 ) (281 ) State and local income taxes, net of federal income tax impact 4,634 9,640 12,081 Foreign losses not benefited and changes in valuation allowance (275 ) (2,408 ) (34,757 ) Foreign tax rate differential (2,125 ) (2,660 ) (942 ) Foreign dividends 1,083 — 68,684 Foreign tax credits — — (62,815 ) Sale of Mexican subsidiaries and related changes in intangible assets (10,065 ) — — Changes in uncertain tax positions (1,540 ) 3,717 921 Other — net 2,275 343 (5,216 ) Income taxes $ 97,150 $ 129,960 $ 104,851
Tax Effects of Significant Temporary Differences and Tax Loss and Tax Credit Carryforwards	The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2015 and 2016 consisted of the following: December 31, 2015 2016 Deferred liabilities: Theatre properties and equipment $ 141,155 $ 176,781 Tax impact of items in accumulated other comprehensive loss 158 — Intangible asset — other 28,889 36,052 Intangible asset — tradenames 112,413 112,747 Investment in partnerships 108,733 107,066 Total deferred liabilities 391,348 432,646 Deferred assets: Deferred lease expenses 26,966 24,026 Exchange (gain) loss 3,736 (731 ) Deferred revenue - NCM 128,642 130,005 Capital lease obligations 75,966 85,721 Tax loss carryforwards 7,379 7,396 Alternative minimum tax and other credit carryforwards 41,300 56,520 Other expenses, not currently deductible for tax purposes 20,204 11,270 Total deferred assets 304,193 314,207 Net deferred income tax liability before valuation allowance 87,155 118,439 Valuation allowance against deferred assets – non-current 50,636 14,524 Net deferred income tax liability $ 137,791 $ 132,963 Net deferred tax liability — Foreign $ 4,212 $ 7,571 Net deferred tax liability — U.S. 133,579 125,392 Total $ 137,791 $ 132,963
Reconciliation of Unrecognized Tax Benefits Excluding Interest and Penalties	The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2014, 2015 and 2016: Year Ended December 31, 2014 2015 2016 Balance at January 1, $ 18,780 $ 16,515 $ 17,133 Gross increases - tax positions in prior periods 10 40 13 Gross decreases - tax positions in prior periods (2,379 ) — — Gross increases - current period tax positions 1,324 2,112 923 Settlements (963 ) (871 ) (924 ) Foreign currency translation adjustments (257 ) (663 ) 258 Balance at December 31, $ 16,515 $ 17,133 $ 17,403

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2016
Rent Expenses	Theatre rent expense was as follows: Year Ended December 31, 2014 2015 2016 Fixed rent expense $ 237,891 $ 240,057 $ 242,927 Contingent rent and other facility lease expenses 79,205 79,704 78,367 Total facility lease expense $ 317,096 $ 319,761 $ 321,294
Estimated Future Minimum Lease Payments	Future minimum lease payments under noncancelable operating and capital leases that have initial or remaining terms in excess of one year at December 31, 2016 are due as follows: Operating Leases Capital Leases 2017 $ 253,824 $ 38,375 2018 231,489 39,104 2019 204,231 38,519 2020 185,508 37,647 2021 163,938 30,636 Thereafter 641,069 169,425 Total $ 1,680,059 353,706 Amounts representing interest payments (98,286 ) Present value of future minimum payments 255,420 Current portion of capital lease obligations (21,139 ) Capital lease obligations, less current portion $ 234,281

Segments (Tables)

Segments (Tables)	12 Months Ended
	Dec. 31, 2016
Selected Financial Information by Reportable Operating Segment	Below is a breakdown of select financial information by reportable operating segment. Year Ended December 31, 2014 2015 2016 Revenues: U.S. $ 1,934,990 $ 2,137,733 $ 2,230,693 International 704,623 728,735 701,573 Eliminations (12,623 ) (13,859 ) (13,501 ) Total revenues $ 2,626,990 $ 2,852,609 $ 2,918,765 Year Ended December 31, Adjusted EBITDA (1) 2014 2015 2016 U.S. $ 457,948 $ 518,165 $ 550,150 International 159,662 166,416 157,690 Total Adjusted EBITDA $ 617,610 $ 684,581 $ 707,840 Year Ended December 31, Capital expenditures: 2014 2015 2016 U.S. $ 148,532 $ 223,213 $ 242,271 International 96,173 108,513 84,637 Total capital expenditures $ 244,705 $ 331,726 $ 326,908 (1) Distributions from NCM are reported entirely within the U.S. operating segment
Reconciliation of Net Income to Adjusted EBITDA	The following table sets forth a reconciliation of net income to Adjusted EBITDA: Year Ended December 31, 2014 2015 2016 Net income $ 195,769 $ 220,391 $ 258,513 Add (deduct): Income taxes 97,150 129,960 104,851 Interest expense (1) 113,698 112,741 108,313 Loss on debt amendments and refinancing — 925 13,445 Other income (2) (22,150 ) (20,041 ) (44,813 ) Other cash distributions from equity investees (3) 19,172 19,027 21,916 Depreciation and amortization 175,656 189,206 209,071 Impairment of long-lived assets 6,647 8,801 2,836 Loss on sale of assets and other 15,715 8,143 20,459 Deferred lease expenses 2,536 (1,806 ) (990 ) Amortization of long-term prepaid rents 1,542 2,361 1,826 Share based awards compensation expense 11,875 14,873 12,413 Adjusted EBITDA $ 617,610 $ 684,581 $ 707,840 (1) Includes amortization of debt issue costs. (2) Includes interest income, foreign currency exchange gain (loss), and equity in income of affiliates and excludes distributions from NCM. (3) Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. In an effort to more closely align our reported Adjusted EBITDA with our operating cash flow, which provides our chief operating decision maker with more comprehensive cash flow information, beginning with the year ended December 31, 2016, Adjusted EBITDA now includes total cash distributions received from equity investees, including the cash distributions recorded as a reduction of the respective investment balance. Adjusted EBITDA for the years ended December 31, 2014 and 2015 has been adjusted to reflect comparable presentations.
Selected Financial Information by Geographic Area	Below is a breakdown of select financial information by geographic area. Year Ended December 31, 2014 2015 2016 Revenues U.S. $ 1,934,990 $ 2,137,733 $ 2,230,693 Brazil 333,919 291,959 304,407 Other foreign countries 370,704 436,776 397,166 Eliminations (12,623 ) (13,859 ) (13,501 ) Total $ 2,626,990 $ 2,852,609 $ 2,918,765 December 31, 2015 2016 Theatres properties and equipment, net U.S. $ 1,175,535 $ 1,306,643 Brazil 163,505 197,896 Other foreign countries 166,029 199,997 Total $ 1,505,069 $ 1,704,536

Valuation and Qualifying Acco46

Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Dec. 31, 2016
Valuation Allowance for Deferred Tax Assets	The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2014, 2015 and 2016 were as follows: Valuation for Deferred Tax Assets Balance at January 1, 2014 $ 25,711 Additions 28,612 Deductions (1,450 ) Balance at December 31, 2014 $ 52,873 Additions 437 Deductions (2,674 ) Balance at December 31, 2015 $ 50,636 Additions 483 Deductions (1) (36,595 ) Balance at December 31, 2016 $ 14,524 (1) See Note 14 for discussion of change in valuation allowance during the year ended December 31, 2016.

Condensed Consolidating Finan47

Condensed Consolidating Financial Statement Information of Subsidiary Guarantors (Tables)	12 Months Ended
	Dec. 31, 2016
Condensed Consolidating Balance Sheet Information	CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503 Other current assets 78,797 18,407 61,432 (32,024 ) 126,612 Accounts receivable from parent or subsidiaries 212,299 — — (211,128 ) 1,171 Total current assets 432,460 114,272 412,706 (243,152 ) 716,286 Theatre properties and equipment - net 539,082 614,821 351,166 — 1,505,069 Investment in subsidiaries 1,326,790 293,900 — (1,620,690 ) — Other assets 1,402,062 135,022 475,187 (105,994 ) 1,906,277 Total assets $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,000 $ — $ 1,405 $ — $ 8,405 Current portion of capital lease obligations 6,426 9,962 2,392 — 18,780 Accounts payable and accrued expenses 197,268 123,759 116,353 (25,396 ) 411,984 Accounts payable to parent or subsidiaries — 23,965 187,163 (211,128 ) — Total current liabilities 210,694 157,686 307,313 (236,524 ) 439,169 Long-term liabilities Long-term debt, less current portion 1,868,763 — 9,534 (105,367 ) 1,772,930 Capital lease obligations, less current portion 114,513 67,440 26,999 — 208,952 Other long-term liabilities and deferrals 404,278 77,774 118,533 (7,255 ) 593,330 Total long-term liabilities 2,387,554 145,214 155,066 (112,622 ) 2,575,212 Commitments and contingencies Equity Cinemark USA, Inc.’s stockholder’s equity: Common stock 49,543 457,369 10,240 (467,609 ) 49,543 Other stockholder’s equity 1,052,603 397,746 755,335 (1,153,081 ) 1,052,603 Total Cinemark USA, Inc. stockholder’s equity 1,102,146 855,115 765,575 (1,620,690 ) 1,102,146 Noncontrolling interests — — 11,105 — 11,105 Total equity 1,102,146 855,115 776,680 (1,620,690 ) 1,113,251 Total liabilities and equity $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 146,855 $ 281,023 $ 133,260 $ — $ 561,138 Other current assets 62,425 15,098 71,706 (34,154 ) 115,075 Accounts receivable from parent or subsidiaries 76,550 121,478 (187,948 ) 10,080 Total current assets 285,830 417,599 204,966 (222,102 ) 686,293 Theatre properties and equipment - net 604,506 678,984 421,046 — 1,704,536 Investment in subsidiaries 1,570,592 132,892 — (1,703,484 ) — Other assets 1,409,320 134,284 488,535 (106,359 ) 1,925,780 Total assets $ 3,870,248 $ 1,363,759 $ 1,114,547 $ (2,031,945 ) $ 4,316,609 Liabilities and equity Current liabilities Current portion of long-term debt $ 4,282 $ — $ 1,409 $ (20 ) $ 5,671 Current portion of capital lease obligations 7,903 9,541 3,695 — 21,139 Accounts payable and accrued expenses 197,789 121,640 113,020 (16,457 ) 415,992 Accounts payable to parent or subsidiaries — — 187,948 (187,948 ) — Total current liabilities 209,974 131,181 306,072 (204,425 ) 442,802 Long-term liabilities Long-term debt, less current portion 1,879,663 — 12,600 (109,822 ) 1,782,441 Capital lease obligations, less current portion 124,944 71,228 38,109 — 234,281 Other long-term liabilities and deferrals 382,729 84,429 120,061 (14,214 ) 573,005 Total long-term liabilities 2,387,336 155,657 170,770 (124,036 ) 2,589,727 Commitments and contingencies Equity Cinemark USA, Inc.’s stockholder’s equity: — Common stock 49,543 457,368 10,239 (467,607 ) 49,543 Other stockholder’s equity 1,223,395 619,553 616,324 (1,235,877 ) 1,223,395 Total Cinemark USA, Inc. stockholder’s equity 1,272,938 1,076,921 626,563 (1,703,484 ) 1,272,938 Noncontrolling interests — — 11,142 — 11,142 Total equity 1,272,938 1,076,921 637,705 (1,703,484 ) 1,284,080 Total liabilities and equity $ 3,870,248 $ 1,363,759 $ 1,114,547 $ (2,031,945 ) $ 4,316,609
Condensed Consolidating Statement of Income Information	CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 851,299 $ 1,084,852 $ 733,435 $ (42,596 ) $ 2,626,990 Cost of operations Theatre operating expenses 693,323 739,686 524,045 (42,596 ) 1,914,458 General and administrative expenses 17,978 74,971 55,639 — 148,588 Depreciation and amortization 50,858 67,460 57,338 — 175,656 Impairment of long-lived assets 6,334 313 — — 6,647 Loss on sale of assets and other 8,954 3,278 3,483 — 15,715 Total cost of operations 777,447 885,708 640,505 (42,596 ) 2,261,064 Operating income 73,852 199,144 92,930 — 365,926 Other income (expense) Interest expense (101,224 ) (9,111 ) (3,392 ) 29 (113,698 ) Distributions from NCM 2,375 — 16,166 — 18,541 Equity in income of affiliates 208,900 53,950 22,464 (262,571 ) 22,743 Other income (expense) 79 — (643 ) (29 ) (593 ) Total other income (expense) 110,130 44,839 34,595 (262,571 ) (73,007 ) Income before income taxes 183,982 243,983 127,525 (262,571 ) 292,919 Income taxes (10,398 ) 71,687 35,861 — 97,150 Net income 194,380 172,296 91,664 (262,571 ) 195,769 Less: Net income attributable to noncontrolling interests — — 1,389 — 1,389 Net income attributable to Cinemark USA, Inc. $ 194,380 $ 172,296 $ 90,275 $ (262,571 ) $ 194,380 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 959,347 $ 1,178,873 $ 764,631 $ (50,242 ) $ 2,852,609 Cost of operations Theatre operating expenses 767,446 804,236 545,131 (50,242 ) 2,066,571 General and administrative expenses 16,152 81,240 56,660 — 154,052 Depreciation and amortization 59,759 73,708 55,739 — 189,206 Impairment of long-lived assets 6,445 1,600 756 — 8,801 (Gain) loss on sale of assets and other 6,191 3,728 (1,776 ) — 8,143 Total cost of operations 855,993 964,512 656,510 (50,242 ) 2,426,773 Operating income 103,354 214,361 108,121 — 425,836 Other income (expense) Interest expense (100,608 ) (8,500 ) (4,009 ) 376 (112,741 ) Loss on debt amendments and refinancing (925 ) — — — (925 ) Distributions from NCM 2,116 — 16,024 — 18,140 Equity in income of affiliates 217,567 55,082 27,262 (271,785 ) 28,126 Other income (expense) 200 20 (7,929 ) (376 ) (8,085 ) Total other income (expense) 118,350 46,602 31,348 (271,785 ) (75,485 ) Income before income taxes 221,704 260,963 139,469 (271,785 ) 350,351 Income taxes 3,172 79,131 47,657 — 129,960 Net income 218,532 181,832 91,812 (271,785 ) 220,391 Less: Net income attributable to noncontrolling interests — — 1,859 — 1,859 Net income attributable to Cinemark USA, Inc. $ 218,532 $ 181,832 $ 89,953 $ (271,785 ) $ 218,532 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,014,713 $ 1,219,218 $ 737,981 $ (53,147 ) $ 2,918,765 Cost of operations Theatre operating expenses 804,041 828,905 540,310 (53,147 ) 2,120,109 General and administrative expenses 13,085 84,453 43,099 — 140,637 Depreciation and amortization 70,654 79,139 59,278 — 209,071 Impairment of long-lived assets 1,929 — 907 — 2,836 Loss on sale of assets and other 5,613 13,759 1,087 20,459 Total cost of operations 895,322 1,006,256 644,681 (53,147 ) 2,493,112 Operating income 119,391 212,962 93,300 — 425,653 Other income (expense) Interest expense (96,442 ) (7,538 ) (5,642 ) 1,309 (108,313 ) Loss on debt amendments and refinancing (13,445 ) — — — (13,445 ) Distributions from NCM 1,414 — 13,242 — 14,656 Equity in income of affiliates 245,010 58,528 30,370 (301,946 ) 31,962 Other income 351 19 13,790 (1,309 ) 12,851 Total other income (expense) 136,888 51,009 51,760 (301,946 ) (62,289 ) Income before income taxes 256,279 263,971 145,060 (301,946 ) 363,364 Income taxes (498 ) 52,277 53,072 — 104,851 Net income 256,777 211,694 91,988 (301,946 ) 258,513 Less: Net income attributable to noncontrolling interests — — 1,736 — 1,736 Net income attributable to Cinemark USA, Inc. $ 256,777 $ 211,694 $ 90,252 $ (301,946 ) $ 256,777
Condensed Consolidating Statement of Comprehensive Income (Loss) Information	CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 194,380 $ 172,296 $ 91,664 $ (262,571 ) $ 195,769 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,759, net of settlements 2,846 — — — 2,846 Unrealized gain due to fair value adjustments on available-for-sale 2,507 — — — 2,507 Other comprehensive income in equity method investments 676 — 643 (643 ) 676 Foreign currency translation adjustments (68,982 ) — (68,997 ) 68,982 (68,997 ) Total other comprehensive loss, net of tax (62,953 ) — (68,354 ) 68,339 (62,968 ) Total comprehensive income, net of tax $ 131,427 $ 172,296 $ 23,310 $ (194,232 ) $ 132,801 Comprehensive income attributable to noncontrolling interests — — (1,374 ) — (1,374 ) Comprehensive income attributable to Cinemark USA, Inc. $ 131,427 $ 172,296 $ 21,936 $ (194,232 ) $ 131,427 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,562, net of settlements 2,636 — — — 2,636 Unrealized loss due to fair value adjustments on available-for-sale (957 ) — — — (957 ) Other comprehensive loss in equity method investments (3,119 ) — (3,086 ) 3,086 (3,119 ) Foreign currency translation adjustments (125,474 ) — (125,512 ) 125,474 (125,512 ) Total other comprehensive loss, net of tax (126,914 ) — (128,598 ) 128,560 (126,952 ) Total comprehensive income (loss), net of tax $ 91,618 $ 181,832 $ (36,786 ) $ (143,225 ) $ 93,439 Comprehensive income attributable to noncontrolling interests — — (1,821 ) — (1,821 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ 91,618 $ 181,832 $ (38,607 ) $ (143,225 ) $ 91,618 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $138, net of settlements 234 — — — 234 Other comprehensive income in equity method investments 89 — 89 (89 ) 89 Foreign currency translation adjustments 26,361 — 26,394 (26,361 ) 26,394 Total other comprehensive income, net of tax 26,684 — 26,483 (26,450 ) 26,717 Total comprehensive income, net of tax $ 283,461 $ 211,694 $ 118,471 $ (328,396 ) $ 285,230 Comprehensive income attributable to noncontrolling interests — — (1,769 ) — (1,769 ) Comprehensive income attributable to Cinemark USA, Inc. $ 283,461 $ 211,694 $ 116,702 $ (328,396 ) $ 283,461
Condensed Consolidating Statement of Cash Flows Information	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 194,380 $ 172,296 $ 91,664 $ (262,571 ) $ 195,769 Adjustments to reconcile net income to cash provided by (used for) operating activities (134,559 ) 42,620 31,874 262,571 202,506 Changes in assets and liabilities 232,167 (246,598 ) 70,284 — 55,853 Net cash provided by (used for) operating activities 291,988 (31,682 ) 193,822 — 454,128 Investing activities Additions to theatre properties and equipment (93,608 ) (52,896 ) (98,201 ) — (244,705 ) Acquisition of theatres in the U.S., net of cash acquired (7,951 ) — — — (7,951 ) Acquisition of screen advertising business — — (1,040 ) — (1,040 ) Proceeds from sale of theatre properties and equipment and other 1,109 98 1,338 — 2,545 Dividends received from subsidiaries 1,094 8 — (1,102 ) — Investments in, and loans to, subsidiaries (1,918 ) — — 1,918 — Investment in joint ventures and other — — (2,188 ) — (2,188 ) Net cash used for investing activities (101,274 ) (52,790 ) (100,091 ) 816 (253,339 ) Financing activities Dividends paid to parent (115,000 ) (700 ) (402 ) 1,102 (115,000 ) Repayments of other long-term debt (7,000 ) — (2,846 ) — (9,846 ) Payments on capital leases (4,082 ) (8,000 ) (1,953 ) — (14,035 ) Capital contributions and loans from parent — 1,918 — (1,918 ) — Other 2,808 (9,861 ) (386 ) — (7,439 ) Net cash used for financing activities (123,274 ) (16,643 ) (5,587 ) (816 ) (146,320 ) Effect of exchange rate changes on cash and cash equivalents — — (15,522 ) — (15,522 ) Increase (decrease) in cash and cash equivalents 67,440 (101,115 ) 72,622 — 38,947 Cash and cash equivalents: Beginning of year 62,065 175,758 362,071 — 599,894 End of year $ 129,505 $ 74,643 $ 434,693 $ — $ 638,841 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Adjustments to reconcile net income to cash provided by operating activities (142,602 ) 39,156 43,223 271,785 211,562 Changes in assets and liabilities 67,253 (67,850 ) 23,869 — 23,272 Net cash provided by operating activities 143,183 153,138 158,904 — 455,225 Investing activities Additions to theatre properties and equipment (98,193 ) (121,605 ) (111,928 ) — (331,726 ) Proceeds from sale of theatre properties and equipment and other 2,737 5,264 1,965 — 9,966 Acquisition of theatre in Brazil — — (2,651 ) — (2,651 ) Dividends received from subsidiaries 1,685 15 — (1,700 ) — Intercompany note issuances (3,500 ) — (100,000 ) 103,500 — Investment in joint ventures and other (518 ) — (3,211 ) 18 (3,711 ) Net cash used for investing activities (97,789 ) (116,326 ) (215,825 ) 101,818 (328,122 ) Financing activities Dividends paid to parent (115,225 ) (1,700 ) — 1,700 (115,225 ) Repayments of long-term debt (8,385 ) — (35 ) — (8,420 ) Payments of debt issue costs (6,957 ) — — — (6,957 ) Payments on capital leases (5,389 ) (9,120 ) (2,004 ) — (16,513 ) Intercompany loan proceeds 100,000 — 3,518 (103,518 ) — Other 2,421 (4,770 ) (1,045 ) — (3,394 ) Net cash provided by (used for) financing activities (33,535 ) (15,590 ) 434 (101,818 ) (150,509 ) Effect of exchange rate changes on cash and cash equivalents — — (26,932 ) — (26,932 ) Increase (decrease) in cash and cash equivalents 11,859 21,222 (83,419 ) — (50,338 ) Cash and cash equivalents: Beginning of year 129,505 74,643 434,693 — 638,841 End of year $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Adjustments to reconcile net income to cash provided by operating activities (189,223 ) 55,128 53,381 301,946 221,232 Changes in assets and liabilities 154,085 (164,005 ) (18,642 ) — (28,562 ) Net cash provided by operating activities 221,639 102,817 126,727 — 451,183 Investing activities Additions to theatre properties and equipment (108,439 ) (130,843 ) (87,626 ) — (326,908 ) Acquisition of theatres in the US (15,300 ) — — — (15,300 ) Acquisition of screen advertising business — — (1,450 ) — (1,450 ) Proceeds from sale of theatre properties and equipment and other 2,912 374 284 — 3,570 Proceeds from sale of marketable securities 13,451 — — — 13,451 Intercompany note issuances (4,455 ) — — 4,455 — Dividends received from subsidiaries 26,033 229,649 — (255,682 ) — Investment in joint ventures and other (1,000 ) — (132 ) — (1,132 ) Net cash provided by (used for) investing activities (86,798 ) 99,180 (88,924 ) (251,227 ) (327,769 ) Financing activities Dividends paid to parent (124,900 ) — (255,682 ) 255,682 (124,900 ) Proceeds from issuance of Senior Notes, net of discount 222,750 — — — 222,750 Retirement of Senior Subordinated Notes (200,000 ) — — — (200,000 ) Repayments of long-term debt (15,201 ) — (1,404 ) — (16,605 ) Payments of debt issue costs (7,217 ) — — — (7,217 ) Intercompany loan proceeds — — 4,455 (4,455 ) — Payments on capital leases (6,645 ) (10,005 ) (2,693 ) — (19,343 ) Other 1,863 (6,834 ) (1,759 ) — (6,730 ) Net cash used for financing activities (129,350 ) (16,839 ) (257,083 ) 251,227 (152,045 ) Effect of exchange rate changes on cash and cash equivalents — — 1,266 — 1,266 Increase (decrease) in cash and cash equivalents 5,491 185,158 (218,014 ) — (27,365 ) Cash and cash equivalents: Beginning of year 141,364 95,865 351,274 — 588,503 End of year $ 146,855 $ 281,023 $ 133,260 $ — $ 561,138

Estimated Useful Lives of Asset

Estimated Useful Lives of Assets (Detail)	12 Months Ended
	Dec. 31, 2016
Buildings On Owned Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	P40Y
Buildings On Leased Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
Land and Buildings under Capital Lease
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life	[1]
Theatre Furniture and Equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	3 years
Theatre Furniture and Equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	15 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
[1]	Amortization of capital lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital lease assets as of December 31, 2015 and 2016 was $150,968 and $175,166, respectively.

Estimated Useful Lives of Ass49

Estimated Useful Lives of Assets (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Accumulated depreciation and amortization	$ 1,355,218	$ 1,182,322
Property Under Capital Lease
Property, Plant and Equipment [Line Items]
Accumulated depreciation and amortization	$ 175,166	$ 150,968

Summary of Significant Accoun50

Summary of Significant Accounting Policies - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)SegmentCommunityCountry	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)Unit
Summary Of Significant Accounting Policies [Line Items]
Lease period of fee owned properties	20 years
Multiple of cash flows used to estimate fair value of long-lived assets	6.5	6.5	6.5
Multiplication Value to Cash flows for the determination of fair value of Reporting units | Unit			8
Reporting unit percentage of fair value in excesses of carrying value amount			10.00%
Requirements to be classified as capital lease, minimum amount of present value of future minimum lease payments against estimated fair value, percentage	90.00%
Requirements to be classified as capital lease, minimum length of lease term against estimated useful life, percentage	75.00%
General liability claim per occurrence, cap	$ 100	$ 100	$ 100
Annual cap per policy year	3,350	2,900	2,670
Medical claim per occurrence, cap	150	125	125
Insurance Reserves	7,837	9,039
Unredeemed gift cards and other advances	11,522	11,786	12,233
Liabilities for advanced sale-type certificates	70,247	68,158
Rewards earned and not redeemed, Current	$ 800
Number of reportable operating segments | Segment	2
Film rentals and advertising costs	$ (962,655)	(945,640)	(856,388)
Utilities and other costs	$ 355,926	355,801	335,109
Scenario, Previously Reported
Summary Of Significant Accounting Policies [Line Items]
Film rentals and advertising costs		(26,664)	(30,950)
Scenario, Adjusted Reported
Summary Of Significant Accounting Policies [Line Items]
Utilities and other costs		$ 26,664	$ 30,950
Minimum
Summary Of Significant Accounting Policies [Line Items]
Amortization period of deferred charges and other assets	2 years
Remaining amortization period for deferred revenues	1 year
Maximum
Summary Of Significant Accounting Policies [Line Items]
Amortization period of deferred charges and other assets	15 years
Remaining amortization period for deferred revenues	20 years
Trade Names
Summary Of Significant Accounting Policies [Line Items]
Fair value in excess of carrying value percentage			10.00%
U.S. Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Number of reporting unit | Community	19
International Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Number of reporting unit | Country	7

Intangible Assets and Amortizat

Intangible Assets and Amortization Method (Detail)	12 Months Ended
	Dec. 31, 2016
Finite-Lived Intangible Assets [Line Items]
Goodwill	Indefinite-lived
Tradename	Indefinite-lived
Vendor Contracts
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from one to four years.
Vendor Contracts | Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Vendor Contracts | Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Favorable Unfavorable Leases
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately three to twenty years.
Favorable Unfavorable Leases | Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years
Favorable Unfavorable Leases | Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	21 years
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to ten years.
Other Intangible Assets | Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Other Intangible Assets | Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	11 years

Investment in National CineMe52

Investment in National CineMedia LLC - Additional Information (Detail) $ / shares in Units, $ in Thousands	Feb. 13, 2007USD ($)	Dec. 31, 2016USD ($)$ / shares$ / Customershares	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Schedule of Equity Method Investments [Line Items]
Theatre access fees per patron | $ / Customer		0.07
Increase in percentage of payment per theatre patron		8.00%
Duration of percentage increase in theatre access fees per patron		5 years
Payment per digital screen	$ 800	$ 1,241	$ 1,182	$ 1,125
Percentage of annual increase in payment per digital screen		5.00%
Minimum percentage of aggregate advertising revenue for payment of fees		12.00%
Remaining term of exhibitor services agreement		20 years
Number of common units of NCM owned by Company | shares		26,384,644
Interest in common units of NCM owned by Company		19.00%
NCM
Schedule of Equity Method Investments [Line Items]
Contract termination costs incurred by NCM		$ 26,800
NCM | Theatre Furniture and Equipment
Schedule of Equity Method Investments [Line Items]
Payment for installation of certain equipment used for digital advertising		$ 49	$ 50	$ 124
Investment In NCM
Schedule of Equity Method Investments [Line Items]
Common unit convertible into share of NCMI common stock, conversion ratio		1
Estimated fair value of investment using NCMI's stock price		$ 388,646
NCMI stock price | $ / shares		$ 14.73

Summary of Common Units Receive

Summary of Common Units Received Under Adjustment Agreement (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]
Fair Value of Common Units Received	$ 11,111	$ 15,421	$ 8,216
Annual Common Unit Adjustment
Schedule of Equity Method Investments [Line Items]
Fair Value of Common Units Received	$ 11,111	$ 15,421	$ 8,216
Number of Common Units Received	753,598	1,074,910	557,631
Date Common Units Received	Mar. 31, 2016	Mar. 31, 2015	Mar. 27, 2014

Summary of Activity with NCM In

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]
Equity in earnings		$ 31,962	$ 28,126	$ 22,743
Equity in other comprehensive income		(89)	3,119	(676)
Other Comprehensive (Income) Loss
Schedule of Equity Method Investments [Line Items]
Ending Balance			2,735	(896)
Cash Received
Schedule of Equity Method Investments [Line Items]
Receipt of excess cash distributions		22,716	29,468	27,352
Receipt under tax receivable agreement		6,158	5,052	6,357
Revenues earned under ESA	[1]	11,048	11,330	9,249
Ending Balance		39,922	45,850	42,958
Other Revenue
Schedule of Equity Method Investments [Line Items]
Revenues earned under ESA	[1]	(11,048)	(11,330)	(9,249)
Ending Balance		20,365	19,836	16,675
Equity in Earnings
Schedule of Equity Method Investments [Line Items]
Equity in earnings		(9,347)	(8,510)	(6,142)
Distributions from NCM
Schedule of Equity Method Investments [Line Items]
Receipt of excess cash distributions		11,483	15,396	14,778
Receipt under tax receivable agreement		3,173	2,744	3,763
Ending Balance		(14,656)	(18,140)	(18,541)
Investment In NCM
Schedule of Equity Method Investments [Line Items]
Beginning Balance		183,755	178,939	178,853
Receipt of common units due to annual common unit adjustment		11,111	15,421	8,216
Receipt of excess cash distributions		(11,233)	(14,072)	(12,574)
Receipt under tax receivable agreement		(2,985)	(2,308)	(2,594)
Equity in earnings		(9,347)	(8,510)	(6,142)
Equity in other comprehensive income			(2,735)	896
Ending Balance		189,995	183,755	178,939
Deferred Revenue
Schedule of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment		(11,111)	(15,421)	(8,216)
Beginning Balance		(342,134)	(335,219)	(334,429)
Ending Balance		(343,928)	(342,134)	(335,219)
NCM
Schedule of Equity Method Investments [Line Items]
Beginning Balance		183,755
Ending Balance		189,995	183,755
Beginning Balance		(342,134)
Ending Balance		(343,928)	(342,134)
NCM | Other Comprehensive (Income) Loss
Schedule of Equity Method Investments [Line Items]
Equity in other comprehensive income			2,735	(896)
NCM | Other Revenue
Schedule of Equity Method Investments [Line Items]
Amortization of deferred revenue		(9,317)	(8,506)	(7,426)
NCM | Equity in Earnings
Schedule of Equity Method Investments [Line Items]
Equity in earnings		(9,347)	(8,510)	(6,142)
NCM | Deferred Revenue
Schedule of Equity Method Investments [Line Items]
Amortization of deferred revenue		$ 9,317	$ 8,506	$ 7,426
[1]	Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire were approximately $11,489, $9,819 and $10,523 for the years ended December 31, 2014, 2015 and 2016, respectively.

Summary of Activity with NCM 55

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]
Company's beverage concessionaire advertising costs	$ 10,523	$ 9,819	$ 11,489

Summary Financial Information f

Summary Financial Information for National CineMedia (Detail) - NCM - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 29, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]
Revenues	$ 305,101	$ 446,463	$ 393,994
Operating income	100,911	140,498	159,624
Net income	49,619	87,474	$ 96,309
Total assets	758,607	782,579
Total liabilities	$ 1,007,704	$ 1,049,145

Summary of Activity for Each of

Summary of Activity for Each of Investment (Detail) - USD ($) $ in Thousands		1 Months Ended	12 Months Ended
		Dec. 31, 2013	Dec. 31, 2016		Dec. 31, 2015		Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			$ 94,973
Equity in income (loss)			(31,962)		$ (28,126)		$ (22,743)
Equity in other comprehensive income(loss)			(89)		3,119		(676)
Cash distributions received	[1]		(21,916)		(19,027)		(19,172)
Investments, ending balance			98,317		94,973
Other Affiliates
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			94,973		77,658		59,657
Cash contributions			717		3,711		2,188
Equity in income (loss)			22,615		19,616		16,601
Equity in other comprehensive income(loss)			89		(384)		(219)
Unrealized holding gain					(1,529)		3,986
Cash distributions received			(7,698)		(2,647)		(4,004)
Other			521		(69)		(551)
Investments, ending balance		$ 59,657	98,317		94,973		77,658
Sale of investment in Taiwan	[2]				(1,383)
Sale of investment	[3]		(12,900)
Other Affiliates | Digital Cinema Implementation Partners LLC
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			71,579		51,277		38,033
Cash contributions			717		3,211		2,188
Equity in income (loss)			21,434		18,522		15,279
Equity in other comprehensive income(loss)			89		(384)		(219)
Cash distributions received			(6,000)		(1,047)		(4,004)
Investments, ending balance		38,033	87,819		71,579		51,277
Other Affiliates | RealD
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			12,900	[4]	14,429		10,443
Unrealized holding gain					(1,529)		3,986
Investments, ending balance		10,443			12,900	[4]	14,429
Sale of investment	[3]		(12,900)
Other Affiliates | AC JV, LLC
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			7,269		7,899		6,426
Cash contributions		268
Equity in income (loss)			311		970		1,473
Cash distributions received			(1,600)		(1,600)
Investments, ending balance		6,426	5,980		7,269		7,899
Other Affiliates | Digital Cinema Distribution Coalition
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			2,562		2,438		2,589
Equity in income (loss)			870		124		(151)
Cash distributions received			(98)
Other			(584)
Investments, ending balance		2,589	2,750		2,562		2,438
Other Affiliates | Other Investment
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			663		1,615		2,166
Cash contributions					500
Other			1,105		(69)		(551)
Investments, ending balance		$ 2,166	$ 1,768		663		$ 1,615
Sale of investment in Taiwan	[2]				$ (1,383)
[1]	Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. In an effort to more closely align our reported Adjusted EBITDA with our operating cash flow, which provides our chief operating decision maker with more comprehensive cash flow information, beginning with the year ended December 31, 2016, Adjusted EBITDA now includes total cash distributions received from equity investees, including the cash distributions recorded as a reduction of the respective investment balance. Adjusted EBITDA for the years ended December 31, 2014 and 2015 has been adjusted to reflect comparable presentations.
[2]	The Company sold its investment in a Taiwan joint venture for $2,634, resulting in a gain of $1,251, which is included in loss on sale of assets and other for the year ended December 31, 2015.
[3]	See further discussion of the sale of the investment held by the Company under RealD, Inc. below.
[4]	The Company's investment in RealD was sold in March of 2016. See discussion at Note 6.

Summary of Activity for Each 58

Summary of Activity for Each of Investment (Parenthetical) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)
Schedule of Equity Method Investments [Line Items]
Proceeds from sale of investment in joint venture	$ 2,634
Gain (loss) on sale of assets and other	$ 1,251

Other Investments - Additional

Other Investments - Additional Information (Detail)	Mar. 22, 2016USD ($)$ / shares	Dec. 31, 2013USD ($)	Mar. 31, 2011$ / shares	Dec. 31, 2016USD ($)ProjectionSystemRenewalOptions	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2011shares
Schedule of Equity Method Investments [Line Items]
Number of shares owned in RealD | shares								1,222,780
Exercise price of options, shares | $ / shares			$ 0.00667
Proceeds from sale of marketable securities				$ 13,451,000
Digital Cinema Implementation Partners LLC
Schedule of Equity Method Investments [Line Items]
Digital projection systems leased under operating lease, initial term				12 years
Number of equipment being leased under master equipment lease agreement | ProjectionSystem				3,795
Number of one-year fair value renewal options | RenewalOptions				10
Minimum annual rent per digital projection system				$ 1,000
Other Affiliates
Schedule of Equity Method Investments [Line Items]
Cash contributions				$ 717,000	$ 3,711,000	$ 2,188,000
Other Affiliates | Digital Cinema Implementation Partners LLC
Schedule of Equity Method Investments [Line Items]
Percentage of voting interest				33.00%
Economic interest in Digital Cinema Implementation Partners				24.30%
Cash contributions				$ 717,000	3,211,000	2,188,000
Other Affiliates | RealD
Schedule of Equity Method Investments [Line Items]
Purchase price per share | $ / shares	$ 11
Gain on investment				3,742,000
Unrealized holding gain previously recorded in AOCI				3,191,000
Proceeds from sale of marketable securities	$ 13,451,000
Other Affiliates | AC JV, LLC
Schedule of Equity Method Investments [Line Items]
Ownership of class A units sold to Founding Members		97.00%
Cash contributions		$ 268,000
Ownership of class A units		1.00%
Ownership of class A units							31.00%
Aggregate value of Class A units							$ 25,000,000
Promissory note term							6 years
Original principal value of promissory note with NCM							$ 8,333,000
Annual Interest rate on promissory note		5.00%					5.00%
Remaining outstanding balance of note payable				4,167,000
Other Affiliates | AC JV, LLC | Film rentals and advertising
Schedule of Equity Method Investments [Line Items]
Event fees				$ 10,871,000	11,440,000	9,273,000
Other Affiliates | Digital Cinema Distribution Coalition
Schedule of Equity Method Investments [Line Items]
Percentage of voting interest				14.60%
Payments for content delivery services				$ 939,000	$ 807,000	$ 741,000

Summary Financial Information60

Summary Financial Information for DCIP (Detail) - Other Affiliates - Digital Cinema Implementation Partners LLC - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]
Net operating revenue	$ 178,836	$ 171,203	$ 170,724
Operating income	107,919	103,449	101,956
Net income	89,152	79,255	$ 61,293
Total assets	906,377	1,004,757
Total liabilities	$ 509,197	$ 675,192

Transaction with DCIP (Detail)

Transaction with DCIP (Detail) - Digital Cinema Implementation Partners LLC - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]
Equipment lease payments	$ 5,217	$ 4,474	$ 4,012
Warranty reimbursements from DCIP	(6,091)	(4,329)	(3,169)
Management services fees	$ 825	$ 825	$ 782

Summary of Goodwill (Detail)

Summary of Goodwill (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015
Goodwill [Line Items]
Beginning Balance	[1]	$ 1,247,548	$ 1,277,383
Acquisition of theatres		7,607	356
Foreign currency translation adjustments		6,398	(30,191)
Ending Balance	[1]	1,262,963	1,247,548
Other acquisitions	[2]	1,410
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	1,156,556	1,156,556
Acquisition of theatres		7,607
Ending Balance	[1]	1,164,163	1,156,556
International Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	90,992	120,827
Acquisition of theatres			356
Foreign currency translation adjustments		6,398	(30,191)
Ending Balance	[1]	98,800	$ 90,992
Other acquisitions	[2]	$ 1,410
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.
[2]	Acquisition of screen advertising companies in Central America and Colombia.

Summary of Goodwill (Parentheti

Summary of Goodwill (Parenthetical) (Detail) $ in Thousands	Dec. 31, 2016USD ($)
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 214,031
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 27,622

Intangible Assets (Detail)

Intangible Assets (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015
Intangible Assets [Line Items]
Intangible assets with finite lives, Beginning balance		$ 99,968	$ 99,922
Intangible assets with finite lives, additions	[1]	503
Other, Gross carrying amount	[2]	(675)	46
Intangible assets with finite lives, Ending balance		99,796	99,968
Net intangible assets with finite lives, Beginning balance		40,262	47,690
Intangible assets with finite lives, additions	[1]	503
Amortization, intangible assets		5,538	(5,716)
Other, Finite lived intangible assets	[2]	(37)	(1,712)
Net intangible assets with finite lives, Ending balance		35,190	40,262
Intangible assets with finite lives, Accumulated amortization, Beginning balance		(59,706)	(52,232)
Accumulated amortization additions	[1]	0
Accumulated amortization		5,538	(5,716)
Other Accumulated Amortization of Intangible Assets	[2]	(638)	(1,758)
Intangible assets with finite lives, Accumulated amortization, Ending balance		(64,606)	(59,706)
Indefinite-lived Intangible Assets, Trade name, Beginning Balance		299,382	300,334
Indefinite lived intangible assets, additions	[1]	0
Other, Trade name	[2]	327	(952)
Indefinite-lived Intangible Assets, Trade name, Ending Balance		299,709	299,382
Total intangible assets - net, Beginning balance		339,644	348,024
Accumulated amortization		5,538	(5,716)
Intangible assets with finite lives, additions	[1]	503
Other, Total intangible assets - net	[2]	290	(2,664)
Total intangible assets - net, Ending balance		$ 334,899	$ 339,644
[1]	Activity for 2016 reflects addition of non-compete agreement and favorable lease associated with theatres acquired in the U.S.
[2]	Activity for 2015 primarily consists of the write-off of intangible assets for closed theatres, the write-off of a vendor contract intangible asset, impairment of a favorable lease and foreign currency translation adjustments. Activity for 2016 includes the write-off of intangible assets for closed theatres and foreign currency translation adjustments.

Estimated Aggregate Future Amor

Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
For the year ended December 31, 2017	$ 4,887
For the year ended December 31, 2018	4,835
For the year ended December 31, 2019	3,973
For the year ended December 31, 2020	4,304
For the year ended December 31, 2021	2,189
Thereafter	15,002
Total	$ 35,190	$ 40,262	$ 47,690

Long-Lived Asset Impairment Cha

Long-Lived Asset Impairment Charges (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	$ 2,836	$ 7,809	$ 6,168
Intangible assets		992	479
Impairment of long-lived assets	2,836	8,801	6,647
U.S. Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	1,929	7,052	$ 6,168
International Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	$ 907	$ 757

Impairment of Long-Lived Asse67

Impairment of Long-Lived Assets - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)
Indefinite-lived Intangible Assets [Line Items]
Estimated aggregate fair value of long-lived assets impaired during current period	$ 1,595

Deferred Charges and Other As68

Deferred Charges and Other Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Other Noncurrent Assets Disclosure [Line Items]
Long-term prepaid rents	$ 5,996	$ 4,278
Construction and other deposits	10,881	8,459
Equipment to be placed in service	12,856	15,388
Other	7,822	10,118
Total	$ 37,555	$ 38,243

Long-Term Debt (Detail)

Long-Term Debt (Detail) - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Cinemark USA, Inc. term loan		$ 663,799	$ 679,000
Other	[1]	4,167	5,572
Total		1,822,966	1,814,572
Less current portion		5,671	8,405
Less debt issuance costs, net of accumulated amortization of $16,058 and $19,364, respectively		34,854	33,237
Long-term debt, less current portion		1,782,441	1,772,930
4.875 % Senior Notes Due May 2023
Debt Instrument [Line Items]
Senior notes		755,000	530,000
Less debt issuance costs, net of accumulated amortization of $16,058 and $19,364, respectively		3,702
5.125% Senior Notes Due 2022
Debt Instrument [Line Items]
Senior notes		$ 400,000	400,000
7.375% Senior Subordinated Notes Due 2021
Debt Instrument [Line Items]
Senior subordinated notes			$ 200,000
[1]	Primarily represents debt owed to NCM in relation to the recently-formed joint venture AC JV, LLC. See Note 4.

Long-Term Debt (Parenthetical)

Long-Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Debt issuance costs, accumulated amortization	$ 19,364	$ 16,058

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail)

Dec. 15, 2016

Jun. 13, 2016

May 16, 2016USD ($)

Mar. 21, 2016USD ($)

May 08, 2015USD ($)

May 24, 2013USD ($)

Dec. 31, 2016USD ($)

Dec. 31, 2015USD ($)

Dec. 31, 2014USD ($)

Dec. 31, 2012

Dec. 18, 2012USD ($)

Jun. 03, 2011USD ($)

Debt Instrument [Line Items]

Incurred debt issue costs

$ 7,217,000

$ 6,957,000

Loss on debt amendments and refinancing

$ 13,445,000

925,000

$ 0

Percentage voting stock of foreign subsidiaries PercentageVotingStockOfForeignSubsidiariesGuaranteedSeniorSecuredCreditFacility

65.00%

Multiple consolidated interest expense under subcondition two of condition two under dividend restriction

1.75

Amount outstanding under the term loan

$ 663,799,000

679,000,000

Debt issuance cost

34,854,000

33,237,000

Principal amount redeemed

200,000,000

Write off of unamortization of debt issuance cost

2,369,000

Carrying value of long-term debt

1,822,966,000

1,814,572,000

Fair value of long-term debt

1,850,212,000

1,806,276,000

Senior Secured Credit Facility | Term Loan Credit Facility

Debt Instrument [Line Items]

Aggregate principal amount issued

$ 700,000,000

Maturity period

7 years

Percentage of Variable rate added to federal funds effective rate

0.50%

Percentage of variable margin rate added to one month Eurodollar rate

1.00%

Percentage of Variable margin rate added to federal funds effective rate

1.25%

Debt instrument description of interest

A Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 2.25% per annum.

Percentage of variable margin rate added to Eurodollar rate

2.25%

Senior Secured Credit Facility | Revolving Credit Line

Debt Instrument [Line Items]

Aggregate principal amount issued

$ 100,000,000

Maturity period

5 years

Percentage of Variable rate added to federal funds effective rate

0.50%

Debt instrument description of interest

A Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 2.00% to 2.75% per annum.

Senior Secured Credit Facility | Revolving Credit Line | Minimum

Debt Instrument [Line Items]

Percentage of variable margin rate added to one month Eurodollar rate

1.00%

Percentage of variable margin rate added to Eurodollar rate

2.00%

Senior Secured Credit Facility | Revolving Credit Line | Maximum

Debt Instrument [Line Items]

Percentage of variable margin rate added to one month Eurodollar rate

1.75%

Percentage of variable margin rate added to Eurodollar rate

2.75%

Amended Senior Secured Credit Facility

Debt Instrument [Line Items]

Quarterly principal payments due

$ 1,750,000

Last quarterly payment date

Mar. 31, 2022

Remaining principal

$ 635,250,000

Incurred debt issue costs

6,957,000

Loss on debt amendments and refinancing

925,000

Amended senior secured credit facility, dividend that could have distributed

$ 2,390,400,000

Amended Senior Secured Credit Facility | Term Loan Credit Facility

Debt Instrument [Line Items]

Aggregate principal amount issued

$ 700,000,000

Maturity latest date

May 8, 2022

Amount outstanding under the term loan

$ 663,799,000

Average interest rate on outstanding borrowings

3.00%

Amended Senior Secured Credit Facility | Revolving Credit Line

Debt Instrument [Line Items]

Available borrowing capacity

$ 100,000,000

Amount outstanding under the revolving credit line

0

$ 0

Senior Secured Credit Facility Agreement

Debt Instrument [Line Items]

Quarterly principal payments due

$ 1,427,000

Last quarterly payment date

Mar. 31, 2022

Remaining principal

$ 635,250,000

Maturity latest date

May 8, 2022

Incurred debt issue costs

3,515,000

Loss on debt amendments and refinancing

410,000

Pre-payment of term loan

$ 13,451,000

First quarterly payment date

Jun. 30, 2017

Debt instrument, reduction in interest rate

(0.50%)

(0.25%)

4.875 % Senior Notes Due May 2023

Debt Instrument [Line Items]

Aggregate principal amount issued

$ 225,000,000

$ 530,000,000

$ 755,000,000

Interest rate

4.875%

4.875%

4.875%

Debt instrument, maturity date

Jun. 1, 2023

Jun. 1, 2023

Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control

99.00%

Debt issuance cost

$ 3,702,000

Debt issue costs,discount

$ 2,250,000

Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control

101.00%

Debt covenants, required minimum coverage ratio

200.00%

Actual coverage ratio

630.00%

Senior notes indenture, amount that could have distributed

$ 2,261,788,000

Price to repurchase the senior notes as a percentage of principal amount plus a make-whole premium in case of redemption at option of company prior to specific date

100.00%

5.125% Senior Notes Due 2022

Debt Instrument [Line Items]

Aggregate principal amount issued

$ 400,000,000

Interest rate

5.125%

Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control

101.00%

Debt covenants, required minimum coverage ratio

200.00%

Actual coverage ratio

640.00%

Senior notes indenture, amount that could have distributed

$ 2,266,521,000

Price to repurchase the senior notes as a percentage of principal amount plus a make-whole premium in case of redemption at option of company prior to specific date

100.00%

Maturity date

Dec. 15, 2022

Maximum percentage of principal amount of the senior subordinated notes that can be redeemed prior to specific date

35.00%

7.375% Senior Subordinated Notes Due 2021

Debt Instrument [Line Items]

Aggregate principal amount issued

$ 200,000,000

Loss on debt amendments and refinancing

$ 1,222,000

Interest rate

7.375%

7.375%

Principal amount redeemed

$ 200,000,000

Percentage of debt repayment premium

104.00%

Write off of unamortization of debt issuance cost

$ 2,369,000

Early retirement of debt

$ 9,444,000

Long-Term Debt Maturities (Deta

Long-Term Debt Maturities (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Long Term Debt Maturities Repayments Of Principal [Line Items]
2,017	$ 5,671
2,018	7,099
2,019	7,099
2,020	5,710
2,021	5,710
Thereafter	1,791,677
Total	$ 1,822,966	$ 1,814,572

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail)	Dec. 31, 2016USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets at fair value on recurring basis	$ 0
Liabilities at fair value on recurring basis	$ 0

Summary of Assets and Liabiliti

Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015		Dec. 31, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap liabilities - current	[1]		$ (373)
Other Investments		$ 98,317	94,973
Other Affiliates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other Investments		$ 98,317	94,973		$ 77,658	$ 59,657
Other Affiliates | RealD
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other Investments			12,900	[2]	$ 14,429	$ 10,443
Level 1 | Other Affiliates | RealD
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other Investments	[2]		12,900
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap liabilities - current	[1]		$ (373)
[1]	The Company was previously party to an interest rate swap agreement. That agreement expired in April 2016.
[2]	The Company's investment in RealD was sold in March of 2016. See discussion at Note 6.

Reconciliation of Beginning and

Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value on Recurring Basis Unobservable Inputs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balances - Liabilities	$ 373	$ 4,572
Total (gain) loss included in accumulated other comprehensive loss	71	(155)
Settlements	$ (444)	(4,790)
Ending balance - Liabilities		$ 373

Foreign Currency Translation -

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Foreign Currency Translation [Line Items]
Accumulated other comprehensive income (loss)	$ (247,013)	$ (271,686)
Cumulative foreign currency adjustments	$ (247,046)	$ (273,407)

Summary of Impact of Translatin

Summary of Impact of Translating Financial Statements of Certain of Company's International Subsidiaries (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ 26,394	$ (125,512)	$ (68,997)
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate	3.26	3.96	2.69
Other comprehensive Income (Loss)	$ 37,286	$ (74,559)	$ (30,723)
Argentina
Foreign Currency Translation [Line Items]
Exchange Rate	16.04	12.95	8.55
Other comprehensive Income (Loss)	$ (13,362)	$ (30,520)	$ (20,197)
Colombia
Foreign Currency Translation [Line Items]
Exchange Rate	3,000.71	3,149.47	2,392.46
Other comprehensive Income (Loss)	$ 1,278	$ (8,043)	$ (7,632)
Chile
Foreign Currency Translation [Line Items]
Exchange Rate	679.09	709.16	606.2
Other comprehensive Income (Loss)	$ 1,855	$ (6,572)	$ (5,580)
Peru
Foreign Currency Translation [Line Items]
Exchange Rate	3.45	3.46	3.05
Other comprehensive Income (Loss)	$ 87	$ (4,882)	$ (2,785)
Other foreign countries
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	(783)	(898)	(2,066)
Total International Subsidiaries | Cinemark USA, Inc. Stockholder's Equity
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ 26,361	$ (125,474)	$ (68,983)

Non-controlling Interests in Su

Non-controlling Interests in Subsidiaries (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 11,142	$ 11,105
Cinemark Partners II
Noncontrolling Interest [Line Items]
Noncontrolling interests	8,249	7,753
Laredo Theatres
Noncontrolling Interest [Line Items]
Noncontrolling interests	1,695	1,761
Greeley Ltd
Noncontrolling Interest [Line Items]
Noncontrolling interests	689	740
Other
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 509	$ 851

Non-controlling Interests in 79

Non-controlling Interests in Subsidiaries (Parenthetical) (Detail)	Dec. 31, 2016	Dec. 31, 2015
Cinemark Partners II
Noncontrolling Interest [Line Items]
Ownership share	24.60%	24.60%
Laredo Theatres
Noncontrolling Interest [Line Items]
Ownership share	25.00%	25.00%
Greeley Ltd
Noncontrolling Interest [Line Items]
Ownership share	49.00%	49.00%

Noncontrolling Interests in S80

Noncontrolling Interests in Subsidiaries - Additional Information (Detail) $ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2016USD ($)	Dec. 31, 2016USD ($)
Noncontrolling Interest [Line Items]
Percentage of share purchased	25.00%
Purchase of noncontrolling interest	$ 450
Buyout of noncontrolling interests' share of Chilean subsidiary		$ 450
Ownership percentage	100.00%	100.00%
Cinemark USA, Inc. Stockholder's Equity
Noncontrolling Interest [Line Items]
Buyout of noncontrolling interests' share of Chilean subsidiary	$ 27	$ 27
Noncontrolling Interest
Noncontrolling Interest [Line Items]
Buyout of noncontrolling interests' share of Chilean subsidiary	$ 423	$ 423

Summary of Impact of Changes in

Summary of Impact of Changes in Company's Ownership Interests in Subsidiary (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Noncontrolling Interest [Line Items]
Net income attributable to Cinemark USA, Inc.	$ 256,777	$ 218,532	$ 194,380
Net transfers from non-controlling interests	(27)
Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests	256,750	$ 218,532	$ 194,380
Chile
Noncontrolling Interest [Line Items]
Decrease in Cinemark USA, Inc. additional paid-in-capital for the buyout of Flix Impirica non-controlling interest	$ (27)

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Stockholders Equity Note [Line Items]
Preferred stock, shares	1,000,000
Preferred stock, par value	$ 1
Preferred stock, issued	0
Preferred stock, outstanding	0
Stock options outstanding				14,584
Weighted Average Exercise Price				$ 7.63
Number of Options, Exercised			(14,584)
Intrinsic value of options exercised			$ 296
Tax benefit recognized on stock option exercised			$ 124
Class A common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	1,500	1,500
Class B common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	182,648	182,648
Restricted Stock
Stockholders Equity Note [Line Items]
Shares of Restricted Stock, Granted	335,707	226,212	269,774
Weighted average market value on grant dates	$ 30.98	$ 42.79	$ 28.93
Minimum forfeiture rate for restricted stock awards	0.00%
Maximum forfeiture rate for restricted stock awards	10.00%
Unrecognized compensation expense	$ 12,328
Remaining Compensation Expense recognition period (in years)	2 years
Restricted Stock | Cinemark USA Inc
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 11,976
Restricted Stock | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 352
Restricted Stock | Director
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock | Minimum
Stockholders Equity Note [Line Items]
Weighted average market value on grant dates	$ 29.83
Restricted Stock | Minimum | Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock | Maximum
Stockholders Equity Note [Line Items]
Weighted average market value on grant dates	$ 38.47
Restricted Stock | Maximum | Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	4 years
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Weighted average market value on grant dates	$ 29.83	$ 43.19	$ 28.54
Unrecognized compensation expense	$ 6,791
Remaining Compensation Expense recognition period (in years)	2 years
Number of hypothetical shares of common stock	253,661	142,917	197,515
Percentage of IRR expected	11.00%
Number of hypothetical shares of common stock	557,077
Actual cumulative forfeitures (in units)	30,598
Restricted Stock Units (RSUs) | Stock Grants 2016
Stockholders Equity Note [Line Items]
Actual IRR calculated for grant	8.00%
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc. | Stock Grants 2016
Stockholders Equity Note [Line Items]
Stock price at the date of modification	$ 37.98
Incremental compensation expense	$ 562
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc. | Stock Grants 2013 and 2014
Stockholders Equity Note [Line Items]
Stock price at the date of modification		$ 33.02
Incremental compensation expense		$ 2,460
Restricted Stock Units (RSUs) | Minimum
Stockholders Equity Note [Line Items]
Expected forfeiture rate	0.00%
Restricted Stock Units (RSUs) | Maximum
Stockholders Equity Note [Line Items]
Expected forfeiture rate	13.00%

Summary of Restricted Stock Act

Summary of Restricted Stock Activity (Detail) - Restricted Stock - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance	757,775	878,897	1,260,913
Shares of Restricted Stock, Granted	335,707	226,212	269,774
Shares of Restricted Stock, Vested	(430,056)	(329,437)	(625,843)
Shares of Restricted Stock, Forfeited	(56,808)	(17,897)	(25,947)
Shares of Restricted Stock, Ending balance	606,618	757,775	878,897
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning	$ 30.73	$ 24.92	$ 21.86
Weighted Average Grant Date Fair Value, Granted	30.98	42.79	28.93
Weighted Average Grant Date Fair Value, Vested	26.60	23.72	20.53
Weighted Average Grant Date Fair Value, Forfeited	33.81	27.58	22.94
Weighted Average Grant Date Fair Value Outstanding, Ending	$ 33.51	$ 30.73	$ 24.92

Summary of Restricted Stock Awa

Summary of Restricted Stock Award Activity (Detail) - Restricted Stock - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period	[1]	$ 7,269	$ 8,715	$ 8,591
Fair value of restricted shares that vested during the period	[2]	13,739	13,276	17,692
Income tax deduction upon vesting of restricted stock awards	[3]	$ 5,167	$ 3,341	$ 5,171
[1]	Cinemark Holdings, Inc. recorded an additional $943, $885 and $981 of compensation expense related to these restricted stock awards during the years ended December 31, 2014, 2015 and 2016, respectively.
[2]	The fair value of shares in which Cinemark Holdings, Inc.'s directors vested was $1,081, $1,148 and $923 during the years ended December 31, 2014, 2015 and 2016, respectively.
[3]	Cinemark Holdings, Inc. recognized an additional tax benefit of $454, $482 and $388 on these vested awards during the years ended December 31, 2014, 2015 and 2016, respectively.

Summary of Restricted Stock A85

Summary of Restricted Stock Award Activity (Parenthetical) (Detail) - Restricted Stock - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period	[1]	$ 7,269	$ 8,715	$ 8,591
Fair value of restricted shares that vested during the period	[2]	13,739	13,276	17,692
Income tax deduction upon vesting of restricted stock awards	[3]	5,167	3,341	5,171
Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period		981	885	943
Fair value of restricted shares that vested during the period		923	1,148	1,081
Income tax deduction upon vesting of restricted stock awards		$ 388	$ 482	$ 454
[1]	Cinemark Holdings, Inc. recorded an additional $943, $885 and $981 of compensation expense related to these restricted stock awards during the years ended December 31, 2014, 2015 and 2016, respectively.
[2]	The fair value of shares in which Cinemark Holdings, Inc.'s directors vested was $1,081, $1,148 and $923 during the years ended December 31, 2014, 2015 and 2016, respectively.
[3]	Cinemark Holdings, Inc. recognized an additional tax benefit of $454, $482 and $388 on these vested awards during the years ended December 31, 2014, 2015 and 2016, respectively.

Financial Performance Factors a

Financial Performance Factors and Respective Vesting (Detail) - Restricted Stock Units (RSUs)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold IRR	6.00%	7.50%	8.50%
Target IRR	8.00%	9.50%	10.50%
Maximum IRR	10.00%	11.50%	12.50%
Threshold IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold IRR	33.30%
Targeted IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target IRR	66.60%
Maximum IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum IRR	100.00%

Summary of Potential Number of

Summary of Potential Number of Units Vesting under Restricted Stock Unit Awards (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Restricted Stock Unit [Line Items]
at threshold IRR		84,554	47,640	65,832
at target IRR		169,107	95,282	131,683
at maximum IRR		253,661	142,917	197,515
at threshold IRR	[1]	$ 2,522	$ 2,057	$ 1,879
at target IRR	[1]	5,044	4,115	3,758
at maximum IRR	[1]	$ 7,568	$ 6,173	$ 5,637
[1]	The grant date fair values for units issued during the years ended December 31, 2014, 2015, and 2016 were $28.54, $43.19 and $29.83, respectively.

Summary of Potential Number o88

Summary of Potential Number of Units Vesting under Restricted Stock Unit Awards (Parenthetical) (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Restricted Stock Units (RSUs)
Schedule of Restricted Stock Unit [Line Items]
Weighted average market value on grant dates	$ 29.83	$ 43.19	$ 28.54

Summary of Restricted Stock Uni

Summary of Restricted Stock Unit Award Activity (Detail) - Restricted Stock Units (RSUs) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period	213,984	123,769	395,751
Fair value of restricted stock unit awards that vested during the period	$ 7,260	$ 5,483	$ 11,420
Accumulated dividends paid upon vesting of restricted stock unit awards	662	442	1,352
Income tax benefit recognized upon vesting of restricted stock unit awards	3,049	2,303	4,796
Compensation expense recognized during the period	$ 5,144	$ 6,158	$ 3,284

Supplemental Information to Con

Supplemental Information to Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Cash Flow, Supplemental [Line Items]
Cash paid for interest		$ 108,101	$ 105,155	$ 107,926
Cash paid for income taxes, net of refunds received		93,368	108,435	122,972
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[1]	(29,471)	2,491	(1,225)
Theatre properties and equipment acquired under capital lease		33,282	36,544	19,908
Investment in NCM - receipt of common units (see Note 3)		$ 11,111	15,421	$ 8,216
Noncash distributions to Cinemark Holdings, Inc.			(17,935)
Receipt of promissory note related to sale of investment in a Taiwan joint venture			2,634
Other Affiliates | Taiwan Joint Venture
Noncash investing and financing activities:
Receipt of promissory note related to sale of investment in a Taiwan joint venture			$ 2,304
[1]	Additions to theatre properties and equipment included in accounts payable as of December 31, 2015 and 2016 were $11,154 and $40,625, respectively.

Supplemental Information to C91

Supplemental Information to Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Schedule of Cash Flow, Supplemental [Line Items]
Additions to theatre properties and equipment included in accounts payable	$ 40,625	$ 11,154

Income Before Income Taxes (Det

Income Before Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Taxes [Line Items]
Income before income taxes	$ 277,474	$ 262,336	$ 208,377
Income before income taxes	85,890	88,015	84,542
Income before income taxes	363,364	350,351	292,919
Current:
Federal	66,210	72,185	62,686
Foreign	32,047	35,874	27,681
State	12,061	10,806	6,256
Total current expense	110,318	118,865	96,623
Deferred:
Federal	(13,667)	10,420	6,322
Foreign	1,674	(3,339)	(6,437)
State	6,526	4,014	642
Total deferred taxes	(5,467)	11,095	527
Income taxes	$ 104,851	$ 129,960	$ 97,150

Reconciliation between Income T

Reconciliation between Income Tax Expenses (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Taxes [Line Items]
Computed statutory tax expense	$ 127,176	$ 122,623	$ 102,522
Foreign inflation adjustments	(281)	(1,295)	641
State and local income taxes, net of federal income tax impact	12,081	9,640	4,634
Foreign losses not benefited and changes in valuation allowance	(34,757)	(2,408)	(275)
Foreign tax rate differential	(942)	(2,660)	(2,125)
Foreign dividends	68,684	0	1,083
Foreign tax credits	(62,815)	0	0
Sale of Mexican subsidiaries and related changes in intangible assets	0	0	(10,065)
Changes in uncertain tax positions	921	3,717	(1,540)
Other - net	(5,216)	343	2,275
Income taxes	$ 104,851	$ 129,960	$ 97,150

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Tax [Line Items]
Accumulated Undistributed earnings	$ 251,000
Change in valuation allowance	14,524	$ 50,636
Gross unrecognized tax benefits, including interest and penalties	18,190	17,008
Unrecognized tax benefit that if recognized would impact effective tax rate	18,190	17,008
Accrued for interest and penalties	$ 4,111	$ 3,198
Foreign | Minimum
Income Tax [Line Items]
Tax credit carryforwards expiring year	2,015
State and Local Jurisdiction [Member] | Minimum
Income Tax [Line Items]
Net operating losses carried forward expiring period	5 years
State and Local Jurisdiction [Member] | Maximum
Income Tax [Line Items]
Net operating losses carried forward expiring period	20 years
Net operating losses carried forward expiring year	2,036

Net Long- Term Deferred Income

Net Long- Term Deferred Income Tax Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Deferred liabilities:
Theatre properties and equipment	$ 176,781	$ 141,155
Tax impact of items in accumulated other comprehensive loss		158
Intangible asset - other	36,052	28,889
Intangible asset - tradenames	112,747	112,413
Investment in partnerships	107,066	108,733
Total deferred liabilities	432,646	391,348
Deferred assets:
Deferred lease expenses	24,026	26,966
Exchange (gain) loss	(731)	3,736
Deferred revenue - NCM	130,005	128,642
Capital lease obligations	85,721	75,966
Tax loss carryforwards	7,396	7,379
Alternative minimum tax and other credit carryforwards	56,520	41,300
Other expenses, not currently deductible for tax purposes	11,270	20,204
Total deferred assets	314,207	304,193
Net deferred income tax liability before valuation allowance	118,439	87,155
Valuation allowance against deferred assets - non-current	14,524	50,636
Net deferred income tax liability	132,963	137,791
Foreign
Deferred assets:
Net deferred income tax liability	7,571	4,212
U.S.
Deferred assets:
Net deferred income tax liability	$ 125,392	$ 133,579

Reconciliation of Unrecognized

Reconciliation of Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reconciliation of Unrecognized Tax Benefits [Line Items]
Beginning Balance	$ 17,133	$ 16,515	$ 18,780
Gross increases - tax positions in prior periods	13	40	10
Gross decreases - tax positions in prior periods			(2,379)
Gross increases - current period tax positions	923	2,112	1,324
Settlements	(924)	(871)	(963)
Foreign currency translation adjustments	258	(663)	(257)
Ending Balance	$ 17,403	$ 17,133	$ 16,515

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Commitments and Contingencies Disclosure [Line Items]
Liability for deferred lease expenses	$ 42,378	$ 43,333
Employment agreements term extension	1 year
Contribution payments	$ 3,187	$ 3,043
Liability recorded for contribution payments	$ 3,522
Tim Warner
Commitments and Contingencies Disclosure [Line Items]
Employment agreement termination date	Apr. 1, 2016
Minimum
Commitments and Contingencies Disclosure [Line Items]
Operating and capital leases with terms generally ranging	10 years
Maximum
Commitments and Contingencies Disclosure [Line Items]
Operating and capital leases with terms generally ranging	25 years

Rent Expenses (Detail)

Rent Expenses (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Lease and Rental Expense [Line Items]
Fixed rent expense	$ 242,927	$ 240,057	$ 237,891
Contingent rent and other facility lease expenses	78,367	79,704	79,205
Total facility lease expense	$ 321,294	$ 319,761	$ 317,096

Future Minimum Lease Payments (

Future Minimum Lease Payments (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Leases Future Minimum Payments [Line Items]
Future minimum operating lease payments, current	$ 253,824
Future minimum operating lease payments, in two years	231,489
Future minimum operating lease payments, in three years	204,231
Future minimum operating lease payments, in four years	185,508
Future minimum operating lease payments, in five years	163,938
Future minimum operating lease payments, thereafter	641,069
Future minimum operating lease payments, total	1,680,059
Future minimum capital leases payments, current	38,375
Future minimum capital leases payments, in two years	39,104
Future minimum capital leases payments, in three years	38,519
Future minimum capital leases payments, in four years	37,647
Future minimum capital leases payments, in five years	30,636
Future minimum capital leases payments, thereafter	169,425
Future minimum capital leases payments, total	353,706
Amounts representing interest payments	(98,286)
Present value of future minimum payments	255,420
Current portion of capital lease obligations	(21,139)	$ (18,780)
Capital lease obligations, less current portion	$ 234,281	$ 208,952

Selected Financial Information

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Segment Reporting Information [Line Items]
Revenues		$ 2,918,765	$ 2,852,609	$ 2,626,990
Adjusted EBITDA	[1]	707,840	684,581	617,610
Capital expenditures		326,908	331,726	244,705
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		2,230,693	2,137,733	1,934,990
Adjusted EBITDA	[1]	550,150	518,165	457,948
Capital expenditures		242,271	223,213	148,532
Operating Segments | International Operating Segment
Segment Reporting Information [Line Items]
Revenues		701,573	728,735	704,623
Adjusted EBITDA	[1]	157,690	166,416	159,662
Capital expenditures		84,637	108,513	96,173
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (13,501)	$ (13,859)	$ (12,623)
[1]	Distributions from NCM are reported entirely within the U.S. operating segment

Reconciliation of Net Income to

Reconciliation of Net Income to Adjusted EBITDA (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Segment Reporting Information [Line Items]
Net income		$ 258,513	$ 220,391	$ 195,769
Add (deduct):
Income taxes		104,851	129,960	97,150
Interest expense	[1]	108,313	112,741	113,698
Loss on debt amendments and refinancing		13,445	925	0
Other income	[2]	(44,813)	(20,041)	(22,150)
Other cash distributions from equity investees	[3]	21,916	19,027	19,172
Depreciation and amortization		209,071	189,206	175,656
Impairment of long-lived assets		2,836	8,801	6,647
Loss on sale of assets and other		20,459	8,143	15,715
Deferred lease expenses		(990)	(1,806)	2,536
Amortization of long-term prepaid rents		1,826	2,361	1,542
Share based awards compensation expense		12,413	14,873	11,875
Adjusted EBITDA	[4]	$ 707,840	$ 684,581	$ 617,610
[1]	Includes amortization of debt issue costs.
[2]	Includes interest income, foreign currency exchange gain (loss), and equity in income of affiliates and excludes distributions from NCM.
[3]	Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. In an effort to more closely align our reported Adjusted EBITDA with our operating cash flow, which provides our chief operating decision maker with more comprehensive cash flow information, beginning with the year ended December 31, 2016, Adjusted EBITDA now includes total cash distributions received from equity investees, including the cash distributions recorded as a reduction of the respective investment balance. Adjusted EBITDA for the years ended December 31, 2014 and 2015 has been adjusted to reflect comparable presentations.
[4]	Distributions from NCM are reported entirely within the U.S. operating segment

Selected Financial Informati102

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 2,918,765	$ 2,852,609	$ 2,626,990
Theatre properties and equipment-net	1,704,536	1,505,069
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	2,230,693	2,137,733	1,934,990
Theatre properties and equipment-net	1,306,643	1,175,535
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	304,407	291,959	333,919
Theatre properties and equipment-net	197,896	163,505
Reportable Geographical Components | Other foreign countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	397,166	436,776	370,704
Theatre properties and equipment-net	199,997	166,029
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ (13,501)	$ (13,859)	$ (12,623)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	1 Months Ended	12 Months Ended
	Dec. 31, 2016USD ($)	Dec. 31, 2016USD ($)LeasesFacilityTheatre	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Related Party Transaction [Line Items]
Cash dividends paid to Cinemark Holdings, Inc.		$ 124,900,000	$ 115,225,000	$ 115,000,000
Noncash distributions to Cinemark Holdings, Inc.			17,935,000
Receivable from Cinemark Holdings, Inc.	$ 10,080,000	$ 10,080,000	1,171,000
Laredo Theatre, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo		75.00%
Lone Star Theatre's interest in Laredo		25.00%
Ownership interest in Lone Star Theatres held by David Roberts		100.00%
Percentage of common stock held by Chairman of the Board of directors		8.00%
Percentage of management fees based on theatre revenues		5.00%
Maximum amount of theater revenue used to calculate management fees		$ 50,000,000
Percentage of management fees based on theatre revenues in excess		3.00%
Minimum amount of theater revenue used to calculate management fees		$ 50,000,000
Management fee revenues		506,000	567,000	564,000
Copper Beech Capital L L C | Aircraft Time Sharing Agreement
Related Party Transaction [Line Items]
Amount paid for the use of aircraft		$ 110,000	410,000	74,000
Pinstack | Company held an event for employees and their families
Related Party Transaction [Line Items]
Amount paid for an event	$ 70,000
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased | Theatre		14
Number of parking facilities leased | Facility		1
Total number of leases | Leases		15
Number of leases with minimum annual rent | Leases		14
Number of leases without minimum annual rent | Leases		1
Total rent paid to Syufy		$ 21,124,000	$ 20,581,000	$ 21,040,000

Valuation Allowance for Deferre

Valuation Allowance for Deferred Tax Assets (Detail) - Valuation Allowance of Deferred Tax Assets - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016		Dec. 31, 2015	Dec. 31, 2014
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning Balance	$ 50,636		$ 52,873	$ 25,711
Additions	483		437	28,612
Deductions	(36,595)	[1]	(2,674)	(1,450)
Ending Balance	$ 14,524		$ 50,636	$ 52,873
[1]	See Note 14 for discussion of change in valuation allowance during the year ended December 31, 2016.

Condensed Consolidating Fina105

Condensed Consolidating Financial Statement Information of Subsidiary Guarantors - Additional Information (Detail) $ in Thousands	Dec. 31, 2016USD ($)
5.125% Senior Notes Due 2022
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 400,000
Interest rate	5.125%
4.875% Senior Notes Due 2023
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 755,000
Interest rate	4.875%

Condensed Consolidating Balance

Condensed Consolidating Balance Sheet Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$ 561,138	$ 588,503	$ 638,841	$ 599,894
Other current assets	115,075	126,612
Accounts receivable from parent or subsidiaries	10,080	1,171
Total current assets	686,293	716,286
Theatre properties and equipment - net	1,704,536	1,505,069
Other assets	1,925,780	1,906,277
Total assets	4,316,609	4,127,632
Current liabilities
Current portion of long-term debt	5,671	8,405
Current portion of capital lease obligations	21,139	18,780
Accounts payable and accrued expenses	415,992	411,984
Total current liabilities	442,802	439,169
Long-term liabilities
Long-term debt, less current portion	1,782,441	1,772,930
Capital lease obligations, less current portion	234,281	208,952
Other long-term liabilities and deferrals	573,005	593,330
Total long-term liabilities	2,589,727	2,575,212
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	49,543	49,543
Other stockholder's equity	1,223,395	1,052,603
Total Cinemark USA, Inc. stockholder's equity	1,272,938	1,102,146
Noncontrolling interests	11,142	11,105
Total equity	1,284,080	1,113,251	1,136,723	1,104,281
Total liabilities and equity	4,316,609	4,127,632
Eliminations
Current assets
Other current assets	(34,154)	(32,024)
Accounts receivable from parent or subsidiaries	(187,948)	(211,128)
Total current assets	(222,102)	(243,152)
Investment in subsidiaries	(1,703,484)	(1,620,690)
Other assets	(106,359)	(105,994)
Total assets	(2,031,945)	(1,969,836)
Current liabilities
Current portion of long-term debt	(20)
Accounts payable and accrued expenses	(16,457)	(25,396)
Accounts payable to parent or subsidiaries	(187,948)	(211,128)
Total current liabilities	(204,425)	(236,524)
Long-term liabilities
Long-term debt, less current portion	(109,822)	(105,367)
Other long-term liabilities and deferrals	(14,214)	(7,255)
Total long-term liabilities	(124,036)	(112,622)
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	(467,607)	(467,609)
Other stockholder's equity	(1,235,877)	(1,153,081)
Total Cinemark USA, Inc. stockholder's equity	(1,703,484)	(1,620,690)
Total equity	(1,703,484)	(1,620,690)
Total liabilities and equity	(2,031,945)	(1,969,836)
Parent Company
Current assets
Cash and cash equivalents	146,855	141,364	129,505	62,065
Other current assets	62,425	78,797
Accounts receivable from parent or subsidiaries	76,550	212,299
Total current assets	285,830	432,460
Theatre properties and equipment - net	604,506	539,082
Investment in subsidiaries	1,570,592	1,326,790
Other assets	1,409,320	1,402,062
Total assets	3,870,248	3,700,394
Current liabilities
Current portion of long-term debt	4,282	7,000
Current portion of capital lease obligations	7,903	6,426
Accounts payable and accrued expenses	197,789	197,268
Total current liabilities	209,974	210,694
Long-term liabilities
Long-term debt, less current portion	1,879,663	1,868,763
Capital lease obligations, less current portion	124,944	114,513
Other long-term liabilities and deferrals	382,729	404,278
Total long-term liabilities	2,387,336	2,387,554
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	49,543	49,543
Other stockholder's equity	1,223,395	1,052,603
Total Cinemark USA, Inc. stockholder's equity	1,272,938	1,102,146
Total equity	1,272,938	1,102,146
Total liabilities and equity	3,870,248	3,700,394
Subsidiary Guarantors
Current assets
Cash and cash equivalents	281,023	95,865	74,643	175,758
Other current assets	15,098	18,407
Accounts receivable from parent or subsidiaries	121,478
Total current assets	417,599	114,272
Theatre properties and equipment - net	678,984	614,821
Investment in subsidiaries	132,892	293,900
Other assets	134,284	135,022
Total assets	1,363,759	1,158,015
Current liabilities
Current portion of capital lease obligations	9,541	9,962
Accounts payable and accrued expenses	121,640	123,759
Accounts payable to parent or subsidiaries		23,965
Total current liabilities	131,181	157,686
Long-term liabilities
Capital lease obligations, less current portion	71,228	67,440
Other long-term liabilities and deferrals	84,429	77,774
Total long-term liabilities	155,657	145,214
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	457,368	457,369
Other stockholder's equity	619,553	397,746
Total Cinemark USA, Inc. stockholder's equity	1,076,921	855,115
Total equity	1,076,921	855,115
Total liabilities and equity	1,363,759	1,158,015
Subsidiary Non-Guarantors
Current assets
Cash and cash equivalents	133,260	351,274	$ 434,693	$ 362,071
Other current assets	71,706	61,432
Total current assets	204,966	412,706
Theatre properties and equipment - net	421,046	351,166
Other assets	488,535	475,187
Total assets	1,114,547	1,239,059
Current liabilities
Current portion of long-term debt	1,409	1,405
Current portion of capital lease obligations	3,695	2,392
Accounts payable and accrued expenses	113,020	116,353
Accounts payable to parent or subsidiaries	187,948	187,163
Total current liabilities	306,072	307,313
Long-term liabilities
Long-term debt, less current portion	12,600	9,534
Capital lease obligations, less current portion	38,109	26,999
Other long-term liabilities and deferrals	120,061	118,533
Total long-term liabilities	170,770	155,066
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	10,239	10,240
Other stockholder's equity	616,324	755,335
Total Cinemark USA, Inc. stockholder's equity	626,563	765,575
Noncontrolling interests	11,142	11,105
Total equity	637,705	776,680
Total liabilities and equity	$ 1,114,547	$ 1,239,059

Condensed Consolidating Stateme

Condensed Consolidating Statement of Income Information (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues		$ 2,918,765	$ 2,852,609	$ 2,626,990
Cost of operations
Theatre operating expenses		2,120,109	2,066,571	1,914,458
General and administrative expenses		140,637	154,052	148,588
Depreciation and amortization		209,071	189,206	175,656
Impairment of long-lived assets		2,836	8,801	6,647
(Gain) loss on sale of assets and other		20,459	8,143	15,715
Total cost of operations		2,493,112	2,426,773	2,261,064
Operating income		425,653	425,836	365,926
Other income (expense)
Interest expense	[1]	(108,313)	(112,741)	(113,698)
Loss on debt amendments and refinancing		(13,445)	(925)	0
Distributions from NCM		14,656	18,140	18,541
Equity in income of affiliates		31,962	28,126	22,743
Other income (expense)		12,851	(8,085)	(593)
Total other income (expense)		(62,289)	(75,485)	(73,007)
Income before income taxes		363,364	350,351	292,919
Income taxes		104,851	129,960	97,150
Net income		258,513	220,391	195,769
Less: Net income attributable to noncontrolling interests		1,736	1,859	1,389
Net income attributable to Cinemark USA, Inc.		256,777	218,532	194,380
Eliminations
Revenues		(53,147)	(50,242)	(42,596)
Cost of operations
Theatre operating expenses		(53,147)	(50,242)	(42,596)
Total cost of operations		(53,147)	(50,242)	(42,596)
Other income (expense)
Interest expense		1,309	376	29
Equity in income of affiliates		(301,946)	(271,785)	(262,571)
Other income (expense)		(1,309)	(376)	(29)
Total other income (expense)		(301,946)	(271,785)	(262,571)
Income before income taxes		(301,946)	(271,785)	(262,571)
Net income		(301,946)	(271,785)	(262,571)
Net income attributable to Cinemark USA, Inc.		(301,946)	(271,785)	(262,571)
Parent Company
Revenues		1,014,713	959,347	851,299
Cost of operations
Theatre operating expenses		804,041	767,446	693,323
General and administrative expenses		13,085	16,152	17,978
Depreciation and amortization		70,654	59,759	50,858
Impairment of long-lived assets		1,929	6,445	6,334
(Gain) loss on sale of assets and other		5,613	6,191	8,954
Total cost of operations		895,322	855,993	777,447
Operating income		119,391	103,354	73,852
Other income (expense)
Interest expense		(96,442)	(100,608)	(101,224)
Loss on debt amendments and refinancing		(13,445)	(925)
Distributions from NCM		1,414	2,116	2,375
Equity in income of affiliates		245,010	217,567	208,900
Other income (expense)		351	200	79
Total other income (expense)		136,888	118,350	110,130
Income before income taxes		256,279	221,704	183,982
Income taxes		(498)	3,172	(10,398)
Net income		256,777	218,532	194,380
Net income attributable to Cinemark USA, Inc.		256,777	218,532	194,380
Subsidiary Guarantors
Revenues		1,219,218	1,178,873	1,084,852
Cost of operations
Theatre operating expenses		828,905	804,236	739,686
General and administrative expenses		84,453	81,240	74,971
Depreciation and amortization		79,139	73,708	67,460
Impairment of long-lived assets			1,600	313
(Gain) loss on sale of assets and other		13,759	3,728	3,278
Total cost of operations		1,006,256	964,512	885,708
Operating income		212,962	214,361	199,144
Other income (expense)
Interest expense		(7,538)	(8,500)	(9,111)
Equity in income of affiliates		58,528	55,082	53,950
Other income (expense)		19	20
Total other income (expense)		51,009	46,602	44,839
Income before income taxes		263,971	260,963	243,983
Income taxes		52,277	79,131	71,687
Net income		211,694	181,832	172,296
Net income attributable to Cinemark USA, Inc.		211,694	181,832	172,296
Subsidiary Non-Guarantors
Revenues		737,981	764,631	733,435
Cost of operations
Theatre operating expenses		540,310	545,131	524,045
General and administrative expenses		43,099	56,660	55,639
Depreciation and amortization		59,278	55,739	57,338
Impairment of long-lived assets		907	756
(Gain) loss on sale of assets and other		1,087	(1,776)	3,483
Total cost of operations		644,681	656,510	640,505
Operating income		93,300	108,121	92,930
Other income (expense)
Interest expense		(5,642)	(4,009)	(3,392)
Distributions from NCM		13,242	16,024	16,166
Equity in income of affiliates		30,370	27,262	22,464
Other income (expense)		13,790	(7,929)	(643)
Total other income (expense)		51,760	31,348	34,595
Income before income taxes		145,060	139,469	127,525
Income taxes		53,072	47,657	35,861
Net income		91,988	91,812	91,664
Less: Net income attributable to noncontrolling interests		1,736	1,859	1,389
Net income attributable to Cinemark USA, Inc.		$ 90,252	$ 89,953	$ 90,275
[1]	Includes amortization of debt issue costs.

Condensed Consolidating Stat108

Condensed Consolidating Statement of Comprehensive Income (Loss) Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Net income	$ 258,513	$ 220,391	$ 195,769
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	234	2,636	2,846
Unrealized gain (loss) due to fair value adjustments on available-for-sale securities, net of taxes		(957)	2,507
Other comprehensive income (loss) in equity method investments	89	(3,119)	676
Foreign currency translation adjustments	26,394	(125,512)	(68,997)
Total other comprehensive income (loss), net of tax	26,717	(126,952)	(62,968)
Total comprehensive income (loss), net of tax	285,230	93,439	132,801
Comprehensive income attributable to noncontrolling interests	(1,769)	(1,821)	(1,374)
Comprehensive income (loss) attributable to Cinemark USA, Inc.	283,461	91,618	131,427
Eliminations
Net income	(301,946)	(271,785)	(262,571)
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) in equity method investments	(89)	3,086	(643)
Foreign currency translation adjustments	(26,361)	125,474	68,982
Total other comprehensive income (loss), net of tax	(26,450)	128,560	68,339
Total comprehensive income (loss), net of tax	(328,396)	(143,225)	(194,232)
Comprehensive income (loss) attributable to Cinemark USA, Inc.	(328,396)	(143,225)	(194,232)
Parent Company
Net income	256,777	218,532	194,380
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	234	2,636	2,846
Unrealized gain (loss) due to fair value adjustments on available-for-sale securities, net of taxes		(957)	2,507
Other comprehensive income (loss) in equity method investments	89	(3,119)	676
Foreign currency translation adjustments	26,361	(125,474)	(68,982)
Total other comprehensive income (loss), net of tax	26,684	(126,914)	(62,953)
Total comprehensive income (loss), net of tax	283,461	91,618	131,427
Comprehensive income (loss) attributable to Cinemark USA, Inc.	283,461	91,618	131,427
Subsidiary Guarantors
Net income	211,694	181,832	172,296
Other comprehensive income (loss), net of tax
Total comprehensive income (loss), net of tax	211,694	181,832	172,296
Comprehensive income (loss) attributable to Cinemark USA, Inc.	211,694	181,832	172,296
Subsidiary Non-Guarantors
Net income	91,988	91,812	91,664
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) in equity method investments	89	(3,086)	643
Foreign currency translation adjustments	26,394	(125,512)	(68,997)
Total other comprehensive income (loss), net of tax	26,483	(128,598)	(68,354)
Total comprehensive income (loss), net of tax	118,471	(36,786)	23,310
Comprehensive income attributable to noncontrolling interests	(1,769)	(1,821)	(1,374)
Comprehensive income (loss) attributable to Cinemark USA, Inc.	$ 116,702	$ (38,607)	$ 21,936

Condensed Consolidating Stat109

Condensed Consolidating Statement of Comprehensive Income (Loss) Information (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 138	$ 1,562	$ 1,759
Unrealized gain (loss) due to fair value adjustments on available-for-sale securities, taxes	$ 0	$ 572	$ 1,479

Condensed Consolidating Stat110

Condensed Consolidating Statement of Cash Flows Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating activities
Net income	$ 258,513	$ 220,391	$ 195,769
Adjustments to reconcile net income to cash provided by (used for) operating activities	221,232	211,562	202,506
Changes in assets and liabilities	(28,562)	23,272	55,853
Net cash provided by operating activities	451,183	455,225	454,128
Investing activities
Additions to theatre properties and equipment	(326,908)	(331,726)	(244,705)
Acquisition of theatres in the U.S., net of cash acquired	(15,300)		(7,951)
Acquisition of screen advertising business	(1,450)		(1,040)
Proceeds from sale of theatre properties and equipment and other	3,570	9,966	2,545
Proceeds from sale of marketable securities	13,451
Investment in joint ventures and other	(1,132)	(3,711)	(2,188)
Net cash provided by (used for) investing activities	(327,769)	(328,122)	(253,339)
Financing activities
Dividends paid to parent	(124,900)	(115,225)	(115,000)
Proceeds from issuance of Senior Notes, net of discount	222,750
Retirement of Senior Subordinated Notes	(200,000)
Repayments of long-term debt	(16,605)	(8,420)	(9,846)
Payments of debt issue costs	(7,217)	(6,957)
Payments on capital leases	(19,343)	(16,513)	(14,035)
Other	(6,730)	(3,394)	(7,439)
Net cash provided by (used for) financing activities	(152,045)	(150,509)	(146,320)
Effect of exchange rate changes on cash and cash equivalents	1,266	(26,932)	(15,522)
Increase (decrease) in cash and cash equivalents	(27,365)	(50,338)	38,947
Cash and cash equivalents:
Beginning of year	588,503	638,841	599,894
End of year	561,138	588,503	638,841
Brazil Theatre
Investing activities
Acquisition of theatre in Brazil		(2,651)
Eliminations
Operating activities
Net income	(301,946)	(271,785)	(262,571)
Adjustments to reconcile net income to cash provided by (used for) operating activities	301,946	271,785	262,571
Investing activities
Intercompany note issuances	4,455	103,500
Dividends received from subsidiaries	(255,682)	(1,700)	(1,102)
Investments in, and loans to, subsidiaries			1,918
Investment in joint ventures and other		18
Net cash provided by (used for) investing activities	(251,227)	101,818	816
Financing activities
Dividends paid to parent	255,682	1,700	1,102
Intercompany loan proceeds	(4,455)	(103,518)
Capital contributions and loans from parent			(1,918)
Net cash provided by (used for) financing activities	251,227	(101,818)	(816)
Parent Company
Operating activities
Net income	256,777	218,532	194,380
Adjustments to reconcile net income to cash provided by (used for) operating activities	(189,223)	(142,602)	(134,559)
Changes in assets and liabilities	154,085	67,253	232,167
Net cash provided by operating activities	221,639	143,183	291,988
Investing activities
Additions to theatre properties and equipment	(108,439)	(98,193)	(93,608)
Acquisition of theatres in the U.S., net of cash acquired	(15,300)		(7,951)
Proceeds from sale of theatre properties and equipment and other	2,912	2,737	1,109
Proceeds from sale of marketable securities	13,451
Intercompany note issuances	(4,455)	(3,500)
Dividends received from subsidiaries	26,033	1,685	1,094
Investments in, and loans to, subsidiaries			(1,918)
Investment in joint ventures and other	(1,000)	(518)
Net cash provided by (used for) investing activities	(86,798)	(97,789)	(101,274)
Financing activities
Dividends paid to parent	(124,900)	(115,225)	(115,000)
Proceeds from issuance of Senior Notes, net of discount	222,750
Retirement of Senior Subordinated Notes	(200,000)
Repayments of long-term debt	(15,201)	(8,385)	(7,000)
Payments of debt issue costs	(7,217)	(6,957)
Intercompany loan proceeds		100,000
Payments on capital leases	(6,645)	(5,389)	(4,082)
Other	1,863	2,421	2,808
Net cash provided by (used for) financing activities	(129,350)	(33,535)	(123,274)
Increase (decrease) in cash and cash equivalents	5,491	11,859	67,440
Cash and cash equivalents:
Beginning of year	141,364	129,505	62,065
End of year	146,855	141,364	129,505
Subsidiary Guarantors
Operating activities
Net income	211,694	181,832	172,296
Adjustments to reconcile net income to cash provided by (used for) operating activities	55,128	39,156	42,620
Changes in assets and liabilities	(164,005)	(67,850)	(246,598)
Net cash provided by operating activities	102,817	153,138	(31,682)
Investing activities
Additions to theatre properties and equipment	(130,843)	(121,605)	(52,896)
Proceeds from sale of theatre properties and equipment and other	374	5,264	98
Dividends received from subsidiaries	229,649	15	8
Net cash provided by (used for) investing activities	99,180	(116,326)	(52,790)
Financing activities
Dividends paid to parent		(1,700)	(700)
Payments on capital leases	(10,005)	(9,120)	(8,000)
Capital contributions and loans from parent			1,918
Other	(6,834)	(4,770)	(9,861)
Net cash provided by (used for) financing activities	(16,839)	(15,590)	(16,643)
Increase (decrease) in cash and cash equivalents	185,158	21,222	(101,115)
Cash and cash equivalents:
Beginning of year	95,865	74,643	175,758
End of year	281,023	95,865	74,643
Subsidiary Non-Guarantors
Operating activities
Net income	91,988	91,812	91,664
Adjustments to reconcile net income to cash provided by (used for) operating activities	53,381	43,223	31,874
Changes in assets and liabilities	(18,642)	23,869	70,284
Net cash provided by operating activities	126,727	158,904	193,822
Investing activities
Additions to theatre properties and equipment	(87,626)	(111,928)	(98,201)
Acquisition of screen advertising business	(1,450)		(1,040)
Proceeds from sale of theatre properties and equipment and other	284	1,965	1,338
Intercompany note issuances		(100,000)
Investment in joint ventures and other	(132)	(3,211)	(2,188)
Net cash provided by (used for) investing activities	(88,924)	(215,825)	(100,091)
Financing activities
Dividends paid to parent	(255,682)		(402)
Repayments of long-term debt	(1,404)	(35)	(2,846)
Intercompany loan proceeds	4,455	3,518
Payments on capital leases	(2,693)	(2,004)	(1,953)
Other	(1,759)	(1,045)	(386)
Net cash provided by (used for) financing activities	(257,083)	434	(5,587)
Effect of exchange rate changes on cash and cash equivalents	1,266	(26,932)	(15,522)
Increase (decrease) in cash and cash equivalents	(218,014)	(83,419)	72,622
Cash and cash equivalents:
Beginning of year	351,274	434,693	362,071
End of year	$ 133,260	351,274	$ 434,693
Subsidiary Non-Guarantors | Brazil Theatre
Investing activities
Acquisition of theatre in Brazil		$ (2,651)

Supplemental Schedules - Conden

Supplemental Schedules - Condensed Consolidating Balance Sheet (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$ 561,138	$ 588,503	$ 638,841	$ 599,894
Other current assets	125,155
Total current assets	686,293	716,286
Theatre properties and equipment, net	1,704,536	1,505,069
Other assets	1,925,780	1,906,277
Total assets	4,316,609	4,127,632
Current liabilities
Current portion of long-term debt	5,671	8,405
Current portion of capital lease obligations	21,139	18,780
Accounts payable and accrued expenses	415,992	411,984
Total current liabilities	442,802	439,169
Long-term liabilities
Long-term debt, less current portion	1,782,441	1,772,930
Capital lease obligations, less current portion	234,281	208,952
Other long-term liabilities and deferrals	573,005	593,330
Total long-term liabilities	2,589,727	2,575,212
Commitments and contingencies
Equity	1,284,080	1,113,251	$ 1,136,723	$ 1,104,281
Total liabilities and equity	4,316,609	4,127,632
Restricted Subsidiaries
Current assets
Cash and cash equivalents	559,964	394,852
Other current assets	224,298
Total current assets	784,262
Theatre properties and equipment, net	1,704,536
Other assets	1,779,736
Total assets	4,268,534
Current liabilities
Current portion of long-term debt	4,282
Current portion of capital lease obligations	21,139
Accounts payable and accrued expenses	416,677
Total current liabilities	442,098
Long-term liabilities
Long-term debt, less current portion	1,999,663
Capital lease obligations, less current portion	234,281
Other long-term liabilities and deferrals	472,878
Total long-term liabilities	2,706,822
Commitments and contingencies
Equity	1,119,614
Total liabilities and equity	4,268,534
Unrestricted Subsidiaries
Current assets
Cash and cash equivalents	1,174	$ 193,651
Other current assets	(98,405)
Total current assets	(97,231)
Other assets	473,063
Total assets	375,832
Current liabilities
Current portion of long-term debt	1,389
Accounts payable and accrued expenses	53
Total current liabilities	1,442
Long-term liabilities
Long-term debt, less current portion	2,778
Other long-term liabilities and deferrals	100,127
Total long-term liabilities	102,905
Commitments and contingencies
Equity	271,485
Total liabilities and equity	375,832
Eliminations
Current assets
Other current assets	(738)
Total current assets	(738)
Other assets	(327,019)
Total assets	(327,757)
Current liabilities
Accounts payable and accrued expenses	(738)
Total current liabilities	(738)
Long-term liabilities
Long-term debt, less current portion	(220,000)
Total long-term liabilities	(220,000)
Commitments and contingencies
Equity	(107,019)
Total liabilities and equity	$ (327,757)

Supplemental Schedules - Con112

Supplemental Schedules - Condensed Consolidating Statement of Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]
Revenues	$ 2,918,765	$ 2,852,609	$ 2,626,990
Cost of operations
Theatre operating costs	2,120,109	2,066,571	1,914,458
General and administrative expenses	140,637	154,052	148,588
Depreciation and amortization	209,071	189,206	175,656
Impairment of long-lived assets	2,836
Loss on sale of assets and other	20,459	8,143	15,715
Total cost of operations	2,493,112	2,426,773	2,261,064
Operating income (loss)	425,653	425,836	365,926
Other income (expense)	(62,289)	(75,485)	(73,007)
Income before income taxes	363,364	350,351	292,919
Income taxes	104,851	129,960	97,150
Net income	258,513	220,391	195,769
Less: Net income attributable to noncontrolling interests	1,736	1,859	1,389
Net income attributable to Cinemark USA, Inc.	256,777	$ 218,532	$ 194,380
Restricted Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Revenues	2,918,765
Cost of operations
Theatre operating costs	2,120,109
General and administrative expenses	140,634
Depreciation and amortization	209,071
Impairment of long-lived assets	2,836
Loss on sale of assets and other	20,459
Total cost of operations	2,493,109
Operating income (loss)	425,656
Other income (expense)	(106,492)
Income before income taxes	319,164
Income taxes	87,878
Net income	231,286
Less: Net income attributable to noncontrolling interests	1,736
Net income attributable to Cinemark USA, Inc.	229,550
Unrestricted
Cost of operations
General and administrative expenses	3
Total cost of operations	3
Operating income (loss)	(3)
Other income (expense)	44,203
Income before income taxes	44,200
Income taxes	16,973
Net income	27,227
Net income attributable to Cinemark USA, Inc.	$ 27,227

Supplemental Schedules - Con113

Supplemental Schedules - Condensed Consolidating of Comprehensive Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Net income	$ 258,513	$ 220,391	$ 195,769
Other comprehensive income, net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	234	2,636	2,846
Other comprehensive income in equity method investments	89	(3,119)	676
Foreign currency translation adjustments	26,394	(125,512)	(68,997)
Total other comprehensive income (loss), net of tax	26,717	(126,952)	(62,968)
Total comprehensive income, net of tax	285,230	93,439	132,801
Comprehensive income attributable to noncontrolling interests	(1,769)	(1,821)	(1,374)
Comprehensive income attributable to Cinemark USA, Inc.	283,461	$ 91,618	$ 131,427
Restricted Subsidiaries
Net income	231,286
Other comprehensive income, net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	234
Foreign currency translation adjustments	26,394
Total other comprehensive income (loss), net of tax	26,628
Total comprehensive income, net of tax	257,914
Comprehensive income attributable to noncontrolling interests	(1,769)
Comprehensive income attributable to Cinemark USA, Inc.	256,145
Unrestricted Subsidiaries
Net income	27,227
Other comprehensive income, net of tax
Other comprehensive income in equity method investments	89
Total other comprehensive income (loss), net of tax	89
Total comprehensive income, net of tax	27,316
Comprehensive income attributable to Cinemark USA, Inc.	$ 27,316

Supplemental Schedules - Con114

Supplemental Schedules - Condensed Consolidating of Comprehensive Income (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 138	$ 1,562	$ 1,759

Supplemental Schedules - Con115

Supplemental Schedules - Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating activities
Net income	$ 258,513	$ 220,391	$ 195,769
Adjustments to reconcile net income to cash provided by operating activities	221,232	211,562	202,506
Changes in assets and liabilities	(28,562)	23,272	55,853
Net cash provided by operating activities	451,183	455,225	454,128
Investing activities
Additions to theatre properties and equipment and other	(326,908)	(331,726)	(244,705)
Acquisition of theatres in U.S.	(15,300)		(7,951)
Acquisition of screen advertising business	(1,450)		(1,040)
Proceeds from sale of theatre properties and equipment and other	3,570	9,966	2,545
Investment in joint ventures and other	(1,132)	(3,711)	(2,188)
Net cash provided by (used for) investing activities	(327,769)	(328,122)	(253,339)
Financing activities
Dividends paid to parent	(124,900)	(115,225)	(115,000)
Proceeds from issuance of Senior Notes, net of discount	222,750
Retirement of Senior Subordinated Notes	(200,000)
Repayments of long-term debt	(16,605)	(8,420)	(9,846)
Payment of debt issue costs	(7,217)	(6,957)
Payments on capital leases	(19,343)	(16,513)	(14,035)
Other	(6,730)	(3,394)	(7,439)
Net cash provided by (used for) financing activities	(152,045)	(150,509)	(146,320)
Effect of exchange rate changes on cash and cash equivalents	1,266	(26,932)	(15,522)
Increase (decrease) in cash and cash equivalents	(27,365)	(50,338)	38,947
Cash and cash equivalents:
Beginning of year	588,503	638,841	599,894
End of year	561,138	588,503	$ 638,841
Restricted Subsidiaries
Operating activities
Net income	231,286
Adjustments to reconcile net income to cash provided by operating activities	239,502
Changes in assets and liabilities	(49,232)
Net cash provided by operating activities	421,556
Investing activities
Additions to theatre properties and equipment and other	(326,908)
Acquisition of theatres in U.S.	(15,300)
Acquisition of screen advertising business	(1,450)
Proceeds from sale of theatre properties and equipment and other	17,021
Investment in joint ventures and other	(417)
Net cash provided by (used for) investing activities	(327,054)
Financing activities
Dividends paid to parent	(124,900)
Proceeds from issuance of Senior Notes, net of discount	222,750
Retirement of Senior Subordinated Notes	(200,000)
Repayments of long-term debt	(15,216)
Payment of debt issue costs	(7,217)
Intercompany loan proceeds	220,000
Payments on capital leases	(19,343)
Other	(6,730)
Net cash provided by (used for) financing activities	69,344
Effect of exchange rate changes on cash and cash equivalents	1,266
Increase (decrease) in cash and cash equivalents	165,112
Cash and cash equivalents:
Beginning of year	394,852
End of year	559,964	394,852
Unrestricted Subsidiaries
Operating activities
Net income	27,227
Adjustments to reconcile net income to cash provided by operating activities	(18,270)
Changes in assets and liabilities	20,670
Net cash provided by operating activities	29,627
Investing activities
Intercompany note issuances	(220,000)
Investment in joint ventures and other	(715)
Net cash provided by (used for) investing activities	(220,715)
Financing activities
Repayments of long-term debt	(1,389)
Net cash provided by (used for) financing activities	(1,389)
Increase (decrease) in cash and cash equivalents	(192,477)
Cash and cash equivalents:
Beginning of year	193,651
End of year	1,174	$ 193,651
Eliminations
Investing activities
Intercompany note issuances	220,000
Net cash provided by (used for) investing activities	220,000
Financing activities
Intercompany loan proceeds	(220,000)
Net cash provided by (used for) financing activities	$ (220,000)